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Corrigendum 
..... synthesis of the natural product; 
insert Ipc = isopinocampheyl; 
Tf = trifluoromethanesulfonyl . 
(i) the illustrated stereochemistries at C15 in compounds 
2, 4, 6, 9 and 12 should be reversed; (ii) the 
stereochemistry at C14 in compounds 6, 12, 158 and 160 
should also be reversed; 
the bond between the carbonyl carbon and ether oxygen 
within compound 10 should be represented by a solid 
line; 
in the caption replace (-)-IpC2BCl with (-)-Ipc2BCl; 
replace the phrase Under .... underwent a. . . with After 
PMB protection of enol carbamate 47, base treatment led 
to a .... ; 
.... trisubstituted alkene 59.; 
(i) delete 11 l 11 from structure 56; (ii) replace the OH group 
in structures 53, 57 and 58 with OMe; (iii) compound 40 
is prepared by LOA-promoted deprotonation of the 
corresponding protonated sulfone in THF at -80 °C; 
note that PMB protection was performed after the 
hydrolysis/cyclisation step. 
... .led to the .... ; 
PCBOH = p-chlorobenzoic acid (a.k.a. p-CBA); 
structure 88 is missing a second sulfur atom in what 
should be a 1,3-dithiane ring; 
11 
.... and acetic acid substituents attached in a cis fashion. 11 
(i) omit .... the .... ; (ii) in structure 39 the stereochemistry 
of the OH group at C-18 is actually opposite to that 
drawn; 
(i) in the caption replace Nmenonic with Mnemonic; (ii) 
a similar replacement is required at Line 3 up on Page 40; 
the structure of compound 136 is given in Page 61; 
.... (see Figure 3.10)51,52 .... (ie. insert reference 
numbers); 
a partial double bond should be inserted between C-13 
and C-14 in the illustrated transition state structure; 
replace downfield with upfield; 
fluoride 
delete the reagents for step i written to the rhs of vertical 
arrow; 
caption referring to stereochemistry at C-12 should be 
replaced by 91 this stereochemistry established by 
serendipitous epimerisation in a Homer-Wittig coupling 
step" ; 
reagent under arrow near top of page should read 
diethyl (-)-tartrate; 
.... hydroxylamine .... ; 
Reference 47 should be I. Ohtani, T. Kusumi, Y. 
Kashman and H. Kakisawa, J. Am. Che,n. Soc., 1991, 
113, 4092. 
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Abstract 
Herboxidiene (a.k.a. TAN-1609, 1) is a secondary metabolite produced by, inter alia, 
Streptomyces species A7847. The compound was so named because it displays 
exceptional phytotoxicity towards a wide range of broadleaf annual weeds such as oilseed 
rape, wild buck wheat, morning glory and hemp sesbania while being harmless to wheat. 
Structurally speaking, herboxidiene is unlike any previously known phytotoxic 
compound and, as such, must be considered an important lead for the development of 
herbicides with new modes of action . 
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Recently, a group of Japanese researchers revealed that herboxidiene blocks the cell-cycle 
at the G2 phase in human and murine tumour cells by inducing apoptosis while another 
group from the same country have reported that the compound up-regulates the gene 
expression of low-density lipoprotein receptors. On this basis, herboxidiene is of some 
interest as a lead compound for the development of novel agents that could be used in the 
treatment of certain tumours as well as excess levels of cholesterol in blood plasma. 
On the basis of the foregoing, herboxidiene must be regarded as a very important 
synthetic target. The work described in this thesis is concerned with the development of 
an enantio-and diastereo-selective total synthesis of herboxidiene (1). This objective has 
been achieved by virtue of having prepared herboxidiene methyl ester (5), the acquisition 
of which constitutes a formal total synthesis of natural product. 
lV 
The thesis begins (Chapter One) with a commentary on the discovery and biological 
properties of herboxidiene (1). This is followed by brief descriptions of (i) degradation 
and synthetic studies leading to the determination of the structure of herboxidiene, (ii) the 
synthesis of aromatic hybrids of herboxidiene, (iii) the synthesis, by others, of a 
diastereoisomer of herboxidiene known as herboxidiene A, (iv) recent work, again by 
others, on the total synthesis of herboxidiene and, finally, (v) the retrosynthetic analysis 
employed by a previous member of the Banwell group and his attempts at 
implementation. 
Chapter Two details the highly enantio- and diastereo-selective synthesis of the 
herboxidiene core molecule 95 using, as a key synthetic step, an early stage Katsuki-
Sharpless asymmetric epoxidation reaction and, at a later stage, a highly diastereo-
selective intramolecular hetero-Michael addition reaction. 
Ph 10 
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Chapter Three describes the enantio- and diastereo-selective synthesis of the C-12 epimer 
of the herboxidiene side chain molecule 94 by a pathway involving, inter alia , an Ireland-
Claisen rearrangement reaction. 
MeO 
12-epi-94 
Chapter Four details the union of core molecule 95 and side chain aldehyde 12-epi-94 
using a Homer-Wittig reaction. Regio- and diastereo-controlled epoxidation of one of the 
resulting trienes then afforded herboxidiene methyl ester (5), the acquisition of which 
constitutes a formal total synthesis of herboxidiene itself. 
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Glossary 
The following abbreviations have been used throughout this thesis: 
Ac 
a.k. a. 
All 
app. 
APT 
aq. 
atm. 
Bn 
BT 
Bu 
But 
C 
ca. 
cat. 
CI 
cone. 
8 
DDQ 
DEAD 
DIAD 
DIBAL 
DMAD 
DMAP 
DME 
acetyl 
also known as 
allyl 
apparent 
attached proton test 
aqueous 
atmosphere 
benzyl 
benzothiazol-2-y 1 
butyl 
tert-butyl 
concentration (g/100 mL) 
circa (approximately) 
catalyst 
chemical ionisation 
concentrated 
chemical shift (parts per million) 
2,3-dichloro-5 ,6-dicyano-1,4-benzoquinone 
diethyl azodicarboxylate 
diisopropy 1 azodicarboxy late 
diisobutylaluminium hydride 
dimethyl acetylenedicarboxylate 
4-(N,N-dimethylamino )pyridine 
1,2-dimethoxyethane 
Vl 
DMF 
DMP 
DMPU 
DMS 
DMSO 
dr 
ee 
EI 
epz-
Et 
etc. 
(EtC0)20 
eV 
{ lH} 13c NMR 
h 
HMPA 
HPLC 
HRMS 
Hz 
IR 
i-Pr 
J 
KHMDS 
KSAE 
K-Selectride® 
LDA 
lit. 
m-CPBA 
M+· 
N,N-dimeth y lf ormamide 
Dess-Martin periodinane 
N,N'-dimethylpropyleneurea 
dimethyl sulfide 
dimethyl sulfoxide 
diastereomeric ratio 
enantiomeric excess 
electron impact 
epimer 
ethyl 
et cetera (and so on) 
propionic anhydride 
electron volt 
fully proton decoupled 13c nuclear magnetic resonance 
hour(s) 
hexamethylphosphoramide 
high performance liquid chromatography 
high resolution mass spectrum 
hertz 
infrared 
iso-propyl 
coupling constant (Hz) 
potassium hexamethyldisilazide 
Katsuki-Sharpless asymmetric epoxidation 
potassium tri-sec-butylborohydride 
lithium diisopropy lamide 
literature 
m-chloroperbenzoic acid 
molecular ion (mass spectra) 
Vil 
Me 
m.p. 
MS 
MIBE 
MfPA 
mlz 
NMO 
NMR 
Vmax 
ORTEP 
p-CBA 
PCC 
Ph 
PMB 
pyr 
Rf 
Rt 
rt 
TBAF 
TBAl 
TBS orTBDMS 
TBDMSCl 
TBDPSCl 
TBME 
TESCl 
TFA 
Tf 
THF 
THP 
methyl 
melting point (°C) 
mass spectrum 
methyl tert-butyl ether 
a-methoxy-a-trifluoromethylphenylacetic acid 
mass-to-charge ratio 
N-methylmorpholine N-oxide 
nuclear magnetic resonance 
infrared absorption maximum 
Oak Ridge Thermal Ellipsoid plot 
p-chlorobenzoic acid 
pyridinium chlorochromate 
phenyl 
p-methoxybenzy 1 
pyridine 
retardation factor 
retention time 
room temperature 
tetrabutylammonium fluoride 
tetrabutylammonium iodide 
tert-butyldimethylsilyl 
tert-butyldimethylsilyl chloride 
tert-butyldiphenylsilyl chloride 
tert-butylmethyl ether 
triethylsilyl chloride 
trifluoroacetic acid 
trifluoromethane sulfonyl 
tetrahydrofuran 
tetrahydropyran 
Vlll 
1LC 
TMSCl 
p-Ts 
UV 
V 
vzz. 
VO(acac)2 
< 
> 
WHE 
thin layer chromatography 
trimethylsilyl chloride 
para-toluenesulfonyl or tosyl 
ultraviolet 
Volts 
videlicet (namely) 
oxyvanadium (IV) bis-(acetylacetonate) 
less than 
greater than 
Wadsworth-Horner-Emmons 
1X 
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Chapter One 
1. 1 Discovery of Herboxidiene and its Biological Activities 
Micro-organisms have demonstrated a remarkable ability to produce structurally diverse 
secondary metabolites that are toxic to plants (viz. the metabolites are phytotoxic ). Such 
compounds offer the potential for controlling noxious weeds either directly or, indirectly, 
by providing chemists with new structural models for analogue synthesis. Examples of 
microbial metabolites which have been found to be toxic to plants are shown in Table 
1.1 la and listed by II phenotype 11 • 
Table 1.1: Examples of Microbial Metabolites Known to be Phytotoxic 
(Classified by Structure and/or Biosynthetic Origin) 
Shikimate 
Anisomycin 
Chloramphenicol 
Cinnamic acid 
Peptide 
AM-Toxins 
Bialaphos 
Phosalacine 
Tentoxin 
Terpenoid 
Fusicoccin 
Helvolic acid 
Ophio bolin A 
Aminoglycoside 
Kanamycin 
Neomycin 
Streptomycin 
Glutarimide 
Cycloheximide 
Polyketide 
Borrelidin 
Filipin 
Herbimycin 
Herboxidiene 
Nigericin 
Trichothecins 
PM-Toxin B 
Nucleoside 
Blasticidin S 
5'-Deoxyguanosine 
Fomycins A & B 
Herbicidins A & B 
Aminoacid Sugar derivative 
Hadacidin Hydantocidin 
Homoalanosine 
Oxetin 
Phosphinothricin 
Tabtoxinine B-lactam 
Alkaloid 
Fusaric acid 
Victoxinine 
2 
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Screening of compounds produced by microbial fermentation provides one method for 
uncovering novel herbicides and this approach led a group at Monsanto 1 to isolate and 
characterise herboxidiene (1), a secondary metabolite produced by Streptomyces sp. 
A7847. 
OH 
Y8J /ill'-(' ,,,,.15 
MeO 
1 
This polyketide displays exceptional phytotoxicity towards a wide range of broadleaf 
annual weeds such as oilseed rape (Brassica napus), wild buck wheat (Polygonum 
convolvulus), morning glory (lpomoea sp.) and hemp sesbania (Sesbania exaltata) (Table 
1.2). 1 Furthermore, even at high dosage levels (5.6 kg per hectare), it is harmless to 
wheat (Triticum aestivum). 
The phytotoxic properties displayed by herboxidiene are of considerable interest to 
Australian agriculture because this country is one of the world's leading producers of 
wheat. Another attraction of herboxidiene as a potential herbicide is that it is likely to be 
an environmentally friendly one on the expectation that it can be easily decomposed 
within the biosphere. 
3 
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Table 1.2: Phytotoxicity of Herboxidiene (1) 
Applic- Soy Rape Wild Morning Wheat Rice Maize 
ation Buck glory 
Rate bean wheat 
(kg/ha) 
( % Inhibition of Growth) 
5.592 100 100 100 100 0 95 100 
1.118 75 100 100 100 0 75 100 
0.279 60 100 98 99 0 25 100 
0.069 20 98 98 99 0 10 90 
0.017 10 75 75 20 0 10 50 
Note: % inhibition studies were performed using a Plant Green House Assay. Seeds of maize, rice, 
soybean, annual morning glory, wheat, oil seed rape, wild buckwheat and hemp sesbania were placed in 
furrows and covered with soil in aluminium pans. When plants reached the 1 to 3 true leaf growth stage, 
known amounts of herboxidiene (dissolved in acetone) were applied to the foliage at the rates indicated. 
The pans were placed in a green house and maintained at day/night temperatures of 30/21 °C. At 27 to 30 
days after treatment, all pans were rated visually against an untreated control with Oto 100% representing 
no injury and complete plant death, respectively. 
Subsequent to the original reportl that herboxidiene is a potent phytotoxic agent, a group 
of Japanese researchers revealed that it also has the potential to lower the risk of coronary 
heart disease because of its capacity to regulate the level of cholesterol in blood plasma. 2 
In addition, the compound reportedly displays significant anti-tumour activity3,4 which 
derives from its capacity to block the cell cycle at the 02 phase of human and murine 
tumour cells3 by inducing apoptosis. The impressive IC 50 values of herboxidiene against 
different lines of murine and human tumour cells are shown in Table 1.3. 
4 
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Table 1.3: The IC50 Values of Herboxidiene (1) Against Various Murine and Human 
Tumour Cell Lines. 
Cell-Line ICso (ng/ml) 
Murine 
P815 mastocytoma 1.64 
Murine EL4 lymphoma 0.79 
Murine B16 melanoma 1.21 
Human 
Epithelioid carcinoma 2.55 
WiDr colon adenocarcinoma 12.2 
SW 48 colon adenocarcinoma 2.83 
A549 lung carcinoma 13.7 
G361 melanoma 13.3 
On this basis, herboxidiene is of some interest as a lead for the development of new 
agents that could be used in the treatment of certain tumours as well as excess levels of 
cholesterol in blood plasma. 
The diverse range of biological properties of herboxidiene, as delineated above, are 
remarkable for a linear polyketide. This situation prompted efforts by Edmunds' group at 
Novartis-AG (Switzerland) to determine the absolute configuration of herboxidiene5 
through a series of studies involving selective degradation of the natural product, 
asymmetric synthesis of the appropriate fragments and an X-ray analysis of herboxidiene 
itself (see Section 1.2 for details). 
Structurally speaking,5 herboxidiene is unlike any previously known phytotoxic 
compound and, as such, it must be considered an important lead for the developn1ent of 
herbicides with new modes of action. As a result, significant effort has been made to 
develop a comprehensive structure-activity relationship (SAR) for this compound. Much 
of this type of work has been undertaken by the Novartis-AG group. For example, they 
demonstrated that irradiation of herboxidiene leads to loss of activity (because the 
5 
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compound is photolabile) as does hydrogenation of the diene moiety. Further, 
considerable reduction in biological activity is observed when epoxide ring opening 
occurs via intramolecular attack by the 18-hydroxyl group (thereby producing 
tetrahydrofuran 2; see Figure 1.1), while if macrolactonisation occurs by attack of the 18-
hydroxyl group at C-1 then the resulting compound 3 is completely inactive. Further, 
compound 4, which is obtained as one of the products of the reaction of herboxidiene 
with anhydrous acid , does not show any useful biological activity. Interestingly, 
herbicidal activity is not lost when the 18-hydroxyl group is converted into an acetate, 
probably because the acetate cannot cyclise onto the epoxide moiety, the presence of 
which seems essential for activity. Perhaps even more significantly, herboxidiene methyl 
ester (5) is actually more active, as a herbicide at least, than the parent compound 1. 6 
Such SAR results are summarised in Figure 1.2. 
MeO 
. 
.. 
~ 
2 
4 
OMe 3 
OH 0 
Figure 1.1: Derivatives of Herboxidiene which are Biologically Inactive. 
OH 
~,,,,.15 
MeO 
5 
6 
0 
Chapter One 
No significant change in activity 
When R2 is Hor COCH3 
\._ ____ ./ 
V 
( Herboxidiene Side Chain) 
No significant change in activity 
When R1 is Hor CH3 
\. ____ ____ ,) 
V 
( Herboxidiene Core) 
Figure 1.2: Structure-Activity-Relationships within the Herboxidiene Framework. 
(Arrows Show Rearrangement Pathways Leading to Inactive Compounds) 
1. 2 Degradation and Synthetic Studies Leading to the Determination of 
the Structure of Herboxidiene 
The complete structure of herboxidiene was published in 1997 by A. J. F. Edmunds and 
his colleagues5 at Novartis AG, Switzerland. This determination was achieved through, 
inter alia, a combination of selective degradation and chemical correlation studies. One 
sequence of reactions used for the conversion of herboxidiene into simpler fragments is 
outlined in Scheme 1. 1. Thus, in an early step the tetrahydrofuran derivative 2 was 
obtained by the HCl-catalysed intramolecular opening of the epoxide-ring within 1 by the 
18-hydroxyl functionality. Compound 2 was then regioselectively dihydroxylated at the 
less hindered ~ 10, 11 - double bond and the resulting diol subjected to oxidative-cleavage 
to give two fragments, the a, ~-unsaturated aldehyde 7 and the 2,2'-linked bis-
tetrahydropyran 6. Each of these degradation products was reduced to the corresponding 
alcohol, viz. compounds 8 and 9 respectively, under standard conditions. The primary 
alcohol moiety within the latter product was selectively protected and the resulting silyl 
ether was subjected to further oxidative cleavage to form two new degradation products 
namely, lactone 10 and ketone 11. 
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1 lR=H 
a~SR=Me 
H 
OH 
OH 
tb 
2 
c, d 
+ 
HO 
10 
OH 
11 
11 
OR 
OMe 
7 
+e 
OMe 
8 
Scheme 1.1: Degradation Sequences Carried out by Edmunds et az5 in Connection with 
the Elucidation of the Structure of Herboxidiene (1). 
Reagents and conditions: (a) K2CO3/DMF/(MeO)2SO2, 90 °C; (b) HCl/MeOH, 0 °C; (c) N-metbyl 
morpholine N-oxide (NMO)/OsO4/acetone-H2O, rt; (d) NaIO4-fH2O-THF, rt; (e) NaBI4/fHF-MeOH, 0 
°C to rt; (f) TBDPSCl, imidazole, DMAP/DMF, 0 °C to rt; (g) PCC, 4 A molecular sieves/CH2Cl2, 
reflux. 
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In an alternate degradation pathway (Scheme 1.2) carried out by the same group, 
herboxidiene methyl ester (5) was reacted with ozone and thereby afforded keto-ester 13 
together with a very unstable aldehyde that was reduced to the corresponding alcohol 
which underwent spontaneous cyclisation to give the isolable and fully characterised 
tetrahydrofuran derivative 12. 
IH J /i8Y ,,,,J5 
MeO 
5 
~b 
t J = = ✓y·····-~o + 
OMe 
MeO H 
~c 
13 
.. "• r I I 
MeO OH 
12 
Scheme 1.2: Conversion of Herboxidiene Methyl Ester (5) into 
Compounds 12 and 13. 
Reagents and conditions: (a) K2CO3/DMF/(MeO)2SO2, 90 °C; (b) O3/CH2Cl2, -78 °C then DMS; (c) 
NaBI4JMeOH/fHF, rt. 
In order to determine the absolute configuration of herboxidiene both degradation 
products 10 and 13 were the subject of asymmetric synthesis studies. To these ends, the 
enantiomerically pure and readily available (R)-aldehyde 14 (Scheme 1.3) was subjected 
to an aldol condensation with the boron enolate derived from sultam 15. After 0-
methylation of the resulting ~-hydroxy ketone with trimethyloxonium tetrafluoroborate 
9 
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compound 16 was obtained in diastereoisomerically pure form. Deprotection of this last 
compound with 5% HF resulted in direct cyclisation to the target lactone 10. This 
synthetic material proved to be identical, in all respects - including specific rotation, with 
the sample obtained by degradation of herboxidiene. 
TBDMSO /yH 
14 0 
+ 
~
/ II N, 
s 
0 0~ ''o 
15 
~b.-. N 
'\ /'.s~ 
OMe O O'/ "o 
16 
C 
.. 
MeO 
Scheme 1.3: Edmunds/Oppolzer Asymmetric Synthesis of Lactone 10. 
··,,,, 
10 
Reagents and conditions: (a) Et2B(OTf)/(i-Pr)2NEt/compound 15/CH2CI2, -5 °C, 0.5 b then add 14; (b) 
Me3O+BF4-/"proton sponge"/CH2CI2, rt; (c) HF (5%)/CH3CN, rt. 
The synthesis of ketone 13 (Scheme 1.4) began with stereoselective C-methylation of the 
commercially available dimethyl (S)-(-)-malate 17 using a procedure developed by 
Seebach. 7 The resulting product, 18, was reduced and after deprotection the triol 19 was 
obtained. Selective protection of the vic-diol moiety within this last compound was 
successfully carried out by using 3-pentanone in the presence of p-TsOH and the 
remaining free (primary) alcohol moiety within product 19 was converted, by standard 
methods, into the corresponding iodide 20. Reaction of compound 20 with the dianion 
of methyl acetoacetate 21 then afforded the ~-ketoester 22. Subsequent deprotection of 
the last compound led to the formation of the internal and bicyclic acetal 23 which was 
regioselectively cleaved to the desired alcohol 24. This alcohol was then subjected to a 
chain extension sequence involving Swem oxidation, reaction of the resulting aldehyde 
with methyl magnesium bromide and Jones oxidation of the ensuing mixture of 
secondary alcohols which afforded the target ketone 13. Once again, compound 13, as 
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obtained by synthesis, was identical in all respects - including specific rotation, with the 
sample obtained by degradation of herboxidiene. 
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Scheme 1.4: Edmunds/Oppolzer Synthesis of the Tetrahydropyranyl Core, 13, of 
Herboxidiene (1). 
Reagents and conditions: (a) LDA/Mel/THF, -78 °C; (b) p-TsOH, dihydropyran/CH2Cl2, rt; (c) 
LiAll4/Et2O, 0 °C; (d) IR-120/MeOH, rt; (e) p-TsOH/3-pentanone/THF, reflux, then separation by flash 
chromatography; (f) p-TsCl/Pyr, 0 °C to rt; (g) Nal/acetone, reflux; (h) LDA/THF/HMPA/21, 0 °C then 
add 20; (i) p-TsOH/CH2Cl2, reflux; (j) Et3SiH/TiCl4/CH2Cl2 , -78 °C to -25 °C; (k) 
DMSO/(COC1)2/CH2CI2 -78 °C then add 24, Et3N, -78 °C to rt; (1) MeMgBr/Et2O, -78 °C to -40 °C; 
(m) Cr03/H2SO4/acetone, rt. 
Edmunds' group established the relative stereochemistries of the substituents associated 
with the herboxidiene framework by X-ray analysis of crystals of the natural product 
obtained from methylene chloride/methanol. A stereoview of the molecule as observed in 
the solid state is shown in Figure 1.3. 5 
Chapter One 
Figure 1.3: Stereo Drawing of the Solid State Conformation of Herboxidiene (1) as 
Determined by Single-crystal X-ray Analysis. 
1. 3 Synthetically-derived Aromatic Hybrids of Herboxidiene 
12 
The synthesis of simplified aromatic hybrids of herboxidiene (Figure 1.4) has been 
described very recently by Edmunds and his colleagues. 6 In undertaking this work they 
envisaged that replacement of the sensitive (E,E)-diene moiety associated with 
herboxidiene by a phenolic ring, and subsequent attachment of various side chains, via 
the ether linkages to the phenolic oxygen, would provide more stable and structurally 
simpler (and therefore synthetically accessible) analogues of herboxidiene that would still 
retain the biological activity. 
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Figure 1.4: Aromatic Hybrids, 25, of Herboxidiene (1). 
To these ends the synthesis of cis-[6-(3-hydroxyphenyl)tetrahydro-2H-pyran-2-yl]acetic 
acid methyl ester 33 was undertaken and this material was obtained by the route shown 
in Scheme 1.5. The reaction sequence involved, as the key step, intramolecular and 
hetero-Michael addition of a hydroxyl group to a tethered acrylate. Several simple side 
chains were then attached to com pound 33 via the phenolic oxygen and this step was 
followed by straightforward manipulations of the resulting products as shown in Scheme 
1.6. Of the compounds 35-38 produced by this means the last one showed significant 
herbicidal activity, controlling biannual weeds at an application rate of 1 kg hectare-1. 
Although herboxidiene methyl ester is 100% effective at this application rate, 1 b these 
results would never-the-less indicate that the diene moiety of herboxidiene itself can be 
mimicked by a phenolic ring system. 
0 a • MeO ~ Br MeO 
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Scheme 1.5: Synthesis of cis-[6-(3-Hydroxyphenyl)tetrahydro-2H-pyran-2-yl]Acetic 
Acid Methyl Ester (33). 
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Reagents and conditions: (a) (i) Mg, THF, cyclopentanone, rt; (ii) aqueous HCl; (b) pyridinium.HCl, 
neat, 150 °C; (c) TBDMSCl, Et3N, DMAP (cat), CH2Cl2, 0 °C to rt; (d) N-Methylmorpholine N-oxide, 
OsO4 (cat), acetone:H2O (3:1), rt; (e) NaIO4, THF:H2O (4:1), rt; (f) Ph3P=CHCO2Me, THF, rt; (g) 
NaBH4, THF, rt or (h) (-)-IpC2BCl, THF, -25 °C; (i) NaH, THF, rt; (j) 95:5 v/v HF (40% in 
H2O)/CH3CN. 
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Scheme 1.6: Synthesis of Herboxidiene Mimics 35-38. 
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d 
Reagents and conditions : (a) (S)- (CH3)2C=CHCH2CH2CH(CH3)CH2CH2OSO2Me, NaH, DMF, 0 °C 
to rt; (b) AD-mix-~ , 1:1 v/v t-BuOH/H2O, 0°C to rt; (c) Ag2O, Mel, DMF, 50 °C; (d) (3R,4R)-
CH3(CH2)3CH(O)CHCH2CH2OSO2Me, NaH, DMF, 0 °C to rt. 
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1.4 Kocienski 's Synthesis of Herboxidiene A, A Diastereoisomer of 
Herboxidiene 
16 
Kocienski's synthesis of Herboxidiene A (39) (Schemes 1.7, 1.8 and 1.9), which was 
undertaken before the full stereostructure of the natural product had been established by 
Edmunds et al, is worthy of close scrutiny because of the various synthetic problems that 
were encountered and solved. 8 As with its natural congener, herboxidiene A can be 
viewed as being composed of two major sub-structures - a polyketide side chain 40 (C-
11 to C-19) and a tetrahydropyranylacetic acid core 41 (C-1 to C-10). 
TBSO 
OH 
-
MeO 
OMe 
39, 
Li N-- ~ 
s)LS 
~~ 0 0 
Herboxidiene Side Chain 40 
OH 
I C02All 
+ 
9 
Herboxidiene Core 41 
Figure 1.5: Key Disconnection Associated with Kocienski's Synthesis of 
Herboxidiene A (39). 
Kocienski's synthesis of the core 41 began (Scheme 1.7) with preparation of enol 
carbamate 47 via a Hoppe homo-aldol reaction. Thus, the starting crotyl carbamate 44 
was first metallated with BuLi/(-)-sparteine to give a diastereomerically pure complex 
which was then converted into a configurationally stable conjugate with Ti(O-i-Pr)4. This 
· conjugate, 45, was condensed with the aldehyde 43 which could be readily obtained 
from the commercially available ethyl (R)-( + )-lactate 42. The condensation reaction led to 
y C0 2Et a,b • y CHO 
OH OTBS 
42 43 
+ 
M 0 
~ ~ )l 
~O N(i-Prh 
c,dr- 44M =H 
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Scheme 1.7: Kocienski's Synthesis of the Herboxidiene A Core 41. 
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Reagents and conditions : (a) TBSCl, DMAP, imidazole/CH2Cl2, rt, 2 h; (b) DIBAL/toluene-CH2Cl2, 
-80 °C (c) BuLi, (-)-sparteine/cyclohexane-pentane, -80 °C, 3 h; (d) Ti(O-i-Pr)4fpentane, -80 °C, 20 min; 
(e) 43 and 45, -80 °C (1.5 h) to rt (1 h); (f) PMBO-C(=NH)CCl3, TMSOTf/Et2O, rt; (g) t-BuLi/Et2O, 
-20 °C; (h) BuLi/THF, -80 °C then ClCO2Me; (i) H2 (1 atm), Pd-C/EtOAc, rt; (j) DIBAL/CH2Cl2, -80 
°C; (k) (EtO)2P(=O)CH2CO2All, NaH/THF, -10 °C; (1) DDQ/CH2Cl2-H2O, rt; (m) t-BuOK/THF, -65 
°C; (n) TBAF, 4 A molecular sieves/THF, rt; (o) PCC, 4 A molecular sieves/CH2Cl2, rt; (p) 
(EtO)2P(=O)CH2CO2But, NaH/THF, 0 °C to rt; (q) TFA, PhSMe/CH2Cl2; (r) [Me2N=CHCl]Cl/THF-
MeCN then LiAlH(OBut)3. 
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a 1 :7 mixture of two diastereoisomeric adducts, 46 and 47, which could be separated 
chromato graphically. 
Under basic conditions, enol carbamate 47 underwent a Fritsch-Buttenburg-Wiechell 
rearrangement8 to the terminal alkyne 48 which was, in tum, converted into the ester 49 
under standard conditions. Reduction of the last compound with DIBAL gave aldehyde 
50 which was subjected to a Wadsworth-Emmons reaction with allyl 
diethylphosphonoacetate to give the allyl ester 51. Under basic conditions (t-BuOK) 
compound 51 engaged in the pivotal intramolecular and hetero-Michael addition reaction 
to produce the allyl ester of (tetrahydro-2H-pyran-2-yl)acetic acid (52). The latter 
compound was then converted into the key aldehyde 41 by a standard reaction sequence 
involving deprotection, oxidation and olefination reactions. 
As far as Kociensk:i's synthesis of the side chain molecule 40 was concerned (Scheme 
1.8), the key step involved a 1,2-metallate rearrangement which stereoselectively 
transformed the (Z)-enol carbamate derivative of 47 into the trisubstitiuted alkene 59. 
Thus, compound 59 was synthesised via coupling of the enol-carbamate 53 (obtained by 
stannylation of precursor 47) and the homocuprate 56 , which was derived from the 
iodoalkane 55 via lithium-for-halogen exchange. The resulting intermediate, 57, 
underwent the key 1,2-metallation rearrangement to form the alkenylcuprate 58 which 
was then alkylated with methyl iodide to afford the trisubstituted alkene 59. Compound 
55 was obtained from the commercially available (S)-3-hydroxy-2-methylpropionate 
(54) by a previously published and straightforward method. 8 In order to connect the side 
chain to the core, compound 59 was converted into the sulfone-stabilised anion 40 by 
standard means. 
Completion of the synthesis of herboxidiene A (39) (Scheme 1.9) was accomplished via 
a modified one-pot Julia olefination reaction involving coupling of anion 40 with the core 
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aldehyde 41. Product 60 was then stereoselectively epoxidised with tert-
butylhydroperoxide in the presence of VO(acac)2. Subsequent allyl-ester deprotection 
then furnished the target compound, viz. herboxidiene A (39). 
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Scheme 1.8: Kocienski's Synthesis of the Herboxidiene A Side Chain 40. 
Reagents and conditions: (a) 4-Me-2,6-di-t-Bupyr, MeOTf/toluene, 70 °C; (b) t-BuLi/TIIF, -85 °C, rt; (c) 
Me3SnCl, -85 °C, rt; (d) TESCl, DMAP, imidazole/CH2Cl2, rt; (e) DIBAL/toluene, -7 8 °C; (f) I2, 
PPh3, imidazole/CH2Cl2, rt; (g) t-BuLi/Et2O-pentane, -80 °C; (h) CuBr.Me2S, Me2S-THF; (i) 53, -35 
to O °C; (j) Mel, HMPA/THF, -20 °C; (k) HF-pyridine/pyridine-THF, 0 °C to rt, 1 h; Cl) 2-
mercaptobenzothiazole, PPh3 , DEAD/TIIF, rt, 30 min; (m) MoCNH4)6, H2O2/EtOH-H2O, 0 °C to rt 5 
h, rt, 24 h. 
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Scheme 1.9: Final Stages of Kocienski's Synthesis of Herboxidiene A (39): Union of 
the Core 41 and the Side Chain 40. 
Reagents and conditions : (a) THF, -78 °C; (b) HF.pyr/THF-pyridine, rt; (c) VO(acac)2, t-
BuOOH/CH2CI2, 0 °C; (d) Pd(PPh3)4, morpholine/TIIF, rt. 
1. 5 Kocienski 's Total Synthesis of Herboxidiene 
The first total synthesis of herboxidiene (1) was published recently by Kocienski and co-
workers9 and exploits many of the developments made during their synthesis of 
herboxidiene A (see Section 1.4 above). Once again, a key feature was the late stage 
union of an appropriate benzothiazolyl sulfone and aldehyde using a modified Julia 
olefination reaction.10,11 The sequence also incorporates the first synthetic application of 
a new variant of the modified Julia olefination reaction based on the use of 1-phenyl-lH-
tetrazol-5-yl sulfones.12 
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The reaction sequence commenced with cx-methylation of the hex-5-enoyl bomane-10,2-
sultam 61 (Scheme 1.10) which afforded product 6 2 with excellent 
diastereoselectivity.13 Ozonolysis of the latter compound in MeOH-CH2Cl2 yielded a 
mixture of the corresponding aldehyde (minor) and dimethyl acetal (major) after reductive 
work-up and this mixture was converted to the crystalline acetal 63 on treatment with 
2,2-dimethylpropane-1,3-diol in the presence of p-TsOH. The alcohol derived from 
reductive removal of the chiral auxiliary was the most sensitive intermediate in the entire 
synthesis owing to easy acid-catalysed intramolecular trans-acetalisation but with due care 
it could be purified by distillation and then oxidised to the corresponding aldehyde 64. 
Addition of KHMDS to a mixture of sulfone 65 and aldehyde 64 in DME gave, via a 
modified Julia olefination reaction, the alkene 66 with good stereoselectivity (E :Z = 
93:7). A highly stereoselective Sharpless asymmetric dihydroxylation reaction then 
delivered the diol 67 together with small amounts of the other diastereoisomer ( ctr = 
93:7). * After protection of the remaining hydroxy group as its PMB-ether the resulting 
compound 69 was subjected to acid-catalysed hydrolysis with aqueous acetic acid and 
thereby affording a mixture of the anomeric lactols 70. The requisite two-carbon chain 
extension was accomplished using a Wadsworth-Horner-Emmons reaction with allyl 
diethylphosphonoacetate in the presence of caesium carbonate whereupon the intermediate 
unsaturated ester underwent ring closure to give a mixture of two isomeric oxaneacetic 
esters (dr = 2:3) in which the desired isomer, 71, was the minor component. However, 
on treatment with potassium tert-butoxide at -65 °C, the mixture isomerised rapidly and 
efficiently to give the desired isomer 71 as the exclusive product of reaction. The latter 
compound was then converted into the key aldehyde 41 by a series of standard 
transformations involving deprotection, oxidation, and olefination reactions. 
* The identical dr for the last two steps implies there was no racemisation in the Julia olefination 
reaction. 
Chapter One 
,\, 
a 
·•' 
Xc~ O 
b '--- ~~ ~ .,,,, 
.. • 
.• 
0 X"' "O C 
61 62 
Y'~.--' f 0 .•· • Y'~ .••'' • 0 .• '--. /'-. ~ ~ .. ,,\' 
-
-67 -OH 
tg 
1 
R 10 
OR2 
68 R1 =Me R2 =H 
h ~ 69 R 1 = Me: R2 = PMB 
• 
/..,.__ N J\r-N 
HO 
10 
I Xe = 02,5 
// \\__ ~ if --- S O2Et 
I 
Ph 
65 
66 l 64 ~o 
j,k 
• 
OPMB CO2All OR 
70 1 71 R=PMB 
1~72 R=H tm 
1
CO2All 
41 
Scheme 1.10: Kocienski's Synthesis of the C-1 to C-10 Core Fragment 41 of 
Herboxidiene (1) 
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Reagents and conditions: (a) (i) BuLi, THF, -80 °C, 2 h; (ii) Mel, DMPU, -80 °C to rt, 12 h; (b) (i) 03, 
MeOH-CH2Cl2 (1:3), -78 °C, 2 h; (ii) Me2S, -78 °C to rt, 12 h; (iii) 2,2-dimethylpropane-1,3 -diol, p-
TsOH, PhMe, heat, (-H2O), 12 h; (c) LiAlH4, Et2O, rt, 12 h; (d) Pyr.SO3, Et3N, DMSO, rt, 30 rnin; 
(e) sulfone 65 , KHMDS, DME, -60 °C, 45 rnin; (f) AD-mix a, MeSO2NH2, t-BuOH-H2O (2:3), 0 °C, 
18 h; (g) p-TsOH, MeOH, rt, 3d, a: ~ = 3 : 1; (h) (i) KHMDS, TIIF, 0 °C, 20 min; (ii) PMBCl, TBAI, 
0 °C to rt, 24 h; (i) AcOH-THF-H2 0 (3 : 2 : 2), 65 °C, 2 h, a : ~ = 3 :2; (j) allyl diethyl 
phosphonoacetate, Cs2CO3, THF, heat, 18 h; (k) t-BuOK, TIIF, -65 °C, 10 rnin, pure cis isomer; (1) 
DDQ, 1: 15 v/v H2O/CH2Cl2, rt, 30 rnin; (m) 4 steps (see ref.10). 
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As far as Kocienski1s synthesis of the herboxidiene side chain (C-11 to C-19) was 
concerned (Scheme 1.11), the reaction sequence commenced with a highly stereoselective 
boron-mediated aldol reaction between propionyl sultam 73 and the (S)-aldehyde 74 so 
as to obtain the aldol product 75. O-Methylation of the compound 75 was achieved by 
using a combination of proton sponge [1,8-bis(dimethylamino)naphthalene] and methyl 
triflate. This conversion was achieved without complications arising from intervention of 
a retroaldolisation process. Reductive removal of the chiral auxiliary gave the alcohol 77 
which was oxidised to aldehyde 78 using the Dess-Martin periodinane. Reaction of this 
aldehyde with isopropenyl magnesium bromide gave a mixture of allylic alcohols (syn 
:anti = 57 :43) which was immediately oxidised to en one 79, once again using Dess-
Martin periodinane. Compound 79 was reduced with LiAlH4 at -100 °C in the presence 
of lithium iodide to afford a diastereoisomeric mixture of alcohol 80 and its C-15 epimer 
( dr = 85: 15) which could be separated using a combination of fractional crystallisation 
and chromatographic techniques. Compound 80 was then converted into the propionate 
ester 81 under standard conditions. The remainder of the side chain synthesis then 
exploited ideas published from these laboratories 14 which involved the Ireland-Claisen 
rearrangement15 as one of the key steps to introduce the C-14 to C-15 trisubstituted 
alkene along \Vith the methyl group at C-12. Rearrangement followed by acid hydrolysis 
of the intermediate silyl esters lead to the formation of a diastereoisomeric mixture of 
carboxylic acids. After reduction to the corresponding alcohols, the diastereoisomers 
\Vere easily separated by flash chromatography and the major isomer, 82 was subj ected 
to a Mitsunobu reaction with 2-mercaptobenzothiazolel6 to give the thioether 83 in good 
yield. The reactivity of an unsaturated alcohol toward VO(acac)2-catalysed epoxidation 
depends on the proximity of the hydroxy group to the alkene.17 In fact, this type of 
oxidation of bis-homoallylic alcohol 84 proved to be extremely slow at sub-ambient 
temperatures and at low catalyst loadings. In addition, when the epoxidation was 
conducted in toluene at 60 °C [3 mol% VO(acac)2, 1.5 equiv. tert-butylhydroperoxide 
TBI-IP)] ring-closure of the product epoxide to a tetrahydrofuran (cf. Scheme 1.1) \Vas 
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Scheme 1.11: Kocienski's Synthesis of the C-11 to C-19 Side Chain Fragment 86 
Associated with Herboxidiene (1). 
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Reagents and conditions: (a) (i) Et2BOTf, CH2CI2, -5 °C; (ii) i-Pr2NEt, 30 min; (iii) 74, -78 °C, 3 h; 
(b) MeOTf, proton sponge, PhMe, 80 °C, 24 h; (c) LiAlH4, Et2O, 0 °C, 15 min; (d) Dess-Martin 
periodinane, CH2CI2, 0 °C to rt, 2 h; (e) (i) CH2=C(Me)MgBr, Et2O, 0 °C, 1 h; (ii) DMP, CH2CI2, rt, 
4 h; (f) LiAlll4, Lil, Et2O, -100 °C, 1 h; (g) (EtCO)2O, DMAP, pyridine, rt, 16 h; (h) (i) LDA, THF, 
-78 °C, 30 min; (ii) TBSCl, DMPU; (iii) -78 °C"""7b., 1 h; (iv) aq. HCl; (i) LiAlH4, Et2O, 0 °C, 10 min; 
(j) BTSH, Ph3P, DIAD, THF, 0 °C to rt, 2 h; (k) TBAF.3H2O, THF, rt, 32 h; (1) Mo(vi), H2O2, H2O-
EtOH, rt, 24 h; (m) VO(acac)2, TBHP, CH2Cl2, -8 °C, 72 h; (n) (i) Ph3P, DMAD, THF, 0 °C; (ii) 
PCBOH, 0 °C to rt, 3 h. 
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observed. Alternatively the reaction could be accelerated at O °C if repeated portions of 
catalyst were added but then acetate derivatives of the product 85 and starting material 84 
were also formed. The most effective directed epoxidation process involved using just 1 
mole % of catalyst and with a cold (-8 °C) solution of the olefin 84 in CH2Cl2 being 
treated with TBHP that was added via syringe pump over a period of 48 h. After the 
addition was complete, the reaction mixture was allowed to stand for a further 24 h 
whereupon the oxirane 85 was obtained completely diastereoselectively and in 69% 
yield. However, 26% of the starting material 84 was also recovered thus serving to 
emphasise the difficulties associated with this type of directed epoxidation reaction. 
Subsequent inversion of the stereo genie centre at C-18 and the protection of the resultant 
hydroxy group furnished the target side chain molecule 86. 
Completion of the synthesis of herboxidiene (Scheme 1.12) was accomplished via a one-
pot Julia reaction involving coupling of sulfone 86 with the core aldehyde 41. In the final 
step, hydrolysis of the resulting herboxidiene methyl ester (5) with potassium carbonate 
in aqueous methanol gave the target compound, viz. herboxidiene (1). Comparison of the 
1 Hand 13c NMR spectroscopic data for synthetic herboxidiene with the data for the 
natural material reported by Isaacla revealed significant discrepancies in the C-1 to C-3 
region. However, the sodium salt of the synthetic material (prepared by treatment with 
Na2CO3 in CD3OD) provided lH and 13c NMR data in complete agreement with those 
reported by Isaac. Therefore, the original NMR data reported le for natural herboxidiene 
likely pertains to a carboxylate salt derivative rather than the free acid. 
The second Julia-type coupling reaction Kocienski used in his work (Scheme 1.12) 
allows for creation of the correct (£,£)-geometry about the 118 ,9_ and 1110,1 l _double-
bonds in target 1. Further, Kocienski's work has shown that, variation of the 
heterocyclic sulfone can be used to optimise the yield and stereoselectivity of this type of 
olefination reaction. The benzo-thiazolyl sulfone unit is superior for the construction of 
the conjugated (E,E)-diene moiety whereas a l-phenyl-lH-tetrazol-5-yl sulfone gave high 
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Scheme 1.12: Completion of Kocienski's Synthesis of Herboxidiene - Union of Core 
41 and Side Chain 86. 
Reagents and conditions: (a) (i) LDA, THF, -78 °C, 15 min; (ii) 41, -78 °C to -20 °C, 1.5 h; (b) 
K2CO3, MeOH, /1, 2 h; (c) K2CO3, H2O-MeOH (1 : 4), /1, 1 h. 
yields and trans-selectivity in the construction of a simple alkene. A detailed study of 100 
examples revealed some important limitations to the method 10, 11 including (i) the fact 
that high stereoselectivities are only obtained in special cases (e.g. when the fom1ation of 
conjugated dienes are involved) and, (ii) some lithiated benzothiazolyl sulfones are 
unstable and undergo self-condensation, even at low temperatures. Interestingly, 
application of the Julia olefination reaction to the synthesis of the conjugated triene 
segment of rapamycin61 (Scheme 1.13) showed that high efficiency and good 
stereoselectivity can be secured by varying the base and the solvent, with best results 
being obtained using LiHMDS in a non-polar solvent. Thus, under such reaction 
conditions the appropriate sulfone was selectively deprotonated and the resultant anion, 
89, underwent reversible addition to the aldehyde. The adduct 90 thus obtained then 
cyclised via addition of the alkoxy anion onto the C=N bond of the benzothiazole unit 
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thereby leading to spirocycle 91, the fragmentation of which was accompanied by loss of 
S02 as well as the lithium derivative of benzothiazolone so as to give the alkenes 92 and 
93 in a 19: 1 ratio. 
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Scheme 1.13: An Example of a One-pot Julia Olefination Reaction as Used in the 
Synthesis of the Rapamycin Fragment 92. 
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1. 6 Objectives of the Work Detailed in this Thesis 
In 1993, in collaboration with Dunlena Pty Ltd, Banwell and Bui, initially located at the 
University of Melbourne and subsequently at the Australian National University, 
embarked on a program aimed at developing an enantio- and diastereo-selective total 
synthesis of herboxidiene. The retrosynthetic analysis employed in their work and 
attempts at implementation are discussed at this point because they have a strong bearing 
on the work described in the subsequent chapters of this thesis. It should be noted that 
Banwell and Bui's work was commenced in 1994 well before the Kocienski syntheses of 
herboxidiene A and herboxidiene were reported and well before Edmunds et al had 
determined the full stereo-structure of herboxidiene. 
Banwell and Bui envisaged that herboxidiene (1) would be disconnected, in the first 
instance, at the C-1 0/C-11 double bond (Scheme 1.14) so as to create the two sub-
targets, 94 and 95. The core sub-structure 95 contains the tetrahydropyranyl ring with 
phosphine oxide and acetic acid side chains attached at the opposing anomeric carbons of 
the six-membered ring. 
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Scheme 1.14: Banwell and Bui's Retrosynthetic Analysis of Herboxidiene (1). 
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Further disconnection at the remaining double-bond within synthon 95 gives rise to the 
ketone 13 which was chosen as the initial synthetic target partly because this material had 
been obtained during the original degradation work carried out on herboxidiene. 
Compound 94, which has been called the herboxidiene side chain, is a polyketide based 
entity containing four centres of asymmetry and it was envisaged that the aldehyde moiety 
within this syn th on could be used for connection to the phosphine oxide 95 under 
standard Horner-Wittig coupling conditions. This approach is reminiscent of that 
undertaken by both the Nicolaou18 and Ley19 groups in their total syntheses of the 
ionophore antibiotic indanomycin (a.k.a. X-14547 A). 
---
-=:.. __ H 
C02H 
·•,,,, 
,\,, . .. 
Indanomycin (a.k.a. X-14547A) 
While the Homer-Wittig reaction between compounds 94 and 95 would create a triene 
product, it was anticipated that the C-18 hydroxyl group could be exploited in a directed 
and stereocontrolled epoxidation of the ~ 14, 15 -double-bond so as to generate 
herboxidiene methyl ester (5) and thereby establishing the full assembly of atoms 
associated with the target 1. Subsequent saponification of the methyl ester moiety at C-1 
within compound 5 would then be expected to deliver herboxidiene itself. 
A completely diastereoselective synthesis of tetrahydropyran 13 is shown in Scheme 
1.15 and was achieved by Bui in these laboratories. 20 The reaction sequence began with 
the Katsuki-Sharpless asymmetric epoxidation (KSAE)21 of nerol (97) using diethyl D-
C-)-tartrate as the chiral ligand. The resulting epoxide 98 was subjected to reductive-
cleavage22,23 with NaCNBH3-BF3-diethyl ether and the ensuing diol 99 (73%) then 
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Scheme 1.15: Enantioselective Route from Nerol (97) to Phosphine Oxide 95. 
Reagents and conditions: (a) KSAE, diethyl D-(-)-tartrate/CH2Cl2; (b) NaBH3CN, BF3.0Et2/THF; (c) 
Ac20, DMAP (trace)/pyridine, 18 °C; (d) 03/CH2Cl2, -78 °C then PPh3; (e) 
Me02CCH2P(O)(OCH2CF3)2, l8-crown-6/CH3CN-complex, KHMDS/THF, -78 °C; (f) 
K2C03/MeOH, rt, then MeOH, H2S04 (trace), rt; (g) PCC, NaOAc/CH2CI2, 18 °C; (h) MeMgCl/rHF, 
0 °C; (i) PCC, NaOAc/CH2CI2, 18 ° C; (j) H2C=C(H)MgBr/THF, -78 °C; (k) PBr3/Et20, 0 °C; (1) 
Ph2POEt/THF, reflux, 2 h. 
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converted into the corresponding diacetate 100 (96%) under standard conditions. 
Ozonolytic cleavage of this last compound furnished the aldehyde 101 (97%) which was 
immediately subjected to Still's modification of the Wadsworth-Emmons olefination 
reaction thereby ensuring almost exclusive formation of the (Z)-unsaturated ester 102 
(78% ). Treatment of acrylate 102 with potassium carbonate in methanol resulted in 
sequential acetate hydrolysis and intramolecular hetero-Michael addition to give 
tetrahydropyran 24 (88% ). Oxidation of the alcohol 24, using PCC, then gave aldehyde 
103 (51 % ) which was immediately reacted with methylmagnesium chloride. Oxidation of 
the resulting mixture of diastereoisomeric diols 104 (77% ), again using PCC, finally 
gave the target compound 13 in 51 % yield. 
The synthetically derived ketone 13 was reacted with vinylmagnesium bromide and in 
this manner a diastereoisomerically pure allylic alcohol 105 was obtained, albeit in only 
50% yield because of the competing formation of the bis-vinylated material arising from 
attack of the Grignard reagent at the C-1 ester moiety. Treatment of the intermediate 3 °-
alcohol (the only observed mono-vinylated material) with phosphorous tribromide in 
ether at O °C afforded the rearranged allylic bromide 106 (91 % ). Reaction of the latter 
compound with diphenylethoxyphosphine in refluxing THF resulted in a Michaelis-
Arbuzov reaction and formation of the phosphine oxide 95 (84%) which was obtained as 
a crystalline solid. 
While the reaction sequence just described proceeds with high levels of diastereo-control, 
the initial KSAE of nerol (97) only proceeds in ca. 50 % ee with the result that phosphine 
oxide 95 is only obtained with the same level of enantiomeric enrichment. However, 
since compound 95 is a crystalline material the ee can be raised to >98% by repeated 
recrystallisation although the attendant loss of material is severe. 
When the initial synthetic approaches to herboxidiene were undertaken by Bui and 
Banwell, many of the stereochemical features associated with the target molecule had not 
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been fully elucidated. In particular, there were ambiguities with respect to the relative 
stereochemistries at C-12, C-16, C-17 and C-18. Furthermore, the absolute 
stereochemistry of this compound had not been determined. Nevertheless, extensive 
efforts to develop an approach to the herboxidiene side chain were undertaken and these 
led to the construction of the aldehyde 122 by the route shown in Scheme 1.16. The 
synthesis began with commercially available methyl (R)-3-hydroxy-2-methylpropionate 
107 which was converted into the corresponding benzyl ether 108 (73%) under 
conditions which avoid racemisation. 40 Ester 108 was then reduced, by standard 
methods, to the corresponding alcohol 109 (85%) and this was, in turn, subjected to 
Swern oxidation to obtain the aldehyde 110 (80% ), a molecule notoriously prone to 
racemisation. 63 Nucleophilic addition of vinylmagnesium bromide to this last compound 
produced a 1: 1 mixture of diastereomeric addition products (70% combined yield) which 
could be separated from one another by flash chromatography. The more polar material 
proved to be compound 111 which was subjected to O-methylation using potassium 
hydride and methyl iodide. In this manner the bis-ether 112 was obtained in (94%) and 
immediately subjected to ozonolytic cleavage thereby affording compound 113 (92% ). 
Reaction of aldehyde 113 with methylmagnesium chloride provided a 4: 1 mixture of 
compound 114 and its C-18 epimer (herboxidiene numbering) (96% combined yield) 
which could only be separated from one another by HPLC techniques. It was more 
convenient, therefore, to convert this mixture into the corresponding te rt-
butyldimethylsilyl ethers, 115 and 18-epi-115 (93% combined yield) and these were 
then hydrogenolysed to give the corresponding mixture of alcohols 116 and 18-epi-116 
(97% combined yield) that could be readily separated by flash chromatography. 
Oxidation of alcohol 116 with the Swern reagent provided the corresponding aldehyde 
117 which was then reacted with isopropenyl cupratel5,50 to give allylic alcohol 118 
(83 % ) as the only detectable product of reaction. For the purposes of unequivocal 
characterisation, compound 118 was desilylated and the structure of the resulting 
crystalline diol was determined by single-crystal X-ray anlysis. 
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Scheme 1.16: Bui's Synthesis of an Isomer, 122, of the Herboxidiene Side Chain. 
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Reagents and conditions: (a) BnOC(NH)CCI3, CF3SO3H (cat.)/CH2CI2, 0 to 18 °C; (b) LiA1H4J'Et2O, 
0-5 °C; (c) Me2SO, CI(CO)2Cl/CH2CI2, -60 °C then NEt3; (d) CH2=C(H)MgBr/THF, 0 °C; (e) Mel, 
KH/fHF, 0 to 18 °C; (f) O3/CH2Cl2, -78 °C then Me2S; (g) MeMgCl/THF, -78 °C; (h) TBDMSCI, 
imidazole/DMF, 60 °C; (i) H2 (1 atm), 10% Pd on C/EtOH, rt; U) Me2SO, Cl(CO)2Cl/CH2CI2, -60 °C 
then NEt3; (k) H2C=C(Me)Br, t-BuLi, CuBr.DMS/Et2O, -78 °C; (1) (EtCO)2O, DMAP, pyridine, rt; (m) 
KN(TMS)2/THF, then TMSCl-Et3N, HMPA then heat at 45 °C; (n) LiA1H4ffit2O, 0 °C; (o) Me2SO, 
Cl(CO)2CI/CH2CI2, -60 °C then NEt3. 
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Completion of the synthesis of the aldehyde 122 involved conversion of alcohol 118 
into the corresponding propionate 119 (82%) which was, in turn, subjected to an 
Ireland-Claisen rearrangement SO by sequential treatment with KHMDS and TMSCl-NEt3 
then heating the resulting (Z)-silyl ketene acetal at 45 °C. In this manner the y, 8-
unsaturated carboxylic acid 120 (80%) was obtained. Reduction of the acid 120 to the 
corresponding alcohol 121 (83%) was achieved with LiAlH4 and the latter compound 
was then oxidised to the required aldehyde 122 (94%) using the Swem reagent. 
Bui connected the side chain aldehyde 122 to the core fragment 95 using a WHE-type 
condensation and obtained a 4: 1 mixture of the (E,E) and (£,Z)-dienes, 123 , 124 
respectively, in a combined yield of 70 % (Scheme 1.17). The major product, 123, could 
be purified by HPLC and the spectroscopic data obtained on this material were in accord 
with the assigned structure. Unfortunately, Bui did not have enough time or material to 
selectively epoxidise compound 123 so as to generate the corresponding herboxidiene 
methyl ester analogue. 
OMe 
TBDMSO 
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95 CO2Me 
+ 124 (10,11-Z-isomer) 
Scheme 1.17: Chin Bui's Synthesis of De-epoxy TBDMS-protected iso-Herboxidiene 
123. 
Reagents and conditions: (a) NaH/fHF, 18 °C to 60 °C then CH2N2/Et2O, -20 °C. 
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While Bui's work represents a ground breaking effort to assemble herboxidiene-like 
compounds there are some significant drawbacks to his methodology that require 
attention before a useful synthesis of target 1 can be attained. The first deficiency of the 
Bui's work is associated with construction of the core phosphine oxide 95 since this 
pivotal molecule is only obtained in ca 50% ee because of the low levels of 
enantioselectivity associated with the initial Katsuki-Sharpless asymmetric epoxidation 
(KSAE) of nerol. The second major deficiency derives from the lack of diastereo-control 
associated with many of the steps involved in assembling of the side chain molecule 122 
as well as the fact that this compound does not have the required stereochemistry at C-12 
and C-16 for incorporation into herboxidiene itself. 
At the time initial studies (both here and overseas) directed toward the total synthesis of 
herboxidiene were commenced neither the complete relative nor absolute 
stereochemistries of herboxidiene were known. Hence, Kocienski's earlier work 
culminated in the preparation of herboxidiene A 39, a diastereoisomer of 1 differing from 
the natural product at C-12, C-17 and C-18.8 In parallel work, in these laboratories 
Chinh Bui produced de-epoxy TBDMS-protected iso-herboxidiene 123. 
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It is against this background that the work described in this thesis was undertaken. The 
primary objective was the development of an enantio- and diastereo-selective total 
synthesis of herboxidiene proper. This could be contemplated as a realistic objective 
because at the time of commencement of this project Edmunds et al had finally established 
the full stereo-structure of the target molecule 1 (see pages 7-12). 
The objectives of the work described in this thesis, then, were to address the above-
mentioned deficiencies in the Bui work and, thereby, achieve a diastereo- and enantio-
selective total synthesis of herboxidiene. The research detailed in the following chapter 
(Chapter Two) was directed toward the development of a highly enantio-selective 
synthesis of phosphine oxide 95, while the research described in Chapter Three has 
culminated in construction of the side chain aldehyde 12-epi-94. 
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C02Me 12-epi-94 
The penultimate Chapter (Four) details the union of these two compounds via Homer-
Wittig chemistry and elaboration of one of the resulting products to herboxidiene methyl 
ester (5), the acquisition of which constitutes a formal total synthesis of herboxidiene 
itself. 
The Final Chapter (Five) provides full experimental details associated with the claims 
made in Chapter Two, Three and Four. 
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Chapter Two 
2. 1 Preparation and Katsuki-Sharpless Asymmetric Epoxidation of 
Allylic Alcohol 127. Formation of Epoxy-alcohol 128 
38 
As noted in the introduction, the initial objective of the work described herein was to 
establish a highly enantioselective route to the pivotal herboxidiene core molecule 95. The 
pivotal step was to involve asymmetric epoxidation of an appropriate allylic alcohol so a 
brief commentary on this type of oxidation reaction is now provided. 
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/ P. 
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Ph 
95 CO2Me 
The asymmetric epoxidation of allylic alcohols using t-butyl hydroperoxide in the 
presence of titanium tetraisopropoxide and a chiral dialkyl tartrate is now described as the 
Katsuki-Sharpless asymmetric epoxidation (KSAE) reaction and this process follows a 
pathway that frequently allows for high optical induction (>90% ee)_24 The major two 
advantages of this enantioselective oxidation reaction are (i) the reaction gives uniformly 
high asymmetric induction for a wide range of primary allylic alcohols and (ii) the 
reaction proceeds in a highly predictable fashion in terms of which enantiomeric form of 
the product is obtained (Figure 2.1). 
[0] D-(-)-DET _ _,,___ 0 
R2 R3~R1 I 
• R2-~ 
~Rl OH 
R3~ 
Ti(O-i-Pr)4 / t-BuOOH, 
f OH 
[0] L-(+)-DET 
CH2Cl2, -20 °C 
2 R1 
• R3~0H 
0 
Figure 2.1: Nmenonic Used in Determining the Absolute Stereochemistry of the 
Epoxidation Product Derived from KSAE of Allylic Alcohols. 
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In contrast to the situation with (Z)-1,2,2,-trisubstituted alkenes (e.g. nerol), the KSAE 
of allylic alcohols proceeds in high ee when (E)-1,2-disubstituted alkenes are employed 
as substrates. 24 Consequently, the allylic alcohol 127 (Scheme 2.1) was chosen as the 
substrate for KSAE on the basis that the product epoxide 128 would be obtained in high 
ee. In addition, it was anticipated that nucleophilic methylation of the latter compound 
could be achieved in both a regio- and diastereo-selective manner so as to produce diol 
130 containing the methyl group required at C-6 (herboxidiene numbering) in the target 
molecule 95. 
HO~ i • EtO 
11 • 
125 O 126 
OH 
130 
127 
iili 
0 
RO~_ .. ,,,~ 
128R=H 
iv C: 129 R = (R)-MTPA 
Scheme 2.1: Enantioselective Synthesis of Diol 130 via KSAE of 
Allylic Alcohol 127. 
Reagents and Conditions: (i) Swem oxidation then Ph3P=C(H)CO2Et/CH2Cl2, 2 h; (ii) DIBAL-H/ 
CH2Cl2, 2 h, -78 °C; (iii) KSAE, diethyl D-(-)-tartrate/CH2Cl2; (iv) DMAP, NEt3/CH2Cl2 then 127 
and Mosher chloride; (v) Me3Al/CH2Cl2, 0 °C to rt, 10 h. 
The pivotal alkene 127 was readily prepared by a "one-pot" procedure involving initial 
oxidation of commercially available (ALDRICH) alcohol 125 to the corresponding 
aldehyde. Using a modification of procedures reported by Barrett,25 Lee 26 and 
Taylor,27 this latter compound was subjected to in situ Wittig olefination with the 
stabilised ylide (carbethoxymethylene)triphenylphosphorane. In this manner the a, ~-
unsaturated ester 12626,28 (98%) was obtained and the illustrated (£)-configuration 
about the ~ 2-double-bond was established from the magnitude of the vicinal spin-spin 
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coupling (J = 15.6 Hz) observed between H-2 and H-3 in the lH NMR spectrum of this 
material. This sequential "one-pot" oxidation-aldehyde olefination procedure is of great 
synthetic value29 as the intermediate aldehyde is difficult to handle due to its high 
volatility and odoriferous nature. 
DIBAL-promoted 1,2-reduction of compound 126 proceeded smoothly to give the target 
alcohol 12726,30 in 85% yield, and the various spectral data derived from this n1aterial 
were in full accord with the assigned structure. KSAE of compound 127 was effected 
under standard conditions using catalytic quantities of diethyl D-(-)-tartrate and in this 
manner the anticipated 2,3-epoxy-alcohol 128 (70%) was obtained. The lH and 13c 
NMR spectra of compound 128 (Figures 2.2 and 2.3, repectively) are in full accord with 
the assigned structure. Epoxy-alcohol 128 was converted, under standard conditions, 
into the corresponding Mosher ester 129 ( 42%) which was obtained as a single 
diastereoisomer (as determined by 1 Hand 13c NMR analysis) and thus suggesting that 
the precursor alcohol was of >95% ee. This interpretation was confirmed by converting 
the racemic modification of epoxide 128 [prepared by treating alkene 127 with m-
chloroperbenzoic acid] into the corresponding 1: 1 mixture of compound 129 and its 
diastereo-isomer and observing that these Mosher esters were readily differentiated from 
one another by 300 MHz 1 H NMR spectrometry (see Experimental Section). The 
assignment of the absolute configuration of epoxide 128 was based, in the first instance, 
on applying the nmenonic shown in Figure 2.1 and this was subsequently confirmed by 
its conversion into the previously reported tetrahydropyran 13, the degradation product 
obtained from herboxidiene. 
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Figure 2.2: 300 MHz 1 H NMR Spectrum of 2,3-Epoxy-alcohol ( + )-128. 
(Spectrum recorded in CDCl3 solution) 
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Figure 2.3: 75.5 MHz APT 13c NMR Spectrum of 2,3-Epoxy-alcohol (+)-128. 
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2. 2 Elaboration of Compound 128 in an Enantio- and Diastereo-
selective Synthesis of the Herboxidiene Core Molecule 95 
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Treatment of epoxy-alcohol 128 with three molar equivalents of trimethylaluminium32 in 
dichloromethane at 0 °C for 10 h resulted in its smooth conversion into diol 130 (83%)10 
the stereochemistry of which follows from its transformation into the previously 
reported20 aldehyde 101. Two-fold acetylation of compound 130 (Scheme 2.2) was 
achieved under standard conditions and the resulting diacetate 131 (96%) was subjected 
to ozonolytic cleavage followed by reductive work-up with triphenyl phosphine to give 
the aldehyde 101 (79% ). This last compound proved identical (as judged by 1 H NMR, 
13c NMR, IR and mass spectral analysis) with the samples obtained by Bui's route.20 
As expected, however, the specific rotation of the material generated by the present route 
was substantially larger { [a]o + 7.3 vs [a]o +3.8} than that observed for the sample of 
aldehyde 101 obtained earlier. 
The completion of the synthesis of the target phosphine oxide 95 followed the route 
established earlier.20 Thus, subjection of compound 101 to the Still-Gennari 
modification33 of the Wadsworth-Emmons reaction afforded the alkene 102 (80%) as 
the only isolable product of reaction. The (Z)-configuration about the double-bond in this 
product follows from the magnitude of the vicinal spin-spin coupling (J = 11.5 Hz) 
observed between H-2 and H-3 in the 1 H NMR spectrum of this material. The 1 H and 
l3c NMR spectra of compound 102 (shown in Figures 2.4 and 2.5, repectively) are in 
full accord with the assigned structure. 
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Scheme 2.2: Completion of the Enantio- and Diastereo-selective Route to the 
Herboxidiene Core Molecule 95. 
Reagents and Conditions: (i) Ac20, DMAP(trace)/pyridine, 18 °C, 3 h; (ii) 03/CH2CI2 then PPh3; (iii) 
Me02CCH2P(O)(OCH2CF3)2, l8-crown-6/CH3CN-complex, KN(TMS)2/THF, -78 °C; (iv) 
K2C03/MeOH, rt, then MeOH, H2S04 (trace), rt; (v) pyridine.S03 complex/DMSO, CH2CI2, 0 °C; 
(vi) MeMgCI/THF, -78 °C to O °C; (vii) Dess-Martin periodinane/CH2Cl2, rt, 1 h; (viii) 
H2C=C(H)MgBr/fHF, -78 °C; (ix) PBr3/Et20, 0 °C; (x) Ph2POEt/THF, reflux, 2 h. 
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Figure 2.4: 300 MHz 1 H NMR Spectrum of Compound 102. 
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Treatment of compound 102 with potassium carbonate in methanol resulted in removal of 
the acetate groups and a subsequent intramolecular hetero-Michael addition reaction to 
give the tetrahydropyranyl acetic acid ester 24 along with varying quantities of the 
corresponding acid. As a consequence, the crude reaction mixture was treated with acidic 
methanol and in this manner compound 24 was obtained in 71 % yield. The C-3 epimer 
of compound 24 was not detected in the reaction mixture and it is believed, on the basis 
of model studies, 34 that the (Z)-geometry about the double bond in substrate 102 exerts 
a controlling influence in ensuring, at least under conditions of kinetic control, a cis-
relationship between the anomeric substituents in the cyclisation product. Thus, the 
conversion 102• 24 is believed to involve a transition state structure such as that 
depicted in Figure 2.6 wherein chelation of the participating metal ion (K+) by two 
partially negatively charged oxygens can only take place because of the (Z)-geometry 
about the double bond. 
H 
H 
OMe 
Figure 2.6: Plausible Transition State Structure Associated with the Cyclisation 
Reaction Leading to Tetrahydropyranylacetic Acid Methyl Ester 24. 
Oxidation of alcohol 24 under Parikh-Doering conditions (pyridine-SO3 activated 
DMSQ)35 afforded the corresponding aldehyde 103 (60%) which proved 
spectroscopically identical with the sample obtained by Bui's earlier route. In addition, 
the optical rotation of this material matched that reported by Edmunds for enantiomerically 
pure material. 5 After considerable experimentation with a range of nucleophilic 
methylating agents, methylmagnesium chloride proved to be the most effective in adding 
to the aldehydic moiety associated with compound 103. The resulting mixture of 
distereoisomeric 2°-alcohols (35%) was immediately oxidised to the corresponding 
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methyl ketone 13 (48%) using the Dess-Martin periodinane.36 The optical rotation of this 
compound matched that reported for a sample obtained by ozonolytic cleavage of 
herboxidiene itself (Table 2.1). 
Table 2.1: Comparison of the Specific Rotations of Compounds 13, 24 and 103 
Prepared in the Course of the Present Work with Literature Values. 
Compound Specific Rotationa Literature V alue5 
13 -91 (1.2) -95 (1.5) 
24 +9.8 (1.0) +9.4 
103 -65 (0.45) -62 (0.5) 
a Specific rotations were determined at 22 °C. Values in parenthesis refer to sample concentrations in 
g/100 mL of CHCl3 (spectroscopic grade). See Experimental Section for details. 
The 1 Hand 13c NMR spectral data obtained on compound 13, (see Figures 2.7 and 
2.8) matched, in all respects, those reported by Edmunds and co-workers. 
Elaboration of ketone 13 to the target phosphine oxide 95 followed the previously 
established procedures of Bui and involved initial reaction of the former compound with 
vinyl magnesium bromide. This resulted in generation of the desired mixture of 
diastereoisomeric 3 °-alcohols albeit in only 60 % yield because of the formation of by-
products deriving from competing nucleophilic addition to the ester moiety. Treatment of 
the intermediate 3 ° -alcohols with phosphorous tribromide, in ether at 0 °C, 18 then 
afforded the allylic bromide 106 (91 %), which engaged in a Michaelis-Arbuzov reaction 
with diphenylethoxyphosphine27 ,38 to deliver, after chromatographic purification, 
compound 95 (84%) as a crystalline solid. 
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Figure 2.7: 300 MHz lH NMR Spectrum of Compound 13. 
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Extensive but nevertheless conventional spectroscopic characterisation of compound 95 
allowed for confident assignment of its structure. In the lH NMR spectrum (Figure 2.9) 
the ten-proton envelope centred at 8 7 .62 was assigned to the protons of the two phenyl 
groups. The olefinic proton, H-9 (herboxidiene numbering), resonated as a multiplet at 8 
5.50 due to, inter alia, allylic coupling to the C-8 methyl group protons. Interestingly, in 
the 13c NMR spectrum (Figure 2.10) the resonance due to C-10 appeared as a doublet at 
8 30.7 with J 13c_3 l P = 70 Hz. The 31 P NMR spectrum showed a single peak at 8 
31.0. The mass spectrum exhibited a strong molecular ion at mlz 426 (51 % ) and the 
fragment ion at m/z 395 derives from the loss of the OCH3 radical. The IR spectrum 
showed absorption bands at 1736 and 1180 cm-1 corresponding to the carbonyl (C=O) 
and phosphine oxide (P=O) groups, respectively. In addition, satisfactory high resolution 
mass spectra was obtained for compound 95. Finally, the melting point of this compound 
(m.p. 125-126 °C) matched that reported earlier for multiply recrystallised materiaI.20 
The specific rotation of compound 95 produced by the route just described was much 
lower { [<X]D -0.4 vs [<X]D -32.8} than that measured for the material generated by Bui's 
original route. Fortunately a sample of compound 95 derived by this earlier sequence was 
still available and a re-determination of the specific rotation resulted in a value identical to 
that observed for the newly prepared sample. Consequently it was concluded that Bui's 
earlier determination of optical rotation for compound 95 is in error. In addition, given 
the absence of any racemisation pathways in the synthetic sequence just described 
together with high levels of enantioselectivity obtained in the KSAE reaction leading to 
compound 95 it is reasonable to conclude that phosphine oxide 95 has been obtained in 
>95% ee. 
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Figure 2.9: 300 MHz 1 H NMR Spectrum of Phosphine Oxide 95. 
(Spectrum recorded in CDCI3 solution) 
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Figure 2.10: 75.5 MHz APT 13c NMR Spectrum of Phosphine Oxide 95. 
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CHAPTER THREE 
Enantio- and Diastereo-selective Synthesis of the 
Herboxidiene Side Chain Molecule 94 
3 .1 Synthesis of the C-16 to C-19 Fragment of Herboxidiene 
from Commercially Available Hydroxy-ester 96 
3. 2 Ireland-Claisen Rearrangement of the Propionate Ester 144: 
Formation of the C-11 to C-19 Fragment 145 
3. 3 Completion of the Synthesis of the C-12 Epimer of the Target 
Aldehyde 94 Embodying C-11 to C-19 ofHerboxidiene 
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3 .1 Synthesis of the C-16 to C-19 Fragment of the Herboxidiene From 
Commercially Available Hydroxy-ester 96 
55 
The synthetic route that was employed in order to achieve a highly diastereo-selective 
synthesis of the side chain 94 (Figure 3.1) associated with herboxidiene is shown in 
Scheme 3.1. It begins with methyl (S)-3-hydroxy-2-methylpropionate 96 which is 
produced in large quantities via microbial oxidation of isobutyric acid62 and which is 
commercially available (e.g. ex SIGMA) in optically pure form (>99% ee). It was 
anticipated that C-2 of this synthon would become C-16 of the herboxidiene side chain 
(Figure 3.1) and this single II purchased II centre of chirality would be employed to 
control all of the other stereogenic centres associated with the side chain of target 1. 
Initial work (Scheme 3.1) was directed toward elaborating the ester moiety within 
substrate 96 so as to install C-17 to C-19 while subsequent elaboration of the hydroxyl 
group within the same starting material would be used for installation of C-14 to C-12 
so as to ultimately produce the target side chain molecule 94. 
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Figure 3.1: Retrosynthetic Relationships between Herboxidiene (1), the Side Chain 
Molecule 94 and the Side Chain Synthon 96. 
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Reagents and conditions: (i) BnOC(NH)CCI3, CF3SO3H (cat.)/CH2CI2, 0 to 18 °C; (ii) 
Me(MeO)NH.HCI, i-PrMgCI/THF, -15 °C; (iii) H2C=C(H)MgBr/THF, 0 °C; (iv) Zn(Bl4)2/CH2CI2, 
-78 °C; (v) Mel, KH/THF, 0 to 18 °C; (vi) O3/CH2CI2, -78 °C then Me2S; (vii) Me2Zn , 
TiCl4/CH2CI2, -78 °C; (viii) TBDMSCl, imidazole/DMF, 60 °C; (ix) H2 (1 atrn), Pd(OH)2 on CJ 
THF, rt; (x) SO3.pyridine complex/DMSO, CH2CI2, rt; (xi) H2C=C(Me)Br, t-BuLi , 
CuBr.DMS/Et2O, -78 °C; (xii) (EtCO)2O, DMAP, pyridine, rt; (xiii) LDA, HMP A/THF, TBDMSCI, 
-78 °C to 50 °C; (xiv) LiAIH4f.Et2O, 0 °C; (xv) Dess-Martin periodinane/CH2CI2, rt. 
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To these ends the hydroxyl group within compound 96 was subjected to protection as the 
corresponding benzyl ether 132 and this was achieved in 97% yield by the method of 
Iverson and Bundle39 using benzyl 2,2,2-trichloroacetimidate and triflic acid as catalyst. 
These conditions have been utilised by Widmer-40 for the protection of a wide-range of ~-
hydroxy esters and he demonstrated that there is no loss of optical purity associated with 
this transformation. The O-benzyl protected ester 132 was converted into the 
corresponding Weinreb amide41 133 in 95% yield { [a]o = -4.6 (c = 2.0)} by the in situ 
generation of the magnesium amide derived from N, O-dimethylhydroxylamine 
hydrochloride using isopropyl magnesium chloride as the base. 42 In this instance in situ 
generation of the magnesium amide is required as the pre-formed species decomposes 
rapidly. The use of N-methoxy-N-methylamides (Weinreb amides) as isolable 
intermediates for the conversion of esters into ketones is now a widely used procedure.43 
This chemistry succeeds because the tetrahedral intermediate (Im, Scheme 3.2) arising 
from nucleophilic addition to the Weinreb amide is a stabilised species (by virtue of metal 
chelation) that does not collapse, under the reaction conditions, to the corresponding 
ketone which would suffer attack by another equivalent of the original nucleophile. 
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Scheme 3.2: Conversion of an Ester to a Ketone Through Controlled Nucleophilic 
Addition to an Intermediate Weinreb Amide. 
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Reaction of vinylmagnesium bromide with the Weinreb amide 133 gave the a-chiral 
ketone 134 in 92% yield43 and this latter compound was subsequently reduced to the 
syn-alcohol 135. To achieve this reduction diastereoselectively, a range of reducing 
agents was investigated (Table 3.1). The best diastereoselectivities (>8: 1 syn /anti) were 
observed when Zn(BH4)2 was used and this useful outcome can be explained by the 
intervention of the effects of 1chelation contror. 44 A possible transition state structure 
is presented in Figure 3.2 in order to highlight chelation of the zinc metal ion and the 
Btirgi-Dunitz trajectory associated with hydride ion attack which gives rise to the major 
product, viz. syn-alcohol 135. 
Table 3.1 : Stereoselectivities obtained by Hydride-Type Reduction of Ketone 134 to 
Alcohols 135 and 136. 
Reducing Solvent Temp °C Ratio of Alcohols* Combined 
agent 135: 136 yield (%) 
DIBAL CH2Cl2 -78 1 : 1 77 
DIBAL THF -78 - -
DIBAL, ZnCl2 THF -78 1 : 1 76 
DIBAL, SnCl4 THF -78 1 : 1 65 
NaBH4, CeCl3 iprOH -20 2 : 1 80 
LiBH4, SnCl4 THF -78 - -
K- Selectride THF -78 1 :3 55 
Zn(BH4)2 CH2Cl2 
-78 > 8: 1 92 
Zn(BH4)2 CH2Cl2 
-100 > 8: 1 92 
Zn(BH4)2 TBME -78 5 : 1 60 
* Ratio determined by HPLC analysis using 7.8 x 300 mm µ-Porasil column, 1:9 v/v ethyl 
acetate:hexane as tbe solvent and a flow rate of 2 ml/min. 
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Figure 3.2: Chelation-controlled Reduction of Ketone 134 Leading to Stereoselective 
Formation of syn-Alcohol 135. 
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The syn- and anti-alcohols were readily separated from one another by preparative 
HPLC techniques and all spectral data obtained on these compounds were in full accord 
with the data reported for their enantiomeric forms (Tables 3.2, 3.3 and 3.4)_46 The 1 H 
NMR spectra of both the syn- and anti-alcohols, 135 and 136 respectively, are shown 
in the Figures 3.3 and 3.4. There are conspicuous differences in the chemical shifts as 
well as the multiplicities of the protons at C-3, C-4 and C-5 in each of these isomers. 
Table 3.2: Comparison of the 300 MHz 1 H NMR Spectral Data of the syn-Alcohol 
135 with Those Reported for its Enantiomer. a 
syn-Alcohol 135 (8H) Alcohol en t - 135 (8H b) 
7.39-7.28 (complex m, 5H) 7.75-7.25 (m, SH) 
5.88 (ddd, 1-17.2, 10.6 and 5.4 Hz, lH) 5.86 (ddd, 1=17 .2, 10.6 and 5.4 Hz, lH) 
5.33-5.16 (complex m, 2H) 5.30-5.14 (m, 2H) 
4.51 (s, 2H) I 4.49 (s, 2H) 
4.28-4.25 (complex m, lH) 
3.56-3.49 (complex m, 2H) 
3.0 (br.s, lH) 
2.12-2.05 (complex m, lH) 
0.91 (d, 1 = 7.0 Hz, 3H) 
4.27-4.22 (m, lH) 
3.53-3.45 (m, 2H) 
2.94 (d, 1 = 5.7 Hz, lH) 
2.13-2.00 (m, lH) 
0.88 (d, 1 = 7.1 Hz, 3H) 
a All data obtained using CDCl3 as solvent; b Data obtained from reference 46. 
Table 3.3: Comparison of the 300 MHz 1 H NMR Spectral Data Derived from anti-
Alcohol 136 with Those Reported for its Enantiomer. a 
anti-Alcohol 136 (8H) Alcohol ent - 136 (8H b) 
7.35-7.29 (complex m, SH) I 7.37-7.25 (m, SH) 
5.88 (ddd, 1 17.2, 10.6 and 5.4 Hz, lH) 5.83 (ddd, 1=6.5, 10.4 and 17.2 Hz, lH) 
5.29-5.13 (complex m, 2H) 5.28-5.11 (m, 2H) 
4.52 (s, 2H) I 4.50 (s, 2H) 
4.03 (t, J = 6.7 Hz, lH) 
3.62 (dd, 1 = 9.2 and 4.3 Hz, lH) 
3.47 (dd, 1 = 9.3 and 7.3 Hz, lH) 
3.36 (br.s, lH) 
1.93-1.89 (complex m, lH) 
0.91 (d, 1 = 7.1 Hz, 3H) 
4.04-3.97 (m, lH) 
3.60 (ddd, 1 = 9.2 ,4.3 and 7.2 Hz, lH) 
3.45 (ddd, 1 = 9.2, 4.3 and 7.2 Hz, lH) 
3.36 (d, 1 = 3.6 Hz, lH) 
1.96-1.83 (m, lH) 
0.90 (d, 1 = 7 .0 Hz, 3H) 
a All data obtained using CDCl3 as solvent; b Data obtained from reference 46. 
OH 
('("o 
135 
7 6 5 4 3 
Figure 3.3: 300 MHz 1 H NMR Spectrum of syn-Alcohol 135. 
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Figure 3.4: 300 MHz 1 H NMR Spectrum of Anti-Alcohol 136. 
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Table 3.4: Comparison of the 75 MHz 13c NMR Spectral Data Derived from the syn-
and anti-Alcohols 135 and 136 with those Reported for the Enantiomers. a 
syn-Alcohol 135 ent-135 anti-Alcohol 136 ent-136 
(8C) (8Ch) (8C) (8Ch) 
138.5 (CH) 138.6 (CH) 139.7 (CH) 139.3 (CH) 
137.9 (CH2) 137.9 (CH2) 138.1 (CH2) 137.7 (CH2) 
128.3 (CH) 128.3 (CH) 128.7 (CH) 128.2 (CH) 
127.6 (2CH) 127.5 (2CH) 128.0 (2CH) 127.5 (2CH) 
115.0 (C) 114.9 (C) 116.1 (C) 115.5 (C) 
75.0 (CH) 74.8 (CH) 76.9 (CH) 77.0 (CH) 
73.6 (CH2) 73.6 (CH2) 74.8 (CH2) 74.1 (CH2) 
73.3 (CH2) 73.2 (CH2) 73.7 (CH2) 73.2 (CH2) 
38.2 (CH) 38.3 (CH) 38.8 (CH) 38.4 (CH) 
11.5 (CH3) 11.4 (CH3) 14.0 (CH3) 13.4 (CH3) 
a All data obtained using CDCl3 as solvent; b Data obtained from reference 46. 
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The (S)- and (R)- MTPA ester derivatives of the major reduction product were prepared 
(by standard methods) in order to confirm the absolute stereochemistry of the newly 
created secondary alcohol stereocentre within compound 135. It has been proposed that 
in deuterated chloroform the MTPA ester derivatives of secondary alcohols exist largely 
in the conformer such as that shown in Figure 3.5 wherein the trifluoromethyl group 
eclipses the ester carbonyl which in tum eclipses the methine hydrogen of the secondary 
alcohol center. For the (R)-MTPA ester derivative 147 it can be seen that when this 
conformer is significantly populated then the phenyl ring is ideally placed to 
anisotropically shield the benzylic region of the ester derivative. Conversely, the 
favoured conformer of (S)-MTPA ester derivative 148 has the methoxy group residing 
close to the benzylic region and hence no shielding is expected. By assigning the spectra 
of both (R)- and (S)- MTPA ester derivatives and comparing the relative shielding 
effects, it is possible to confirm the absolute stereochemistry of a secondary alcohol. 4 7 
An inspection of the data in Table 3.5 reveals a shielding pattern consistent with the 
absolute configurations shown. 
Chapter Three 
Ph )6 Ph )6 
0 
_Js Ph 
;>:ro~~~e 
11/ jtt 0 
0 
_)s OMe 
xo~~:3 
1 // j~ 0 
147 148 
Figure 3.5: (R)- and (S)- Mosher Ester Derivatives of the syn-Alcohol 135. 
Table 3.5: Analysis of the Differences in the Proton Chemical Shifts for Equivalent 
Protons within Mosher Esters 147 and 148. 
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Hydrogen 8 (R)-MTPA 8 (S)-MTPA ~ [8 (R)-8 (S)] 
(147) (148) 
Ci-trans H 5.3305 5.2415 + 0.089 
C1-cis H 5.2825 5.232 + 0.050 
C2-H 5.8371 5.750 +0.087 
C3-H 5.670 5.664 +0.006 
C4-H 2.066 2.111 -0.045 
C5-H 3.2596 3.342 -0.082 
C6-H 4.411 4.466 -0.055 
C4-Me 0.900 0.961 -0.061 
Continuing with the synthesis of the target side chain molecule 94, the HPLC purified 
syn-alcohol 135 was O-methylated using methyl iodide and KH and the resulting bis-
ether 137 was obtained in 85% yield { [ a]D = + 12.2 ( c = 1.3)}. All spectral data 
obtained on this latter compound were fully consistent with the gross structure. Most 
particularly, the 1 H NMR spectrum of this material showed a new methoxy methyl 
resonance at 8 3.27. Compound 137 was subjected to ozonolytic cleavage thereby 
affording the unstable aldehyde 138 { 90%, [a]D = +22.5 (c = 2.2)} which was 
immediately reacted with dimethyl zinc in the presence of TiCl4 48 to give the 
diastereoisomerically pure syn-alcohol 139 {70%, [a]D = +8.6 (c = 2.8)} as the only 
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isolable reaction product. On the basis that addition of the methyl nucleophile to 
aldehyde 138 should proceed with 1chelation control', the stereochemical relationship 
between the vicinally related hydroxy and methoxy groups would be expected to be 
syn. 48, 49 A possible transition state structure according with this general idea is 
shown in the Figure 3.6 in order to highlight the 1chelation contror exerted by the Ti 
cation and the trajectory of attack of the methyl nucleophile which result in preferential 
formation of the syn-alcohol 139. 
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Figure 3.6: Probable Transition State Structure (centre) Associated with the 
1Chelation-controlled 1 Addition of a Methyl Nucleophile to Aldehyde 138. 
Once again, the (R)- and (S)- MTP A ester derivatives of alcohol 139 were prepared and 
used to confirm the absolute stereochemistry of the newly created stereogenic centre 
associated with the secondary alcohol moiety (see Table 3.6). 
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Table 3.6: Analysis of the Differences in the Proton Chemical Shifts for Equivalent 
Protons within Mosher Esters 149 and 150. 
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Hydrogen 8 (R)-MTPA 8 (S)-MTPA ~ [8 (R)-8 (S)] 
(149) (150) 
C1-Me 1.232 1.293 -0.061 
C1-H 5.169 5.198 -0.029 
C2-OMe 3.307 3.050 +0.257 
C2-H 3.323 3.256 +0.067 
C3-Me 0.871 0.841 +0.03 
C3-H 1.990 1.929 +0.061 
C4-H 3.438 3.367 +0.071 
C5-H 4.491 4.456 +0.035 
The secondary alcohol 139 was protected using TBDMSCl under standard conditions 
and the TBDMS-ether 140 thereby obtained in 80% yield. 
With the acquisition of compound 140 the left-hand half (C-15 to C-19) of the side 
chain had been constructed. To complete the synthesis of target 94, this fragment now 
needed to be extended to the right. To these ends compound 140 was subjected to 
hydrogenolytic debenzylation using Pearlman's catalyst [Pd(OH)2 on carbon] and the 
ensuing 1 °-alcohol 141, which was obtained in 80% yield, in1mediately oxidised to the 
corresponding ~-methoxy-aldehyde 142 using the Parikh-Doering reagent.35 Reaction 
of compound 142 with the Gilman reagent derived from 2-bromopropene then gave, 
via a chelation controlled process (Figure 3.7),50 the diastereoisomerically pure allylic 
alcohol 143 in 70% yield {[a]D = +3.2 (c = 1.2)}. Extensive efforts to prepare the 
Mosher ester derivatives of this allylic alcohol (and thereby confirm the stereochemistry 
at C-15) were not successful perhaps because of unfavourable steric interactions caused 
by the folding of this compound. Despite this difficulty, the stereochen1istry at C-15 
could be deduced via chemical correlation studies as described later in this chapter as 
well as in the following one. 
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3. 2 lreland-Claisen Rearrangement of the Propionate Ester 144: 
Formation of the C-11 to C-19 Fragment 145 
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The allylic alcohol with the putative stereostructure 143 was treated with propionic 
anhydride in pyridine in the presence of DMAP as a catalyst and in this manner the 
propionate ester 144 was obtained in 90% yield { [a]o = -22.0 (c = 1.6) }. The derived 
1 Hand l3c NMR spectra are shown in Figures 3.8 and 3.9, respectively. Compound 
144 was subjected to an Ireland-Claisen rearrangement14,50 involving sequential 
treatment with LDA then TBDMSCl in HMPA/THF from -78 to 50 °C. The (12R)-
stereochemistry and the (£)-geometry about the double-bond in the ensuing y,8-
unsaturated carboxylic acid 145 (75%) { [a]o = +5.8 (c = 2.2)} were initially proposed 
on the basis of the well-defined outcomes associated with the Ireland-Claisen 
rearrangements of related substrates (see Figure 3.10) under the same reaction 
conditions. The probable transition state structure associated with the pivo tal 
rearrangement is shown in Figure 3 .11. 
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Figure 3.8: 300 MHz 1 H NMR Spectrum of Compound 144. 
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Figure 3.9: 75.5 MHz APT 13c NMR Spectrum of Compound 144. 
(Spectrum recorded in CDCl3 solution) 
I 2101 II ppm 
n 
::r 
~ ,..,. 
(0 
1--1 
~ g-
(0 
(0 
0-... 
00 
0 
00 
'Yit'i ___ ( 
~/1 
151 
,OBn 
, .. 
...___. 
Chapter Three 
1 
• 
~ 11 • 
0 
153 
0~ 
HO~,,-··H;---1( 
152 
,OBn 
., .. 
·,, 
o 'co2H 
154 
Figure 3.10: Examples of the Ireland-Claisen Rearrangement which Involve 
Formation and Rearrangement of an Intermediate (Z)-Silyl Ketene Acetal. 
69 
Reagents and conditions: (i) (a) LDA, THF, HMPA, -78 °C; (b) TBDMSCl, THF, -78 °C to rt; (c) 50 
°C, 6h; (ii) LDA, HMPA, TMSCl / NEt3 , -100 °C to rt. 
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Figure 3.11: Formation and Ireland-Claisen Rearrangement of the (Z)-Silyl Ketene 
Acetal Derived from Propionate Ester 144: Diastereoselective Formation of y,8-
Unsaturated Acid 145. 
On the basis of this analysis the stereochemistry at C-12 in compound 145 is opposite to 
that required at the equivalent centre in target 1. As will be seen in the following chapter, 
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this "stereochemical error" can be corrected ( via an epimerisation process) but in the 
longer term the correct stereochemistry at C-12 could be established through formation 
and Ireland-Claisen rearrangement of the (E)-silyl ketene acetal derived from propionate 
ester 144_53 Efforts are underway within the Banwell group to exploit such possibilities. 
LiAlH4-promoted reduction of compound 145 afforded the corresponding alcohol 146 
(80%) { [a]o = +6.4 (c = 1.6)} and the spectroscopic data obtained on this material were 
in full accord with the assigned structure. In the 1 H NMR spectrum of compound 146 
(Figure 3.12) the C-15 olefinic proton resonates as a doublet at 8 5.20 while the protons 
associated with the quaternary methyl group at C-14 resonate as a singlet at 8 1.62. The 
three doublets in the downfield region correspond to the protons associated with the three 
secondary methyl groups. The 13c NMR spectrum (Figure 3.13) displayed the expected 
seventeen resonances, the diagnostic ones being at 8 132.0 and 8 130.8 which 
correspond to the olefinic carbons at C-15 and C-14, respectively. The 70 eV electron 
impact mass spectrum of compound 146 exhibited a molecular ion at m/z 344 (9% ), 
while logical fragment ions were observed at mlz 287 [(M-C4H9-)+, 17%] and 255 [(M-
C4H9- -MeOH)+, 12%]. 
In an effort to confirm the assigned stereochemistry at C-12 within compound 146, it 
was subjected to epoxidation with dimethyl dioxirane (Scheme 3.3). The resulting 
diastereoisomeric n1ixture of epoxides, 155 and 156, was then treated with traces of 
mineral acid where-upon cyclisation took place so as to produce the tetrahydrofuran 
derivatives 157 and 158. This mixture of products was subjected to desilylation so as to 
generate corresponding diols 159 and 160, which were separated from one another by 
HPLC techniques. Spectroscopic analysis of these compounds clearly indicated that they 
were structurally related to but stereochemically distinct from the diol 12 obtained during 
the degradation studies carried out by Edmunds et al on herboxidiene. 5 These results are 
taken as confirmation of the proposal (vide infra) that the carboxylic acid 145 arising 
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Figure 3.12: 300 MHz 1 H NMR Spectrum of Compound 146. 
(Spectrum recorded in CDCI3 solution) 
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from the aforementioned Ireland-Claisen rearrangement posseses R- rather than the S-
stereochemistry at C-12. 
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Scheme 3.3: Attempted Chemical Correlation Studies Aimed at Establishing the 
Stereochemistry at C-12 in Compound 146. 
Reagents and conditions: (i) Dimethyldioxirane/acetone, -78 °C to rt; (ii) H+ (trace); (iii) TBAF/THF, 0 
°C to rt. 
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3. 3 Completion of the Synthesis of the C-12 Epimer of the Target 
Aldehyde 94 Embodying C-11 to C-19 of Herboxidiene 
74 
The completion of the present synthetic sequence (Scheme 3.1) simply involved 
oxidation, using the Dess-Martin periodinane,36 of alcohol 146. In this manner the 
unstable C-12-epimer, viz. compound 12-epi-94, of the target aldehyde 94 was 
obtained in 80% yield. 
OMe OMe 
TBDMSO TBDMSO 
12-epi-94 94 
The following chapter describes the means by which compound 12-epi-94 can be 
converted into the target herboxidiene methyl ester (5). As noted earlier (page 30) in the 
discussion of the retrosynthetic analysis pertaining to this work, it was considered 
prudent to delay introduction of the epoxide ring associated with herboxidiene side 
chain for as long as possible and certainly until after the side chain and core fragments 
of the target had been united. This argument derives from the observations, made both 
within this group and by Kocienski et al, 8 that once this epoxide ring is in place rather 
unstable molecules result that make handling and characterisation of such species very 
difficult. 
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Chapter Four 
4 .1 Horner-Wittig Coupling of Phosphine Oxide 95 with C-12 epimer 
of the Aldehyde 94: Formation of Triene 161 
76 
With the _ready acquisition, in enantiopure form, of both the phosphine oxide 95 and the 
aldehyde 12-epi-94 the stage was now set for the crucial Horner-Wittig reaction, and, 
thence, the final stages of the total synthesis of herboxidiene. In the event (Scheme 4.1) 
coupling of the aldehyde and phosphine oxide could be effected using sodium hydride as 
base. This reaction was accompanied by C-12 epimerisation * of the former substrate as 
well as saponification of the initial coupling product (presumably due to the presence of 
residual base). As a consequence of the latter process the crude reaction mixture obtained 
on acidic work up was subjected to re-esterification with CH2N2. After this sequence of 
manipulations a 3:2 mixture of triene 161 (39%) { [a]D = +0.4 (c = 2.3)} and its C-12-
epimer 162 (26%) {[a]D = +18.4 (c = 1.5)} was obtained.9 These products could be 
separated from one another using semi-preparative HPLC techniques and the 
spectroscopic data obtained on the chromatographically less-mobile compound were in 
full accord with the assigned structure. However, as might be appreciated, it was very 
difficult to differentiate between these Homer-Wittig coupling products, viz. (compounds 
161 and 162) by comparison of the respective 1 H NMR spectra. It was fortunate, 
therefore, that in arbitrarily selecting the major fraction for elaboration, that this was 
correlated, chemically, with herboxidiene methyl ester (vide infra). The ls and 13c 
NMR spectra of compound 161 are shown in Figures 4.1 and 4.2, respectively. The 
assignment of (£)-geometry to the newly installed ~10,l l_double-bond within product 
161 follows from the model studies carried out by Bui et al 20 and from the conversion 
of this compound into herboxidiene methyl ester (5). Desilylation of compound 161 was 
accomplished using tetra-n-butylammonium flouride (TBAF) in THF and in this manner 
compound 163 (68%) was obtained. 
* This type of epiinerisation was also observed by Smith and co-workers in their total synthesis of 
milbemycin ~3 and its C-12-epimer. The same group has reported that such epimerisation was not 
observed when a completely soluble base such as KHMDS was used. 50 
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Scheme 4.1: Union of Core and Side Chain with Subsequent Regio- and Diastereo-
controlled Epoxidation of the Resulting Triene 163: Formation of Herboxidiene Methyl 
Ester (5). 
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Reagents and Conditions: (i) NaH/THF, 55 °C then CH2N2; (ii) TBAF/THF, 0 °C to rt.; (iii) t-BuOOH, 
VO(acac)2/CH2Cl2, -8 °C, 72 b. 
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Figure 4.1: 300 MHz lH NMR Spectrum of Compound 161. 
(Spectrum recorded in CDCI3 solution) 
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4.2 Regio- and Diastereo-controlled Epoxidation of Triene 163: 
Formation of Herboxidiene Methyl Ester (5) 
Given the precedence afforded by Kocienski and Evans's work on directed epoxidation 
of bis-homoallylic alcohols,9, 17 a solution of alcohol 163 in CH2Cl2 was treated, at -8 
~C, with 1 mole % of the catalyst vanadyl bis(acetylacetonate) [VO(acac)2] then tert-
butylhydroperoxide with the latter being added via a syringe pump over 48 h. After the 
addition was complete, the reaction mixture was allowed to stand at -8 °C for a further 24 
h. These rather specific reaction conditions were considered necessary because of the 
observations made by Kocienski et al during the course of a related epoxidation reaction 
(see Chapter 1, page 23). Thus, it was expected that using more vigorous conditions 
could lead to nucleophilic attack of the C-18 hydroxy-group (within product 5) at the 
newly formed epoxide ring and thereby producing tetrahydrofurans such as 2 (see Figure 
1.1, page 6). The use of rather low catalyst loadings in the present reaction derives from 
the need to suppress trans-acylation reactions that would result in formation of the C-18 
acetate derivatives of either the starting alkene and/or product epoxide. Upon work-up of 
the reaction mixture obtained on operating under these conditions a ca. 4: 1 mixture of 
herboxidiene methyl ester (5) (73%) {[cx]o = +1.3 (c = 0.2)}, lit.9 {[cx]o = +0.9 (c = 
0.7)} and an isomer tentatively identified as 164 was produced. These epoxides could be 
separated from one another by semi-preparative HPLC. 
The hydroxyl-directed epoxidation of bis-homoallylic alcohol 163 is believed to proceed 
via the intermediate shown in Figure 4.3 in which (i) the coordination geometry at y5+ is 
trigonal bipyramidal; (ii) the C-15 to C-18 position of the herboxidiene-type chain adopts 
a pseudo-chair conformation; (iii) steric interactions between the substituents and the 
vanadium ligands are minimised; and (iv) cleavage of the peroxide bond occurs from the 
backside along the axis of the 0-0 bond. 54,55 The intervention of such factors account 
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for the observed diastereofacially-selective epoxidation reaction with the resulting 
preferential formation of product 5 over isomer 164. 
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Figure 4.3: Likely Vanadate Intermediate Associated with the Hydroxyl-directed 
Epoxidation of Triene 163. 
The spectral data obtained on compound 5 matched, in all respects, those reported by 
Kocienski and co-workers9 (Tables 4.1 and 4.2). The 1 H NMR spectrum of 
synthetically derived herboxidiene methyl ester (5) is shown in Figure 4.4 and is in full 
accord with the assigned structure. Analogous data could not be obtained on isomer 164 
because of the small amount of material available so the assignment of the illustrated 
structure to this substance must remain tentative at this stage. 
The acquisition of herboxidiene methyl ester (5) by the means described here constitutes 
a formal total synthesis of herboxidiene, since Kocienski and co-workers have simply 
saponified the C-1-ester functionality using K2C03 in methanol in order to obtain the 
herboxidiene. During the course of the Homer-Wittig coupling reaction associated with 
the present work ready hydrolysis of the C-1-ester group was observed thus, suggesting 
the desired saponification should be readily achieved. The only reason for this step not 
having been carried out thus far is that insufficient quantities of the methyl ester 5 are 
available at the present time. 
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Table 4.1: Comparison of the 300 MHz 1 H NMR Spectral Data Obtained on that 
Sample of Herboxidiene Methyl Ester (5) Derived from Present Work with those 
Reported by Kocienski et al. a 
Herboxidiene Methyl ester 
Kocienski (<SHb) 
6.24 (dd, J = 15.0 and 10.8 Hz, lH) 
5.90 (d, J = l 1.0 Hz, lH) 
5.45 (dd, J = 14.9 and 8.8 Hz, lH) 
3.90-3.83 (m, lH) 
3.82-3.73 (m, lH) 
3.67 (s, 3H) 
3.55 (s, 3H) 
3.33 (d, J = 9.8 Hz, lH) 
2.98 (t, J = 5.3 Hz, lH) 
2.60 (dd, J = 15.2 and 6.2 Hz, lH) 
2.56 (d, J 9.7 Hz, lH) 
2.45-2.37 (m, lH) 
2.41 (dd J = 15.2 and 6.7 Hz, lH) 
1.90 (dd, J = 13.6 and 4.7 Hz, lH) 
1.88-1.81 (m, lH) 
1.71 (s, 3H) 
1.70-1.50 (m, 3H) 
1.40-1.20 (m, 3H) 
1.29 (s, 3H) 
1.19 (d, J = 6.4 Hz, 3H) 
1.05 (d, J = 6.7 Hz 3H) 
0.88 (d, J = 6.9 Hz 3H) 
0.67 (d, J = 6.6 Hz, 3H) 
Herboxidiene Methyl ester 
Synthetic (8H) 
6.23 (dd, J = 15.3 and 10.6 Hz, lH) 
5.90 (d, J = 10.9 Hz, lH) 
5.43 (dd, I= 14.9 and 8.8 Hz, lH) 
3.86-3.77 (m, lH) 
3.76-3.75 (m, lH) 
3.66 (s, 3H) 
3.54 (s, 3H) 
3.32 (d, I= 9.8 Hz, lH) 
2.97 (t, J = 5.4 Hz, lH) 
2.63-2.54 (complex m, lH) 
2.63-2.54 (complex m, lH) 
2.43-2.36 (complex m, lH) 
2.43-2.36 (complex m, lH) 
1.92 (dd, I= 13.7 and 4.7 Hz, lH) 
1.86-1.81 (m, lH) 
1.70 (s, 3H) 
1.67-1.56 (complex m, 3H) 
1.54-1.30 (complex m, 3H) 
1.28 (s, 3H) 
1.18 (d, I= 6.4 Hz, 3H) 
1.04 (d, J = 6.7 Hz, 3H) 
0.87 (d, J = 6.7 Hz, 3H) 
0.66 (d, I= 6.6 Hz, 3H) 
a All data obtained using CDCl3 as solvent; b Data obtained from reference 9. 
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Table 4.2: Comparison of the 7 5 MHz 13c NMR Spectral Data Obtained on that 
Sample of Herboxidiene Methyl Ester (5) Derived from Present Work with those 
Reported by Kocienski et al.a 
Herboxidiene Methyl Ester 
Kocienski (8C h) 
172.0 (0) 
139.4 (1) 
135.4 (0) 
128.3 (1) 
125.4 (1) 
90.8 (1) 
87.8 (1) 
74.0 (1) 
68.4 (1) 
66.2 (1) 
61.5 (0) 
61.5 (3) 
51.7 (3) 
47.1 (2) 
41.5 (2) 
35.5 (1) 
35.3 (1) 
32.4 (2) 
32.3 (1) 
31.8 (2) 
22.2 (3) 
19.2 (3) 
17.8 (3) 
16.7 (3) 
12.1 (3) 
12.0 (3) 
Herboxidiene Methyl Ester 
Synthetic (8C) 
171.8 (0) 
139.2 (1) 
135.2 (0) 
128.1 (1) 
125.2 (1) 
90.6 (1) 
87.6 (1) 
73.8 (1) 
68.2 (1) 
66.0 (1) 
61.4 (3) 
61.3 (0) 
51.6 (3) 
46.9 (2) 
41.3 (2) 
35.3 (1) 
35.2 (1) 
32.2 (2) 
32.0 (1) 
31.6 (2) 
22.1 (3) 
18.9 (3) 
17.6(3) 
16.5 (3) 
11.9 (3) 
11.9(3) 
a All data obtained using CDCI3 as solvent; b Data obtained from reference 9. 
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4.3 Summary 
The formal total synthesis of herboxidiene described in the preceding sections of this 
thesis exploits the Katsuki-Sharpless asymmetric epoxidation, a chiral pool starting 
material and substrate-directed transformations for establishing the correct 
stereochemistry associated with eight of the nine centres of chirality contained in the target 
molecule. A summary of the relevant chemistry is provided in Figure 4.5. 
C-18-hydroxyl directed regio- and 
diastereo-controlled epoxidation 
of triene 163 
'Chelation controlled' 
reduction of ketone 134 
IHOH i ,,, 1: = / t '•. -o 
MeO 1 
'purchased' chiral centre I 
'Chirality transfer' during the Ireland-Claisen 
rearrangement of the (Z)-silyl ketene acetal 
derived from propionate ester 144 which in 
turn , was obtained from 'chelation controlled' 
isopropenylation of the aldehyde 142 and the 
subsequent esterification 
KS~ reaction of alkene 127 I 
.. Intramolecular and diastereo-
selective hetero-Michael addition 
reaction of compound 102 
'Chelation controlled' nucleophilic 
methylation of aldehyde 138 
Regio- and diastereo-selecti ve 
nucleophilic methylation of 
epoxyalcohol 128 
Figure 4.5: Substrate-directed Transformations used in the Present Work for 
Establishing the Correct Stereochemistry Associated with Herboxidiene (1). 
The combination of such techniques has resulted in a reasonably concise formal total 
synthesis of herboxidiene. The present work provides good prospects for acquiring 
useful amounts of this natural product and a range of analogues that could be exploited in 
developing a detailed understanding of the SAR associated with this class of compound. 
Work directed toward these ends is now underway within these laboratories. 
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5. 1 General Protocols 
Proton ( 1 H) and carbon ( 13c) NMR spectra were recorded on a Varian Gemini 
300 spectrometer, operating at 300 MHz for proton and 75.4 MHz for carbon. All such 
spectra were recorded in deuterochloroform ( chloroform-ct) solution at 22 °C. Chemical 
shifts are recorded as 8 values in parts per million (ppm). For 1 H NMR spectra recorded 
in deuterochloroform, the peak due to residual CHCl3 (8 7 .26) was used as the internal 
reference. Data are recorded as follows: chemical shift (8), multiplicity (s : singlet, d : 
doublet, t : triplet, q : quartet, m : multiplet, dd : doublet of doublets etc., br : broad), 
coupling constant(s) (J Hz), relative integral (for proton spectra) and assignment (where 
possible). The digital resolution within spectra varies slightly depending on the selection 
of spectral width and number of data points allocated to the time domain. However, in all 
cases this is, at worst, of the order of 0.4 Hz/point for one dimensional spectra. The 
protonicities of the carbon atoms observed in 13c NMR spectra were determined by 
attached proton test (apt) experiments, i.e. by the phase of the resonance relative to the 
solvent signal, viz. C and CH2 were of the same phase as the CDCl3 triplet, whilst CH 
and CH3 resonances were of the opposite phase. The central peak (8 77 .0) of the CDCl3 
triplet was used as the reference for { 1 H} 13c NMR spectra. APT 13c NMR spectral 
data are recorded as follows: chemical shift (8) and protonicity (C = quaternary, CH = 
methine, CH2 = methylene, CH3 = methyl, C/CH2 = quaternary or methylene, CH/CH3 
= methine or methyl). 
Infrared spectra were recorded with either a Perkin-Elmer 683G Infrared 
Spectrophotometer or a Perkin-Elmer 1800 Series Fourier Transform Infrared 
Spectrophotometer. Samples were analysed as thin liquid films on potassium bromide 
(KBr) plates. 
Low and high resolution electron-impact mass spectra were recorded at 70 e Von 
a VG Fisons AUTOSPEC three sector (E / B / E) double-focussing Mass Spectrometer, 
using positive-ion electron impact techniques (unless otherwise 
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specified). Chemical ionisation (CI) mass spectra were recorded on the VG Fisons 
AUTOSPEC spectrometer, with NH3 as the reactant gas. Mass spectral data are listed as 
mass-to-charge ratio (m/z), assignment (where possible) and relative intensity(% of base 
peak). 
Optical rotations were measured using a Perkin-Elmer 241 Polarimeter at the 
sodium D line (589 nm) with spectroscopic grade chloroform as solvent (unless 
otherwise specified) at the temperature (T) and concentration (c) (g/100 rnL) indicated in a 
cell with a path length (1) of 1 dm. Specific rotations { [CX]D T} were calculated using the 
equation: [a]DT = (100.a) / (Le) and estimated to be within+ 0.05 x 10-l deg cm2 g-1. 
Melting points were recorded with a Kofler hot stage apparatus and are 
uncorrected. 
Ozonolyses were performed using a Wallace and Tiernan Ozonator with the 
oxygen flow rate and power adjusted to approximately 25 L/h and 200 V, respectively. 
Analytical thin layer chromatography (TLC) was conducted on aluminium-backed 
0.2 mm thick silica gel 60 F254 plates (Merck) and the chromatograms were visualised 
under a 254 nm UV lamp and/or by treatment with a reagent solution [ either 
anisaldehyde/sulfuric acid/ethanol (2 : 5 : 93), phosphomolybdic acid/ethanol (8g : 200 
ml) or phosphomolybdic acid/eerie (IV) sulfate/sulfuric acid/water (37 .5 g / 7 .5 g / 37 .5 
ml / 720 ml)] followed by heating with a hair dryer or on a hot plate. Flash 
chromatography was conducted according to the method of Still and co-workers58 using 
230-400 mesh silica and the analytical reagent (AR) grade solvents indicated. 
High performance liquid chromatography (HPLC) was conducted on a Waters µ-
Porasil™ semi-preparative silica column (7.8 x 300 nm) connected to an ISCO Model 
2350 pump and eluting with the indicated HPLC-grade solvents. The peaks were detected 
using a Waters Lamda-Max Model 481 UV Detector connected to a Spectra-Physics 
SP4270 Reporting Integrator. 
Many reagents were available from the Aldrich Chemical Company and were used 
as supplied. Drying agents and other inorganic salts were purchased from AJAX or BDH 
Chemicals. Reaction solvents and reagents were purified according to established 
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procedures.59 The concentrations of alkyl lithium solutions obtained from Aldrich were 
determined by titration with sec-butanol ( 1.0 M solution in toluene) using 1, 10-
phenanthroline as indicator. 60 Tetrahydrofuran (THF) and diethyl ether (ether) were 
dried with sodium and then distilled under nitrogen from sodium benzophenone ketyl. 
Benzene, toluene, dichloromethane, hexane and N,N-dimethylformamide (DMF) were 
distilled from calcium hydride. Pyridine was distilled from and stored over potassium 
hydroxide pellets. Diisopropylamine was refluxed over calcium hydride for 4 h then 
distilled under vacuum and stored under nitrogen. Dimethyl sulfoxide (DMSO) was dried 
0 O 
with 4 A molecular sieves, then distilled and stored over 4 A molecular sieves. 
Triethylamine was refluxed over calcium hydride for 2 h then distilled from calcium 
hydride and stored over potassium hydroxide pellets. 
Reactions employing air- and/or moisture-sensitive reagents were carried out 
under an atmosphere of dry, oxygen-free nitrogen in oven- or flame-dried apparatus. 
Organic solutions obtained from work-up and/or extraction of reaction mixtures were 
dried with magnesium sulphate (MgS04) unless otherwise specified. Solutions were 
concentrated under reduced pressure on a rotary evaporator with the water bath 
temperature generally not exceeding 30 °C. When reactions were conducted at, or below 0 
°C, the internal temperature was monitored using an alcohol thermometer. 
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5. 2 Experimental Procedures Associated with Work Described in 
Chapter Two 
Ethyl (E)-2,6-Heptadienoate (126) 
HO~ 
125 
(i) Swern 
oxidation 
• 
(ii) Ph3P=C(H)C02Et 
EtO 
0 
126 
90 
DMSO (23.7 ml, 334 mmol) was added to a magnetically stirred solution of oxalyl 
chloride (13.4 ml, 153 mmol) in dichloromethane ( 480 ml) maintained under a nitrogen 
atmosphere at -78 °C. After 0.1 h 4-penten-1-ol (125) (12.0 g, 139 mmol, ex 
ALDRICH) was added, dropwise, followed, after a further 0.25 h, by triethylamine (134 
ml, 961 mmol). The resulting mixture was stirred for 0.5 h at -78 °C then warmed to 
room temperature and treated with (carbethoxymethylene)triphenylphosphorane 56 (72.8 
g, 209 mmol) in dry dichloromethane (110 ml). After 2 h at room temperature, the 
reaction mixture was quenched with water (200 ml) and the separated aqueous layer was 
extracted with dichloromethane (3 x 100 ml). The combined organic layers were washed 
with brine (1 x 75 ml) then dried, filtered and concentrated under reduced pressure to give 
a light-yellow oil. An ethyl acetate/hexane (1 :9 v/v) solution of this material was filtered 
through a short pad of t.l.c. grade silica gel to afford, after concentration of the filtrate, 
the title ester 12626,28 (21.0 g, 98%) as a light-yellow oil. This material was of 
sufficient purity for use in the next step of the reaction sequence. 
lH NMR (300 MHz, CDCl3) 8 6.93 (dt, 13,2 = 15.6 and 13,4 = 5.7 Hz, lH), 5.84-
5.73 (complex m, 2H), 5.06-4.96 (complex m, 2H), 4.15 (q, l = 7.1 Hz, 2H), 2.32-
2.17 (complex m, 4H), 1.26 (t, l = 7.1 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 166.5 (C), 148.2 (CH), 137.0 (CH), 121.6 (CH), 
115.4 (CH2), 60.1 (CH2), 32.0 (CH2), 31.4 (CH2), 14.2 (CH3). 
IR (KBr plate, cm-1) 3078, 2980, 2933, 1721, 1655, 1446, 1367, 1315, 1266, 1206, 
1176, 1044, 9 8 9, 914, 8 5 2. 
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Mass Spectrum (70 eV) m/z (%) 154 (M+·, 6), 125 [(M-C2H5-)+, 6], 109 [(M-
C2H5O·)+, 30), 81 [(M-C2H5OCO·)+, 100], 55 (34). 
(E)-2,6-Heptadien-1-ol (127) 
EtO DIBAL HO 
• 
0 
126 127 
Diisobutylaluminium hydride (325 ml of a 1.0 M solution in hexane, 325 mmol, ex 
ALDRICH) was added, dropwise, via syringe to a magnetically stirred solution of ethyl 
(E)-2,6-heptadienoate (126) (20.0 g, 130 mmol) in dichloromethane (650 ml) maintained 
under a nitrogen atmosphere at -78 QC. The resulting mixture was stirred for 2 h at -78 QC 
and then warmed to 18 °C and quenched with tartaric acid (200 ml of a 1 M aqueous 
solution). Stirring was continued until two distinct layers were observed (0.25 h). The 
separated aqueous layer was extracted with dichloromethane (3 x 200 ml) and the 
combined organic phases were washed with brine ( 1 x 200 ml) then dried, filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.25) then afforded the title compound 12726,30 (12.4 g, 
85%) as a light-yellow oil. 
lH NMR (300 MHz, CDCl3) 8 5.85-5.65 (complex m, 3H), 5.04-4.94 (complex m, 
2H), 4.07 (d, J = 4.4 Hz, 2H), 2.15-2.13 (complex m, 4H), 1.67 (s, lH). 
13C NMR (75.5 MHz, CDC13) 8 138.0 (CH), 132.4 (CH), 129.3 (CH), 114.8 (CH2), 
63.7 (CH2), 33.2 (CH2), 31.5 (CH2). 
IR (KBr plate, cm-1) 3326, 2923, 1641, 1437, 1087, 1000, 970,911. 
Mass Spectrum (70 eV) m/z (%) 111 [(M-H·)+, 1], 94 [(M-HO·)+, 13], 83 (13), 79 
[(M-C2H3O·)+, 100], 70 (42), 66 (16), 57 (65). 
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(2R-trans )-2,3-0xiranehept-6-en-1-ol [ ( + )-128] 
HO 
127 
KSAE 
• diethyl(-)tartrate 
0 
HO~_ ..,,,~ 
(+)-128 
0 
92 
A magnetically stirred suspension of finely powdered and activated 4 A molecular sieves 
(LO g) in dry dichloromethane (137 ml) was cooled to -40 °C then treated, sequentially, 
with diethyl D-(-)-tartrate (0.92 ml, 5.38 mmol), Ti(O-i-Pr)4 (1.32 ml, 4.50 mmol) and 
tert-butyl hydroperoxide (TBHP) (17.2 ml of a 5.2 M solution in isooctane, 89 mmol, 
prepared by iso-octane extraction of 70 % tert-butyl hydroperoxide ex ALDRICH31 ). 
The resulting mixture was stirred at -40 °C for 0.5 h then a solution of compound 127 
(5.0 g, 44.64 mmol) in dichloromethane (20 ml) was added, via cannula, at such a rate as 
to maintain the reaction temperature below -20 °C. After an additional 3 hat -20 °C the 
reaction mixture was warmed to O °C then treated with water (26 ml). The reaction 
mixture was then warmed to 18 °C and after a further 1 h treated with NaOH (6.0 ml of a 
30% aqueous solution saturated with sodium chloride) and stirred vigorously. After ca. 
0.2 h of stirring, the mixture was filtered through a small pad of Celite™ then the 
separated aqueous layer was extracted with dichloromethane (3 x 150 ml). The combined 
organic layers were dried, filtered and concentrated under reduced pressure and the oily 
residue thus obtained was subjected to flash chromatography (silica, 3 :7 v/v ethyl 
acetate/hexane elution). Concentration of the appropriate fractions (Rf = 0.3) then 
afforded the title compound ( + )-128 ( 4.0 g, 70%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.90-5.73 (complex m, lH), 5.10-4.95 (complex m, 
2H), 3.94-3.88 (complex m, lH), 3.66-3.58 (complex m, lH), 3.01-2.90 (complex m, 
2H), 2.20 (m, 2H), 1.76 (t, J = 6.5 Hz, lH), 1.71-1.64 (complex m, 2H). 
13C NMR (75.5 MHz, CDC13) 8 137.4 (CH), 115.3 (CH2), 61.7 (CH2), 58.6 (CH), 
55.4 (CH), 30.8 (CH2), 30.1 (CH2). 
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IR (KBr plate, cm-1) 3401, 3078, 2979, 2928, 1641, 1449, 1088, 1030, 997, 914, 
882, 720, 642. 
Mass Spectrum (70 eV) m/z (%) 97 [(M-OHCH2·)+, 18], 83 (14), 67 (100), 55 (75). 
Specific Rotation [a]n +33 (c 1.2) 
(±)-trans-2,3-0xiranehept-6-en-1-ol [ (±)-128] 
HO 
0 
m-CPBA HO~_.,,,,~ 
~ 
127 (+) 128 
A magnetically stirred solution of allylic alcohol 127 (50 mg, 0.45 mmol) in 
dichloromethane (2.5 ml) was treated, portionwise, with m-chloroperbenzoic acid (132 
mg of technical grade material containing ca. 70% peracid, ca. 0.54 mmol). After 2 h the 
reaction mixture was quenched with Na2S2O5 (5 ml of a 1.0 M aqueous solution). The 
separated organic phase was washed with NaHCO3 (1 x 5 ml) and water (1 x 5 ml) then 
dried, filtered and concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane 
elution) followed by concentration of the appropriate fractions (Rf= 0.3) then afforded 
the title compound ( + )-128 (25 mg, 44%) as a clear, colourless oil. This material was 
identical, as judged by 1 H NMR, 13c NMR and infrared spectroscopic analysis, with the 
material obtained using the KSAE protocol described above. 
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Mosher Ester Analysis of Epoxides ( + )-128 and (±)-128. Formation of 
Ester 129 and a Diastereoisomer there-of. 
0 
HO~_., ,,~ 
( + )-128 
p JJCH3 
-•---- F3?yo----<f_.,,,~ 
0 
129 
A nitrogen atmosphere was established over a magnetically stirred solution of DMAP (18 
mg, 0.15 mmol) and triethylamine (0.1 ml) in dichloromethane (0.5 ml), which was then 
treated with epoxy-alcohol ( + )-128 ( 19 .2 mg, 0.15 mmol) and ( + )-a-methoxy-a-
(trifluoromethy l)phenylacetyl chloride31 (0.04 ml. 0.20 mmol). The resulting solution 
became warm and turned orange in colour. After 0.1 h the reaction mixture was treated 
with NaHCO3 (5 ml of a saturated aqueous solution) and extracted with dichloromethane 
(2 x 10 ml). The combined organic extracts were washed with brine (1 x 5 ml) then dried, 
filtered and concentrated under reduced pressure to afford a pale-yellow oil which was 
subjected to flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution). 
Concentration of the appropriate fractions (Rf= 0.4) afforded Mosher ester 129 (21.7 
mg, 42%) as a clear colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.82 (d, J = 7.6 Hz, 2H), 7.35-7.05 (complex m, 3H), 
5.69 (m, lH), 5.00 (m, 2H), 4.30 (dd, J = 12.2 and 3.2 Hz, lH), 3.80 (dd, J = 12.2 
and 5.8 Hz, lH), 3.54 (s, 3H), 2.63 (m, lH), 2.53 (m, lH), 1.97 (m, 2H), 1.32 (m, 
2H). 
13C NMR (75.5 MHz, C6D6) 8 166.9 (C), 138.0 (CH), 133.1 (C), 130.2 (CH), 
129.1 (CH), 127.9 (CH), 127.9 (CH), 127.8 (CH), 126.5 (C), 122.6 (C), 115.7 
(CH2), 66.1 (CH2), 55.9 (CH3), 55.8 (CH), 55.8 (CH), 31.2 (CH2), 31.0 (CH2). 
The racemic epoxide ( + )-128 (25 mg, 0.2 mmol) was converted into the corresponding 
mixture of diastereoisomeric Mosher esters by reaction with ( + )-a-methoxy-a-
(trifluoromethyl)phenylacetyl chloride under the conditions described immediately 
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above. 1 H NMR and 13c NMR spectroscopic analysis of this material revealed it to be a 
1: 1 mixture of compound 129 and the diastereoisomeric ester derived from ent- 128. 
The most diagnostic 1 H NMR signals due to the (R)-MTPA ester derivative of ent-128 
appear (in C6D6) at 8 4.14 (dd, J = 12.2 and 3.2 Hz, lH) and 3.90 (dd, J = 12.2 and 
5.8 Hz, lH) [the corresponding signals for 129 appear at 8 4.30 and 3.80 respectively 
(see preceding paragraph)]. 
(2S ,3S)-3-Methyl-6-heptene-1,2-diol (130) 
0 
HO~_ .. ,,,~ 
( + )-128 
Me3Al 
• 
OH 
130 
Me3Al (131 ml of a 2.0 M solution in hexane, 262 mmol, ex ALDRICH) was added, 
dropwise, to a magnetically stirred solution of epoxide ( + )-128 (11.15 g, 87 mmol) in 
dichloromethane (90 ml) maintained at O °C under a nitrogen atmosphere. After addition 
was complete, the reaction mixture was stirred at 18 °C for 10 hand then chilled (0 °C) 
and quenched (CAUTION) with HCl (75 ml of a 1 M aqueous solution). The aqueous 
layer was extracted with dichloromethane (3 x 150 ml) and the combined organic layers 
washed with water ( 1 x 100 ml) then dried, filtered and concentrated under reduced 
pressure. The oily residue obtained in this manner was subjected to flash chromatography 
(silica, 1: 1 v/v ethyl acetate/hexane elution). Concentration of the appropriate fractions 
(Rf= 0.4) then afforded the title compound 130 (10.41 g, 83%) as a clear, colourless 
oil. 
lH NMR (300 MHz, CDCl3) 8 5.78 (m, lH), 5.03-4.88 (complex m, 2H), 3.70-3.60 
(complex m, lH), 3.53-3.40 (complex m, 2H), 3.20 (br s, 2H), 2.20-2.08 (complex m, 
lH), 2.05-1.90 (complex m, lH), 1.70-1.54 (complex m, 2H), 1.29-1.18 (complex m, 
lH), 0.88 (d, J = 7.0 Hz, 3H). 
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13C NMR (75.5 MHz, CDCl3) 8 138.8 (CH), 114.5 (CH2) , 76.1 (CH), 64.6 (CH2), 
35.5 (CH), 31.6 (CH2), 31.1 (CH2), 15.1 (CH3). 
IR (KBr plate, cm-1) 3368, 3077, 2962, 2928, 1640, 1458, 1380, 1073, 995, 909, 
880, 637. 
Mass Spectrum (70 eV) m/z (%) 145.1 (M+H+, 3), 144 (M+·, 3), 143 [(M-H·)+, 2], 
126 (33), 111 (36), 108 (12), 101 (15), 95 (100), 87 (10), 83.1, (24), 79 (25), 71 (53), 
61 (48), 55 (76). 
HRMS calcd for C8H16O2 (M-H·)+, 143.1072. Found: (M-H·)+, 143.1070. 
Specific Rotation [a]o -5.7 (c 1.2) 
(2S ,3S)-3-Methyl-6-heptene-1,2-diol Diacetate (131) 
OH OAc 
HO AcfJ , DMAP AcO 
• pyridine 
130 131 
A magnetically stirred solution of diol 130 (5.54 g, 38.5 mmol) in pyridine (21 ml) was 
treated with acetic anhydride (12.7 ml, 134 mmol) and 4-(N,N-dimethylamino)pyridine 
(10 mg, 0.08 mmol). The resulting mixture was stirred at 18 °C for 3 h then poured onto 
ice (ca. 50 g) and extracted with ether (1 x 100 ml). The separated organic phase was 
washed with HCl (2 x 20 ml of a lM aqueous solution), NaHCO3 (2 x 20 ml of a 
saturated aqueous solution) and brine ( 1 x 20 ml) then dried, filtered and concentrated 
under reduced pressure. The oily residue thus obtained was subjected to flash 
chromatography (silica, 3:7 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf= 0.65) then afforded the title compound 131 (8.40 g, 96%) as 
a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.76 (m, lH), 5.03-4.90 (complex m, 3H), 4.27 (dd, J 
= 12.0 and 3.0 Hz, lH), 4.05 (dd, J = 12.0 and 4.2 Hz, lH), 2.15-1.90 (complex 
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m, 2H), 2.06 (s, 3H), 2.03 (s, 3H), 1.85-1.73 (complex m, lH), 1.50 (m, lH), 1.23 
(m, lH), 0.92 (d, J = 6.9 Hz, 3H). 
13C NMR (75.5 MHz, CDCl3) 8 170.8 (C), 170.6 (C), 138.2 (CH), 114.8 (CH2), 
74.9 (CH), 63.6 (CH2), 33.6 (CH), 31.3 (CH2), 31.0 (CH2), 21.0 (CH3), 20.9 
(CH3), 15.0 (CH3). 
IR (KBr plate, cm-1) 2973, 2937, 1744, 1641, 1458, 1371, 1227, 1048, 1020, 913, 
605. 
Mass Spectrum (70 eV) m/z (%) 229 (M+H+, 2), 213 [(M-H3C·)+, 24], 169 (38), 
145 (18), 126 (42), 115 (76), 114 (78), 108 (90), 95 (100), 93 (96), 86 (38), 79 (70), 
67 (64), 55 (76). 
HRMS calcd for C12H21O4 (M+H+), 229.1439. Found: (M+H+), 229.1439. 
Specific Rotation [a]n +5.24 (c 1.3) 
[S-(R *, R *) ]-5,6-bis(Acetyloxy)-4-methylhexenal (101) 
OAc OAc 
AcO 03, Ph:,P AcO 
• 
131 101 
A magnetically stirred solution of diacetate 131 (10.50 g, 45.65 mmol) in 
dichloromethane (575 ml) was cooled to -78 °C then treated with a stream of ozone gas 
until a blue colour persisted. The reaction mixture was then warmed to -30 °C and 
triphenyl phosphine (12.0 g, 45.65 mmol) was carefully added in portions. After the 
addition was complete, the reaction mixture was allowed to warm to room temperature 
then concentrated under reduced pressure. The residue there-by obtained was subjected to 
flash chromatography (silica, 3:7 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rf= 0.3) gave the title compound 10120 (8.37 g, 79%) as a pale-
yellow oil. 
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lH NMR (300 MHz, CDCl3) 8 9.77 (s, lH), 4.94 (m, lH), 4.31 (dd, J = 12.1 and 
2.9 Hz, lH), 4 .05 (dd, I= 12.1 and 6.8 Hz, lH), 2.60-2.30 (complex m, 2H), 2.07 (s, 
3H), 2.04 (s, 3H), 1.90-1.72 (complex m, 2H), 1.54-1.44 (complex m, lH), 0.93 (d, J 
= 6.8 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 201.8 (CH), 170.8 (C), 170.6 (C), 74.5 (CH), 63.4 
(CH2), 41.2 (CH2), 33.5 (CH), 24.1 (CH2), 21.0 (CH3), 20.8 (CH3), 15.1 (CH3). 
IR (KBr plate, cm-1) 2967, 2727, 1744, 1371, 1227, 1048, 959,605. 
Mass Spectrum (70 eV) m/z (%) 231 (M+H+, 15), 213 (6), 187 (23), 171 (27), 157 
(8), 145 (38), 126 (33), 115 (60), 103 (53), 97 (100), 84 (48), 72 (38). 
HRMS calcd for C11H13O5 (M+H)+, 231.1232. Found: (M+H)+, 231.1232. 
Specific Rotation [cx]n +7.3 (c 2.0 in MeOH) 
Methyl {S-[R * ,R *-(Z)] }-7 ,8-bis (Acety loxy)-6-methyl-2-octenoate (102) 
OAc 
AcO 
101 
Still-Gennari AcO 
• 
olefination 
OAc 
C02Me 
102 
KHMDS (73.0 ml of a 0.5 M solution in toluene, 36.52 mmol) was added, dropwise, to 
a magnetically stirred solution of bis(2,2,2-trifluoroethyl) 
(methoxycarbonylmethyl)phosphonate (7.73 ml, 36.5 mmol) and l8-crown-6/CH3CN 
complex57 (48.3 g, 183 mmol) in dry THF (140 ml) maintained at -78 °C under an 
atmosphere of nitrogen. The reaction mixture was stirred at -78 °C for 0.5 h then treated 
with aldehyde 101 (8.40 g, 36.52 mmol). After 1 h at this temperature, the reaction 
mixture was quenched with NH4Cl (60 ml of a saturated aqueous solution ) then allowed 
to warm to room temperature. The resulting mixture was extracted with ether (3 x 50 ml) 
and the combined organic phases were washed with water (1 x 100 ml) then 
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dried, filtered and concentrated under reduced pressure. The oily residue thus obtained 
was subjected to flash chromatography (silica, 3:7 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf= 0.4) gave the title ester 10220 (8.35 g, 
80%) as a pale-yellow oil. 
lH NMR (300 MHz, CDCl3) 8 6.18 (m, lH), 5.78 (br. d, J = 11.5 Hz, lH), 4.95 (td, 
J = 6.8 and 2.9 Hz, lH), 4.29 (dd, J = 12.0 and 2.9 Hz, lH), 4.06 (dd, J = 12.0 and 
7.1 Hz, lH), 3.70 (s, 3H), 2.68 (m, 2H), 2.07 (s, 3H), 2.04 (s, 3H), 1.82 (m, lH), 
1.65-1.50 (complex m, lH), 1.35-1.20 (complex m, lH), 0.96 (d, J = 7.0 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 170.8 (C), 170.6 (C), 166.7 (C), 149.8 (CH), 119.7 
(CH), 74.9 (CH3), 63.5 (CH2), 51.0 (CH), 33.9 (CH), 31.3 (CH2), 26.3 (CH2), 21.0 
(CH3), 20.8 (CH3), 15.0 (CH3). 
IR (KBr plate, cm- 1) 2953, 1743, 1645, 1439, 1371, 1226, 1176, 1048, 821. 
Mass Spectrum (70 eV) m/z (%) 287 (M+H+, 5), 255 (10), 226 (10), 213 (27), 194 
(35), 184 (29), 166 (52), 153 (70), 139 (100), 107 (74), 81 (90), 72 (34). 
HRMS calcd for C14H22O6 (M+H)+, 287.1494. Found: (M+H)+, 287.1495. 
Specific Rotation [cx]n +9.9 (c 5.4) 
Methyl [2R-(2cx,58,6cx) ]-Tetrahydro-6-(hydroxymethyl)-5-methyl-2H -
pyran-2-acetate (24) 
OAc 
AcO 
102 
(i) K2CO3, 
MeOH 
CO
2
Me (ii) MeOH, 
H2SO4 
• 
C02Me 
24 
A mixture of ester 102 (8.35 g, 29.20 mmol), K2CO3 (20.20 g, 146 mmol) and 
methanol ( 42 ml) was stirred at 18 °C for 24 h then filtered through a sintered-glass 
funnel. Water (100 ml) was added to the filtrate which was acidified to pH 2-3 with 
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HCl (concentrated aqueous solution). The resulting mixture was extracted with diethyl 
ether (3 x 50 ml) and the combined extracts dried, filtered and then concentrated under 
reduced pressure. The light-yellow oil obtained in this manner was suspended in 
methanol (50 ml) containing H2SO4 (six drops of 98% acid) and the resulting mixture 
stirred at 18 °C for 16 h and then poured onto crushed ice (50 g) and extracted with 
diethyl ether (3 x 50 ml). The combined organic extracts were washed with NaHCO3 (1 x 
50 ml of a saturated aqueous solution) then dried, filtered and concentrated under reduced 
pressure. The ensuing oily residue was subjected to flash chromatography (silica, 3:7 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.25) 
then afforded the title compound 2420 ( 4.18 g, 71 % ) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 3.80-3.63 (complex m, 2H), 3.65 (s, 3H), 3.47 (ddd, 
l= 11.4, 7.1 and 4.3 Hz, lH), 3.10 (ddd, l= 9.8, 7.1 and 2.7 Hz, lH), 2.53 (dd, l= 
15.2 and 7.7 Hz, lH), 2.40 (dd, J = 15.2 and 5.4 Hz, lH), 2.21 (dd, J = 8.2 and 4.4 
Hz, lH), 1.80-1.72 (complex m, lH), 1.70-1.60 (complex m, lH), 1.48-1.12 (complex 
m, 3H), 0.80 (d, J = 6.5 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 171.6 (C), 83.5 (CH), 74.0 (CH), 63.7 (CH2), 51.6 
(CH3), 41.1 (CH2), 32.1 (CH2), 31.5 (CH2), 31.1 (CH) 17 .1 (CH3). 
' 
IR (KBr plate, cm-1) 3458 br, 2928, 2873, 1738, 1437, 1199, 1087, 1019. 
Mass Spectrum (70 eV) mlz (%) 203 (M+H+, 26), 184 (23), 171 [(M-H3CO·)+, 
100)], 139 (73), 129 (57), 111 (49), 97 (54), 81 (36), 71 (48), 55 (46). 
HRMS calcd for C10H13O4 (M-H2O)+·, 184.1099. Found: (M-H2O)+·, 184.1097. 
Specific Rotation [a]D +9.8 (c 1.0) {lit.5 [a]D = +9.4 } 
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Methyl [2R-(2cx,58,6cx)]-6-Formyltetrahydro-5-methyl-2H-pyran-2-acetate 
(103) 
C02Me 
24 
Parikh-Doering 
oxidation ..., 
C02Me 
103 
A solution of alcohol 24 (1.0 g, 4.95 mmol) and triethylamine (4.5 ml, 32.1 mmol) in 
dichloromethane (14.2 ml) was added, dropwise, to a magnetically stirred solution of 
sulfur trioxide/pyridine complex (2.52 g, 15.84 mmol, ex ALDRICH) in dimethyl 
sulfoxide/dichloromethane (15.6 ml of a 3:2 v/v mixture) maintained at O °C (ice-bath) 
under a nitrogen atmosphere. The resulting mixture was warmed to 18 °C and stirred for a 
further hour before being quenched with water (130 ml) and extracted with hexane (3 x 
75 ml). The combined organic phases were washed with brine (1 x 50 ml) then dried, 
filtered and concentrated under reduced pressure. The oily residue thus obtained was 
subjected to flash chromatography (silica, 3:7 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf= 0.4) afforded the title compound 10320 
(594 mg, 60%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 9.51 (d, J = 2.3 Hz, lH), 3.80 (m, lH), 3.67 (s, 3H), 
3.41 (dd, J = 10.6 and 2.3 Hz, lH), 2.61 (dd, J = 15.4 and 7.6 Hz, lH), 2.44 (dd, J = 
15.4 and 5.4 Hz, lH), 1.88 (m, lH), 1.70 (m, lH), 1.64-1.50 (complex m, lH), 1.45-
1.20 (complex m, 2H), 0.91 (d, J = 6.6 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 200.6 (CH), 171.4 (C), 86.7 (CH), 73.5 (CH), 51.7 
(CH3), 41.0 (CH2), 32.1 (CH2), 30.8 (CH2), 30.5 (CH), 16.3 (CH3). 
IR (KBr plate, cm-1) 2932, 1740, 1437, 1200, 1090, 1021, 857. 
Mass Spectrum (70 eV) m/z (%) 201 (M+H+, 14), 183 (17), 171 [(M-CHO·)+, 100], 
139 (88), 127 (52), 121 (26), 111 (57), 97 (88), 81 (57), 69 (59), 55 (66). 
HRMS calcd for C10H16O4 (M-CHO·)+, 171.1021. Found: (M-CHO·)+, 171.1020. 
Specific Rotation [cx]D -65 (c 0.45) {lit.5 [cx]D = -62 (c 0.5 in CHCl3)} 
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Methyl [2R-(2a,58,6a) ]-6-Acetyltetrahydro-5-methyl-2H-pyran-2-acetate 
(13) 
C02Me 
103 
(i) MeMgCl 
(ii) Dess-Martin 
oxidation 
• 
C02Me 
13 
Methylmagnesium chloride (0.83 ml of a 3M solution in THF, 2.5 mmol, ex ALDRICH) 
was added, dropwise, to a magnetically stirred solution of aldehyde 103 (500 mg, 2.5 
mmol) in THF (12.5 ml) maintained at -78 °C under a nitrogen atmosphere. After the 
addition was complete the reaction mixture was allowed to warm to 0 °C stirred at this 
temperature for a further 1 h then poured onto a mixture of ice (ca. 20 g) and NH4Cl (20 
ml of a saturated aqueous solution). The resulting mixture was extracted with ether (3 x 
20 ml) and the combined organic phases were washed with water (1 x 30 ml) then dried, 
filtered and concentrated under reduced pressure. The oily residue thus obtained was 
subjected to flash chromatography (silica, 3:7 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf= 0.3) afforded a diastereoisomeric mixture 
of secondary alcohols (190 mg, 35 % ) as a clear, colourless oil. This material was 
dissolved in dichloromethane (8.0 ml) and the resulting solution treated with the Dess-
Martin periodinane36 (560 mg, 1.32 mmol). The mixture thus obtained was stirred at 18 
°C for 1 h then diluted, successively, with diethyl ether (10 ml), NaHCO3 (5 ml of a 
saturated aqueous solution) and Na2S2O3 (5 ml of a 1 M aqueous solution). Stirring was 
continued until two layers become apparent. The separated aqueous phase was extracted 
with diethyl ether (3 x 10 ml) and the combined organic phases were washed with brine 
(lx 10 ml) then dried, filtered and concentrated under reduced pressure. The resulting 
light-yellow oil was subjected to flash chromatography (silica, 3:7 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.3) then 
afforded the title compound 1320 (90 mg, 17%) as a clear, colourless oil. 
Chapter Five 103 
lH NMR (300 MHz, CDCl3) 8 3.78 (m, lH), 3.67 (s, 3H), 3.41 (d, J = 10.2 Hz, 
lH), 2.57 (dd, J = 15.1 and 7.6 Hz, lH), 2.44 (dd, J = 15.1 and 5.4 Hz, lH), 2.14 (S, 
3H), 1.87 (m, lH), 1.72-1.67 (complex m, lH), 1.60-1.18 (complex m, 3H), 0.82 (d, J 
= 6.6 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 207.9 (C), 171.5 (C), 89.0 (CH), 73.7 (CH), 51.7 
(CH3), 41.1 (CH2), 32.2 (CH2), 31.8 (CH3), 31.1 (CH2), 25.8 (CH), 16.9 (CH3). 
IR (KBr plate, cm-1) 2931, 1741, 1719, 1437, 1354, 1199, 1083, 1022, 894. 
Mass Spectrum (70 eV) m/z (%) 215 (M+H+, 5), 183 (10), 171 [(M-CH3CO·)+, 
100], 139 (95), 121 (27), 111 (61), 97 (92), 83 (44), 69 (49), 55 (58). 
HRMS calcd for C11H13O4 (M+H)+, 215.1283. Found: (M+H)+, 215.1282. 
Specific Rotation [a]D -91 (c 1.2) {lit.5 [a]D = -95 (c 1.5 in CHCl3) 
Me thy I { 2R -[ 2 a, 5 8, 6 a ( E) }- 6 -( 3 -Brom o -1- methyl -1- prop en y I) tetra hydro -
5-methyl-2H-pyran-2-acetate (106) 
C02Me 
13 
(i) H2C=C(H)MgBr 
• (ii) PBr3 
Br 
H 
o)!/:6 
< H 
C02Me 
106 
Vinylmagnesium bromide (1.60 ml of a 1 M solution in THF, 1.58 mmol, ex ALDRICH) 
was added, dropwise, to a magnetically stirred solution of ketone 13 (339 mg, 1.58 
mmol) in THF (65 ml) maintained at -78 °C under a nitrogen atmosphere. The resulting 
mixture was stirred at -78 °C for a further 1 h then warmed to O °C, poured into NH4Cl 
(25 ml of a saturated aqueous solution) and extracted with diethyl ether (3 x 50 ml). The 
combined organic extracts were dried, filtered and concentrated under reduced pressure to 
give a light-yellow oil (203 mg) which was subjected to flash chromatography (silica, 1 :4 
v/v ethyl acetate/hexane elution). Concentration of the appropriate fractions (Rf= 0.3) 
then afforded the expected vinyl alcohol 105. This material was immediately subjected to 
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the brominative rearrangement reaction. Thus, PBr3 (50 µl, 0.50 mmol) was injected, via 
syringe, into a magnetically stirred solution of vinyl alcohol (100 mg, 0.41 mmol) in 
diethyl ether (10 ml) maintained at 0 °C under a nitrogen atmosphere. After the addition 
was complete, the reaction mixture was stirred at 0 ° C for a further 1 h and then poured 
onto crushed ice (ca. 10 g). The resulting mixture was extracted with diethyl ether (1 x 30 
ml) and the separated organic phase dried, filtered and then concentrated under reduced 
pressure. Subjection of this material to flash chromatography (silica, 1 :4 v/v ethyl 
acetate/hexane elution) afforded, after concentration of the appropriate fractions (Rf= 
0.3), the title bromide 10620 (117 mg, 93 %) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.69 (t, J = 9.0 Hz, lH), 4.00 (m, 2H), 3.80-3.70 
(complex m, lH), 3.66 (s, 3H), 3.35 (d, J = 9.8 Hz, lH), 2.58 (dd, J = 15.2 and 6.5 
Hz, lH), 2.40 (dd, J = 15.2 and 6.5 Hz, lH), 1.90-1.80 (complex m, lH) , 1.69 (s, 
3H), 1.70-1.65 (complex m, lH), 1.62-1.47 (complex m, lH), 1.40-1.15 (complex m, 
2H), 0.71 (d, J = 6.7 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 171.7 (C), 141.5 (C), 123.9 (CH), 89.5 (CH), 73.8 
(CH), 51.6 (CH3), 41.2 (CH2), 32.3 (CH), 32.2 (CH2), 31.5 (CH2), 28.2 (CH2), 
17.4 (CH3), 11.5 (CH3). 
IR (KBr plate, cm-1) 2951, 2926, 1740, 1436, 1200, 1069, 1019, 865. 
Mass Spectrum (70 eV) m/z (%) 224 [(M-Br·)+ , 8), 194 (49), 178 (13), 134 (46), 
121 (100). 
HRMS calcd for C13H21BrO3 (M-Br·)+, 225.1491. Found: (M-Br·)+, 225.1495. 
Specific Rotation [cx]n -29 (c 2.1) {lit20 [cx]n = -5.2 (c 1.5 in CHCl3)} 
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Methyl {2R -[2a,5 8,6 a( E) }-6-[3-Dipheny lphosphinoy 1)-1-methy 1-1-
propeny I] tetrahydro-5-methy l-2H -pyran-2-acetate (95) 
Br 
Ph2POEt 
• 
C02Me 
106 
0 
11 
P 
.,....,P 
h / 
Ph 
C02Me 
95 
A magnetically stirred solution of bromide 106 (100 mg, 0.33 mmol) and 
diphenylethoxyphosphine (143 µl, 0.66 mmol ex ALDRICH)) in THF (10 ml) was 
heated at reflux until the starting materials had been consumed (ca. 2 h). The cooled 
reaction mixture was then concentrated under reduced pressure and the resulting solid 
recrystallised (diethyl ether) to give the phosphine oxide 9520 ( 119 mg, 85%) as a fine 
white powder, mp 125-126 °C {lit.20 m.p. 125-126 °C}. 
lH NMR (300 MHz, CDCl3) 8 7.74 (m, 4H), 7.50 (m, 6H), 5.50 (m, lH), 3.72-3.60 
(complex m, lH), 3.63 (s, 3H), 3.26 (d, J = 9.7 Hz, lH), 3.23-3.10 (complex m, 2H), 
2.54 (dd, J = 15.1 and 6.5 Hz, lH), 2.37 (dd, J = 15.1 and 6.4 Hz, lH), 1.78-1.60 
(complex m, 2H), 1.47 (s, 3H), 1.45-1.10 (complex m, 3H), 0.42 (d, J = 6.6 Hz, 3H). 
13C NMR (75.5 MHz, CDC13) 8 171.7 (C), 140.0 (d, C), 133.2 (d, C), 131.9 (CH), 
131.0 (d, CH), 128.5 (d, CH), 116.9 (d, CH), 90.0 (CH), 73.8 (CH), 51.5 (CH3), 
41.3 (CH2), 32.1 (CH2), 32.0 (CH3), 31.5 (CH2), 30.7 (d, CH2), 17.2 (CH), 12.2 
(CH3) [d = doublet (due to 13c_3lp coupling)]. 31p NMR 8 31.0. 
IR (KBr disc, cm-1) 2924, 2847, 1736, 1437, 1180, 1120, 1069, 1018, 745,719,697, 
555, 512. 
Mass Spectrum (70 eV) m/z (%) 426 (M+·, 51), 395 (10), 324 (16), 285 (16), 216 
(14), 203 ( 28), 202 [(Ph2POH)+·, 100], 201 [(Ph2PO)+·, 94], 77 (24). 
HRMS calcd for C25H31O4P (M+·), 426.1960. Found: (M+·), 426.1962. 
Specific Rotation [a]D -0.4 (c 1.4) 
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5. 3 Experimental Procedures Associated with Work Described in 
Chapter Three 
Methyl (2S)-3-Benzyloxy-2-methylpropionate (132) 
MeO:zC~OH BnOC(NH)CCl3, MeO:zC~OBn 
------jll•- ' 
TfOH, DCM 
96 132 
106 
Tifluoromethanesulfonic acid (3.40 ml, 38.1 mmol) was added, via syringe, to a 
magnetically stirred solution of methyl (2S)-3-hydroxy-2-methylpropionate 96 (15.0 g, 
127 mmol, ex SIGMA) and benzyl 2,2,2-trichloroacetimidate (28.3 ml, 152.4 mmol) in a 
mixture of cyclohexane (200 ml) and dichloromethane ( 100 ml) maintained under a 
nitrogen atmosphere at 0 °C (ice bath). The reaction mixture was allowed to warm to 
room temperature, stirred for 16 h then filtered through a sintered glass funnel. The 
filtrate was washed with NaHCO3 (1 x 200 ml of a saturated aqueous solution) and water 
(1 x 200 ml) then dried, filtered and concentrated under reduced pressure. The oily 
residue thus obtained was subjected to flash chromatography (silica, 1 :9 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.25) afforded 
the title compound 132 (25.6 g, 97%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.30-7.38 (complex m, 5H) , 4.52 (s, 2H), 3.70 (s, 
3H), 3.68 (dd, J = 8.7 and 7.3 Hz, lH) , 3.50 (dd, J = 9.l and 5.9 Hz, lH) , 2.81-2.75 
(complex m, lH), 1.18 (d, J = 7.1 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 175.6 (C), 138.4 (C) , 128.6 (CH) , 127.9 (CH), 
127.8 (CH), 73.3 (CH2), 72.2 (CH2), 52.0 (CH3) , 40.4 (CH), 14.2 (CH3). 
IR (KBr plate, cm-1) 2862, 1740, 1455, 1201 , 1098, 738,699. 
Mass Spectrum (70eV) m/z (%) 208 ( M+·, 9) , 177 [(M-CH3O·)+, 4] , 121 (16) , 107 
( 5 3), 91 ( 100). 
HRMS calcd for C12H16O3 (M+·), 208.1099. Found: (M+·) , 208.1096. 
Specific Rotation [a]D +12.5 (c 2.4) 
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(2S)-3-Benzyloxy-N-methoxy-N-methyl-2-methylpropanamide (133) 
0 
MeO:zC~OBn Me(MeO)NH.HCl 
• 
i-PrMgCl, THF 
Me, ~OBn N : 
I ~ 
OMe 
132 133 
Isopropylmagnesium chloride(l55.8 ml of a 2.0 M solution in THF, 311.5 mmol, ex 
ALDRICH) was added, steadily and over 0.5 h, to a magnetically stirred suspension of 
ester 132 (21.6 g, 103.8 mmol) and N, O-dimethylhyroxylamine hydrochloride (15.7 g, 
161.0 mmol) in THF (230 ml) maintained under a nitrogen atmosphere at -15 °C. The 
resulting mixture was stirred for 0.5 h at -15 °C by which time TLC analysis revealed 
complete consumption of the starting material. At this point the reaction was quenched 
with NH4Cl (150 ml of a saturated aqueous solution), diluted with water (150 ml) and 
extracted with diethyl ether (3 x 100 ml). The combined organic extracts were washed 
with brine (1 x 100 ml) then dried, filtered and concentrated under reduced pressure. The 
oily residue thus obtained was subjected to flash chromatography (silica, 3:7 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.3) afforded 
the Weinreb amide 133 (23.4 g, 95%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.34-7.27 (complex m, 5H), 4.52 (m, 2H), 3.72 (app. 
t., J = 8.6 Hz, lH) 3.70 (s, 3H), 3.43 (dd, J = 8.8 and 5.9 Hz, lH), 3.25 (m, lH), 
3.22 (s, 3H), 1.12 (d, J = 7.1 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 175.8 (C), 138.3 (C), 128.2 (CH), 127.5 (CH), 
127.4 (CH), 73.1 (CH2), 72.5 (CH2), 61.5 (CH3), 35.8 (CH), 32.2 (CH3), 14.2 
(CH3). 
IR (KBr plate, cm-1) 2862, 1660, 1454, 1102, 994, 739, 699. 
Mass Spectrum (70eV) m/z (%) 238 (M+H+, 11), 206 [(M-CH3O·)+, 11], 177 (25), 
131 (70), 91 (100), 77 (44), 65 (58). 
HRMS calcd for C13H20NO3 (M+H+), 238.1443. Found: (M+H+), 238.1442. 
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Specific Rotation [a]o +4.62 (c 2.0) 
(2S)-1-Benzyloxy-2-methyl-4-penten-3-one (134) 
0 
Me..._ ~OBn N : 
I i 
OMe 
133 
CH2=C(H)MgBr, 
• 
THF 
108 
0 
OBn 
134 
Vinylmagnesium bromide (126.4 ml of a 1.0 M solution in THF, 126.4 mmol, ex 
ALDRICH) was added, dropwise, to a magnetically stirred solution of Weinreb amide 
133 (20.0 g, 84.3 mmol) in THF (833 ml) maintained under a nitrogen atmosphere at 0 
~C (ice bath). The reaction mixture was stirred for a further 0.5 hat this temperature and 
then quenched with NH4Cl ( 450 ml of a saturated aqueous solution). The aqueous layer 
was extracted with diethyl ether (3 x 250 ml) and the combined organic extracts were 
washed with brine (1 x 300 ml) then dried, filtered and concentrated under reduced 
pressure. The oily residue thus obtained was subjected to flash chromatography (silica, 
1 :4 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf = 
0.5) afforded the title ketone 134 (15.8 g, 92%) as a pale-yellow oil. 
lH NMR (300 MHz, CDCl3) 8 7.35-7.25 (complex m, 5H), 6.45 (dd, J = 17.5 and 
10.4 Hz, lH), 6.25 (dd, J = 17.5 and 1.5 Hz, lH), 5.79 (dd, J = 10.4 and 1.5 Hz, lH), 
4.49 (m, 2H), 3.70 (dd, J = 9.2 and 8.4 Hz, lH), 3.47 (dd, I= 9.2 and 5.9 Hz, lH), 
3.18 (m, lH), 1.12 (d, J = 7.0 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 202.5 (C), 138.1 (CH2), 135.5 (CH), 128.4 (C), 
128.3 (CH), 127.5 (C), 73.2 (CH2), 72.0 (CH2), 43.6 (CH), 13.9 (CH3). 
IR (KBr plate, cm-1) 2859, 1697, 1454, 1198, 1101, 1028, 737,698. 
Mass Spectrum (70eV) m/z (%) 205 (M+H+, 10), 107 (35), 98 (75), 91 (100), 77 
(25), 65 (35). 
HRMS calcd for C13H17O2 (M+H+), 205.1229, Found: (M+H+), 205.1226. 
Specific Rotation [a]o + 13.5 (c 2.8) 
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(3S, 4S)-4-Methyl-5-(phenylmethoxy)-l-penten-3-ol (135) and (3R, 
4S)-4-Methyl-5-(phenylmethoxy )-1-penten-3-ol ( 136) 
0 
OBn 
134 
Zn(BH4)2, 
DCM 
OH 
• ~OBn + 
135 
OH 
OBn 
136 
Zinc borohydride (318.1 ml of a 0.43 M solution in diethyl ether, 136.8 mmol, which 
was prepared from zinc chloride and sodium borohydride44) was added, dropwise, to a 
magnetically stirred solution of vinyl ketone 134 (18.6 g, 91.2 mmol) in 
dichloromethane (890 ml) maintained under a nitrogen atmosphere at -78 °C. The 
resulting mixture was stirred for 2 hat -78 °C then warmed (0 °C) and stirred for a further 
0.5 h. The reaction was quenched by transferring the reaction mixture via cannula to a 
rapidly stirred solution of HCl (600 ml of a 1 M aqueous solution) maintained at 0 °C. 
The aqueous layer was extracted with dichloromethane (3 x 250 ml) and the combined 
organic extracts were washed successively with NaHCO3 (1 x 250 ml of a saturated 
aqueous solution) and brine ( 1 x 250 ml) then dried, filtered and concentrated under 
reduced pressure. The ensuing oily residue was then subjected to HPLC (µ-Porasil 40 x 
100 mm cartridge column, 1:9 v/v ethyl acetate/hexane elution, flow rate 30 ml/min) and 
two fractions, A and B, were obtained. 
Concentration of fraction A (Rt 12 min) afforded compound 135 (15.4 g, 82%) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.39-7.28 (complex m, 5H), 5.88 (ddd, I= 17.2, 10.6 
and 5.4 Hz, lH), 5.33-5.16 (complex m, 2H), 4.51 (s, 2H), 4.28-4.25 (complex m, 
lH), 3.56-3.49 (complex m, 2H), 3.0 (br. s, lH), 2.12-2.05 (complex m, lH), 0.91 (d, 
J = 7.0 Hz, 3H) 
13c NMR (75.5 MHz, CDCl3) 8 138.5 (CH), 137.9 (CH2), 128.3 (CH), 127.6 
(CH), 127.55 (CH), 115.0 (C), 75.0 (CH), 73.6 (CH2), 73.3 (CH2), 38.2 (CH), 11.5 
(CH3). 
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IR (KBr plate, cm-1) 3440, 2966, 2860, 1454, 1097, 737, 698. 
Mass Spectrum (70eV) m/z (%) 206 (M+·, 19), 188 (26), 144 (56), 108 (46), 91 
(100). 
HRMS calcd for C13H16O2 (M+·), 206.1307. Found: (M+·), 206.1310. 
Specific Rotation [a]D -9.6 (c 2.8). 
Concentration of fraction B (Rt 16.5 min) afforded compound 13 6 (3 .4 g, 18 % ) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.35-7.29 (complex m, 5H), 5.88 (ddd, J = 17.2, 10.6 
and 5.4 Hz, lH), 5.29-5.13 (complex m, 2H), 4.52 (s, 2H), 4.03 (t, J = 6.7 Hz, lH), 
3.62 (dd, J = 9.3 and 4.3 Hz, lH), 3.47 (dd, J = 9.3 and 7.2 Hz, lH), 3.37 (br. s, lH), 
1.91 (m, lH), 0.91 (d, J = 7.1 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 139.7 (CH), 138.1 (CH2), 128.7 (CH), 128.2 
(CH), 128.0 (CH), 127.9 (CH), 116.1 (C), 76.9 (CH), 74.8 (CH2), 73.7 (CH2), 38.8 
(CH), 14.0 (CH3). 
IR (KBr plate, cm-1) 3430, 2962, 2857, 1454, 1097, 737, 698. 
Mass Spectrum (70eV) m/z (%) 206 (M+·, 37), 188 (54), 144 (82), 108 (50), 91 
(100). 
HRMS calcd for C13H16O2 (M+·), 206.1307. Found: (M+·), 206.1308. 
Specific Rotation [a]D +28.2 (c 2.5). 
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(3R, 4S)-4-Methyl-5-(phenylmethoxy)-1-penten-3-yl (2R )-2-Methoxy-2-
phenyl-2-trifluoromethylacetate (147) 
OH 
rrOBn 
135 
(R)-( + )-MTP A 
(COClh, DMF 
• 
NEt3, DMAP 
0 
Meo,._ Jl 
9 Ph1 ,: CF3rrOBn 
I - 141 
Oxalyl chloride (12.5 µl, 0.14 mmol) followed by N, N-dimethylformamide (1 drop) 
was added to a magnetically stirred solution of (R)-(+)-MTPA (74 mg, 0.32 mmol) in 
dichloromethane (2 ml) maintained at 0 °C (ice bath) under a nitrogen atmosphere. The 
reaction mixture was allowed to warm to room temperature, stirred for a further 0.75 h 
and then transferred, via cannula, to a chilled (0 °C) and magnetically stirred solution of 
the alcohol 135 (24 mg, 0.12 mmol), triethylamine (34 µl, 0.24 mmol) and DMAP (2 
mg) in dichloromethane (3 ml). The cold bath was removed and the reaction mixture was 
stirred at room temperature for 16 h. The solution was then partitioned between 
dichloromethane (10 ml) and NaHCO3 (10 ml of a saturated aqueous solution) and the 
phases separated. The aqueous layer was extracted with dichloromethane (3 x 10 ml) and 
the combined organic fractions were washed with brine (1 x 10 ml) then dried, filtered 
and concentrated under reduced pressure to give a pale-yellow oil. Subjection of the crude 
material to flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution) provided, 
after concentration of the appropriate fractions (Rf= 0.4 ), the title compound 147 (27 
mg, 55%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.53-7.30 (complex m, l0H), 5.84 (ddd, I= 17.2, 
10.4 and 7.0 Hz, lH), 5.67 (dd, J = 7.1 and 4.4 Hz, lH), 5.30 (dd, I= 18.4 and 10.4 
Hz, 2H), 4.40 (d, J = 5.9 Hz, 2H), 3.53 (s , 3H) , 3.26 (dd, I= 6.l and 2.7 Hz, 2H), 
2.10 (m, lH), 0.90 (d, J = 6.9 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 165.8 (C), 138.3 (CH2) , 133.9 (CH), 132.6 (C), 
129.6 (CH), 128.44 (CH), 128.37 (CH) , 127.6 (CH), 127.51 (CH), 127.48 (CH), 
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121.6 (C), 119.6 (C), 115.2 (C), 77.9 (CH), 73.2 (CH2), 71.5 (CH2), 55.4 (CH3), 
37.9 (CH), 11.5 (CH3). 
(3R, 4S)-4-Methyl-5-(phenylmethoxy)-l-penten-3-yl (2R )-2-Methoxy-2-
phenyl-2-trifluoromethylacetate (148) 
OH 
('Y"'OBn 
135 
(S)-(-)-MTPA 
(COClh, DMF 
• NEt3, DMAP 
0 Ph0 ',. 0 
MeO ~ 
CF3~0Bn 
11 i 
148 
Oxalyl chloride (25 µl, 0.29 mmol) followed by N, N-dimethylformamide (1 drop) was 
added to a magnetically stirred solution of (S)-(-)-MTPA (120 mg, 0.51 mmol) in 
dichloromethane (2 ml) maintained at 0 °C (ice bath) under a nitrogen atmosphere. The 
reaction mixture was allowed to warm to room temperature, and stirred for a further 0.75 
h and then transferred, via cannula, to a chilled (0 °C) and magnetically stirred solution of 
the alcohol 135 (50 mg, 0.24 mmol), triethylamine (68 µl, 0.48 mmol) and DMAP (2 
mg) in dichloromethane (3 ml). The cold bath was removed and the reaction mixture was 
stirred at room temperature for 16 h. The solution was then partitioned between 
dichloromethane (10 ml) and NaHCO3 (10 ml of a saturated aqueous solution) and the 
phases separated. The aqueous layer was extracted with dichloromethane (3 x 10 ml) and 
the combined organic fractions were washed with brine (1 x 10 ml) then dried, filtered 
and concentrated under reduced pressure to give a pale-yellow oil. Subjection of the crude 
material to flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution) provided, 
after concentration of the appropriate fractions (Rf= 0.4) , the title compound 148 (48 
mg, 47 % ) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.52-7.30 (complex m, l0H), 5.76 (dd, J = 10.6 and 
4.0 Hz, lH), 5.68 (complex m, 2H), 5.24 (d, J = 16.5 Hz, lH), 5.23 (d, J = l 1.0 Hz, 
lH), 4.50 (d, J = 1.8 Hz, 2H), 3.50 (s, 3H), 3.34 (d, J = 6.6 Hz, 2H), 2.12-2.08 
(complex m, lH), 0.96 (d, J = 7.0 Hz, 3H). 
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13c NMR (75.5 MHz, CDCl3) 8 165.8 (C), 138.2 (CH2), 133.8 (CH), 132.2 (C), 
129.6 (CH), 128.41 (CH), 128.35 (CH), 128.3 (CH), 127.63 (CH), 127.58 (CH), 
127.56 (CH), 121.5 (C), 118.3 (C), 77.8 (CH), 73.2 (CH2), 71.6 (CH2), 55.4 (CH3), 
37.6 (CH), 11.6 (CH3). 
(3S, 4S)-3-Methoxy-4-methyl-5-(phenylmethoxy)-1-pentene (137) 
OH 
~OBn 
135 
Mel, KH, THF 
• 
OMe 
~OBn 
137 
A solution of alcohol 135 ( 4.50 g, 21.8 mmol) in THF (20 ml) was added, dropwise, to 
a magnetically stirred suspension of KH (6.3 g of 35% (w/w) dispersion in mineral oil, 
54.6 mmol) in THF (150 ml) maintained under a nitrogen atmosphere. The resulting 
mixture was stirred at room temperature for 0.25 h then chilled (0 °C) and treated, via 
syringe, with a solution of methyl iodide (3.4 ml, 54.6 mmol) in THF (25 ml). The 
reaction mixture was then allowed to warm to room temperature and stirred for a further 
0.25 h then cautiously poured onto ice (50 g). The resulting mixture was extracted with 
ether (3 x 200 ml) and the combined organic phases were dried, filtered and concentrated 
under reduced pressure. The ensuing oily residue was subjected to flash chromatography 
(silica, 1 :9 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions 
(Rf= 0.6) afforded the title bis-ether 137 (4.1 g, 85%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.35-7.27 (complex m, 5H), 5.69 (ddd, J = 16.5, 10.9 
and 7.7 Hz, lH), 5.24-5.17 (complex m, 2H), 4.50 (s, 2H), 3.62 (t, J = 7.0 Hz, lH), 
3.51 (dd, J = 8.l and 4.5 Hz, lH), 3.31 (dd, J = 9.0 and 6.4 Hz, lH), 3.27 (s, 3H), 
1.94-1.85 (complex m, lH), 0.96 (d, J = 7.1 Hz, 3H) 
13c NMR (75.5 MHz, CDCl3) 8 138.7 (C), 137.1 (CH), 128.3 (CH), 127.6 (CH), 
127.47 (CH), 127.45 (CH), 117.4 (CH2), 83.5 (CH), 73.1 (CH2), 72.4 (CH2), 56.8 
(CH3), 38.5 (CH), 12.2 (CH3). 
Chapter Five 114 
IR (KBr plate, cm-1) 2902, 2856, 1454, 1095, 925, 736, 698. 
Mass Spectrum (70eV) m/z (%) 220 (M+·, 20), 205 (15), 188 (11), 129 (16), 112 
(16), 91 (83), 71 (100), 67 (24). 
HRMS calcd for C14H20O2 (M+·), 220.1463. Found: (M+·), 220.1464. 
Specific Rotation [CX]D +12.2 (c 1.3). 
(2R, 3S)-2-Methoxy-3-methyl-4-(phenylmethoxy)butanal (138) 
OMe 
~OBn 
137 
03, DCM 
• 
then Me2S 
OMe 
nToBn 
-
0 . 
138 
A magnetically stirred solution of alkene 137 (2.0 g, 9.1 mmol) in dichloromethane (200 
ml) was cooled to -78 °C then treated with a stream of ozone gas until a blue colour 
persisted. The reaction mixture was warmed to -30 °C and then dimethyl sulfide (1.3 ml, 
18.2 mmol) was added in small portions. The reaction mixture was allowed to warm to 
room temperature and the solvent was removed under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 1 :9 v/v ethyl acetate/hexane 
elution) and concentration of the appropriate fractions (Rf= 0.4) afforded the title 
aldehyde 138 (1.45 g, 72%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 9.68 (d, J = 1.5 Hz, lH), 7.35-7.29 (complex m, 5H), 
4.50 (q, J = 12.0 and 5.6 Hz, 2H), 3.74-3.39 (complex m, 3H), 3.43 (s, 3H), 2.33-
2.30 (complex m, lH), 0.91 (d, l= 7.1 Hz, 3H) 
13c NMR (75.5 MHz, CDCl3) 8 203.8 (CH), 138.1 (C), 128.4 (CH), 127.6 (CH), 
86.5 (CH), 73.0 (CH2), 71.0 (CH2), 58.9 (CH3), 35.6 (CH), 11.5 (CH3). 
IR (KBr plate, cm-1) 2934, 1732, 1454, 1204, 1091, 738 , 699. 
Mass Spectrum (70eV) m/z (%) 193 [(M- CHO·)+, 18], 131 (18), 107 (40), 91 (100), 
71 (24). 
Specific Rotation [CX]D +22.5 (c 2.2). 
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(2R, 3R, 4S)-3-Methoxy-4-methyl-5-(phenylmethoxy)pentan-2-ol (139) 
OMe OMe 
~OBn 
0 -
Me2Zn, TiCl4, 
• 
DCM 
~
: : OBn 
- . 
- -
- -
OH 
138 139 
A magnetically stirred solution of the aldehyde 138 (1.0 g, 4.5 mmol) in 
dichloromethane ( 45 ml) was cooled to -78 °C then treated with neat TiCl4 (0.5 ml, 4.5 
mmol). After 0.08 h, (Me)2Zn (2.25 ml of 2.0 M solution in THF, 4.5 mmol) was 
added. The resulting mixture was stirred at -78 °C for 0.25 h then water was cautiously 
added at -78 °C and the reaction mixture was allowed to warm to room temperature and 
extracted with dichloromethane (3 x 100 ml). The combined organic extracts were 
washed with brine ( 1 x 25 ml) then dried, filtered and then concentrated under reduced 
pressure. The oily residue thus obtained was subjected to flash chromatography (silica, 
3:7 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf= 
0.25) afforded the title compound 139 (0.75 g, 70%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.35-7.31 (complex m, SH), 4.51 (s, 2H), 3.80 (m, 
lH), 3.48 (s, 3H), 3.44 (d, J = 6.4 Hz, lH), 3.07 (m, lH), 2.60 (br s, lH), 2.10-2.03 
(complex m, lH), 1.19 (d, J = 6.4 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 138.1 (C), 128.4 (CH), 127.7 (CH), 127.6 (CH), 
86.4 (CH), 73.1 (CH2), 72.6 (CH2), 67.9 (CH), 61.0 (CH3), 35.2 (CH), 19.4 (CH3), 
11.8 (CH3). 
IR (KBr plate, cm-1) 3451, 2972, 1454, 1365, 1090, 737, 698. 
Mass Spectrum (70eV) m/z (%) 238 (M+·, 11), 193 (21), 131 (20), 107 (13), 91 
(100), 71 (24), 57 (17). 
HRMS calcd for C14H22O3 (M+·), 238.1569. Found: (M+·), 238.1560. 
Specific Rotation [a]n +8.6 (c 2.8). 
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(2R, 3R, 4S)-3-Methoxy-4-methyl-5-(phenylmethoxy)pentan-2-yl (2R)-2-
Methoxy-2-phenyl-2-trifluoromethylacetate (149) 
OMe 
~
· · OBn . .
-
OH 
139 
(R)-( + )-MTP A 
(COClh, DMF 
• 
NEt3, DMAP 
OMe 
Ph~ Me~b , OBn 
0 149 
Oxalyl chloride (11.5 µl, 0.13 mmol) followed by N, N-dimethylformamide (1 drop) 
was added to a magnetically stirred solution of (R)-( + )-MTPA (31 mg, 0.13 mmol) in 
dichloromethane (0.5 ml) maintained at 0 °C (ice bath) under a nitrogen atmosphere. The 
reaction mixture was allowed to warm to room temperature, stirred for a further 0.75 h 
then transferred, via cannula, to a chilled (0 °C) and magnetically stirred solution of the 
alcohol 139 (15 mg, 63 µmol), triethylamine (18.4 µl, 0.13 mmol) and DMAP (2 mg) in 
dichloromethane (3 ml). The cold bath was removed and the reaction mixture was stirred 
at room temperature for 16 h. The solution was then partitioned between dichloromethane 
(10 ml) and NaHCO3 (10 ml of a saturated aqueous solution) and the phases separated. 
The aqueous layer was extracted with dichloromethane (3 x 10 ml) and the combined 
organic fractions were washed with brine (1 x 10 ml) then dried, filtered and concentrated 
under reduced pressure to give a pale-yellow oil. Subjection of the crude material to flash 
chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution) provided, after concentration 
of the appropriate fractions (Rf= 0.4), the title compound 149 (19 mg, 65%) as a clear, 
colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.55-7.28 (complex m, l0H), 5.17 (m, lH), 4.49 (s, 
2H), 3.54 (s, 3H), 3.47-3.41 (complex m, 2H), 3.34 (d, J = 5.5 Hz, lH), 3.31 (s, 3H), 
2.05-1.90 (complex m, lH), 1.23 (d, J = 6.3 Hz, 3H), 0.87 (d, J = 7.1 Hz, 3H). 
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13c NMR (75.5 MHz, CDCl3) 8 166.1 (C), 138.2 (C), 132.6 (C) , 129.4 (CH), 128.4 
(CH), 128.3 (CH), 127.8 (CH), 127.7 (CH), 127.2 (CH), 125.3 (C) , 122.0 (C), 82.2 
(CH), 75.8 (CH), 73.1 (CH2), 72.3 (CH2) , 60.8 (CH3) , 55.6 (CH3), 35.0 (CH), 16.7 
(CH3), 10.4 (CH3). 
(2R, 3R, 4S)-3-Methoxy-4-methyl-5-(phenylmethoxy)pentan-2-yl (2S)-2-
methoxy-2-phenyl-2-trifluoromethy laceta te ( 150) 
OMe 
~
: : OBn 
-
OH 
139 
(S)-(-)-MTPA 
(COClh, DMF 
• 
NEt3 , DMAP 
OMe 
OM~ p~b ' OBn 
0 150 
Oxalyl chloride (11.5 µl, 0.13 mmol) followed by N, N-dimethylformamide (1 drop) 
was added to a magnetically stirred solution of (S)-(-)-MTPA (31 mg, 0.13 mmol) in 
dichloromethane (0.5 ml) maintained at O °C (ice bath) under a nitrogen atmosphere. The 
reaction mixture was allowed to warm to room temperature, stirred for a further 0.75 h 
then transferred, via cannula, to a chilled (0 °C) and magnetically stirred solution of the 
alcohol 139 (15 mg, 63 µmol), triethylamine (18.4 µl , 0.13 mmol) and DMAP (2 mg) in 
dichloromethane (3 ml). The cold bath was removed and the reaction mixture was stirred 
at room temperature for 16 h. The solution was then partitioned between dichloromethane 
(10 ml) and NaHCO3 (10 ml of a saturated aqueous solution) and the phases separated. 
The aqueous layer was extracted with dichloromethane (3 x 10 ml) and the combined 
organic fractions were washed with brine ( 1 x 10 ml) then dried, filtered and concentrated 
under reduced pressure to give a pale-yellow oil. Subjection of the crude material to flash 
chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution) provided, after concentration 
of the appropriate fractions (Rf= 0.4), the title compound 150 (19 mg, 65%) as a clear, 
colourless oil. 
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lH NMR (300 MHz, CDCl3) 8 7.58-7.28 (complex m, l0H), 5.20 (m, lH), 4.46 (s, 
2H), 3.60 (s, 3H), 3.40-3.34 (complex m, 2H), 3.26 (dd, J = 9.0 and 5.4 Hz, lH), 
3.05 (s, 3H), 1.94-1.90 (complex m, lH), 1.29 (d, J = 6.4 Hz, 3H), 0.84 (d, J = 6.9 
Hz, 3H). 
(2R, 3R, 4S)-2-(t-Bu tyldimethylsiloxy )-3-methoxy-4-methyl-5-(phenyl 
methoxy)pentane (140) 
OMe 
~
: : OBn 
- . 
- -
- -
OH 
139 
TBDMSCl, 
• 
Imidazole / DMF 
OMe 
~
: : OBn 
. . 
- -
- = 
= -
TBDMSO 
140 
A magnetically stirred solution of alcohol 139 ( 1.0 g, 4.2 mmol) and imidazole (0.43 g, 
6.3 mmol) in N, N-dimethylformamide (30 ml) maintained under nitrogen was treated 
with t-butyldimethylsilyl chloride (0.76 g, 5.04 mmol) and the resulting mixture was 
heated at 60 °C ( oil bath) for 3 h. The reaction mixture was then cooled, poured onto 
crushed ice (25 g) and extracted with ether (3 x 40 ml). The combined organic extracts 
were dried, filtered and then concentrated under reduced pressure. The oily residue thus 
obtained was subjected to flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane 
elution) and concentration of the appropriate fractions (Rf= 0.7) then afforded the title 
compound 140 ( 1.2 g, 80%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 7.36-7.28 (complex m, 5H), 4.51 (s, 2H), 3.85 (m, 
lH), 3.53-3.47 (complex m, lH), 3.44 (s, 3H), 3.30 (dd, J = 9.0 and 6.2 Hz, lH) 3.10 
(dd, J = 7.1 and 3.4 Hz, lH), 2.01-1.98 (complex m, lH), 1.10 (d, J = 6.4 Hz, 3H), 
0.90 (s, 9H), 0.86 (d, J = 7.0 Hz, 3H), 0.07 (s, 6H). 
13c NMR (75.5 MHz, CDCl3) 8 138.6 (C), 128.3 (CH), 127.7 (CH), 127.5 (CH), 
85.5 (CH), 73.3 (CH2), 73.0 (CH2), 70.5 (CH), 61.0 (CH3), 35.0 (CH), 26.0 (CH3), 
20.2 (CH3), 18.1 (C), 10.9 (CH3), -4.7 (CH3). 
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IR (K.Br plate, cm-1) 2930, 1455, 1255, 1100, 834, 776. 
Mass Spectrum (70e V) rn/z (%) 295 [ (M-C4H9· )+, 6)], 173 (30), 159 ( 45), 91 ( 100), 
73 (40), 59 (19). 
HRMS calcd for C16H27O3Si (M-C4H9-)+, 295.1730. Found: (M-C4H9·)+, 
295.1730. 
Specific Rotation [a]D + 10.4 (c 1.5). 
(2S, 3R, 4R )-4-(t-Butyldimethylsiloxy)-3-methoxy-2-methylpentan-1-ol 
(141) 
OMe 
~
· · OBn . . 
TBDMSO 
140 
H2, Pd(OHh on C 
• 
THF 
OMe 
~
· · OH . . 
TBDMSO 
141 
A mixture of compound 140 (1.0 g, 2.84 mmol), palladium hydroxide on carbon 
(Pearlman's catalyst) (0.15 g) and THF (50 ml) was stirred vigorously under an 
atmosphere of hydrogen (760 mmHg) for 3 h. The reaction mixture was then filtered 
through a 2 cm deep pad of TLC grade silica and the filtrate concentrated under reduced 
pressure. The ensuing oily residue was subjected to flash chromatography (silica, 3:7 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.5) then 
afforded the title alcohol 141 (0.7 g, 97%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 4.12-3.97 (complex m, lH), 3.60-3.45 (complex m, 
2H), 3.43 (s, 3H), 3.00 (br. s, lH), 2.90 (dd, J = 7.2 and 4.9 Hz, lH), 1.90-1.84 
(complex m, lH), 1.20 (d, J = 6.3 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.91 (s, 9H), 
0.12 (s, 6H). 
13c NMR (75.5 MHz, CDCl3) 8 88.1 (CH), 69.2 (CH), 66.4 (CH2), 59.9 (CH3), 
36.9 (CH), 25.8 (CH3), 18.4 (CH3), 18.0 (C), 13.2 (CH3), -4.8 (CH3), -4.9 (CH3). 
IR (K.Br plate, cm-1) 3444, 2961, 2888, 2861, 1463, 1256, 1094, 835, 809, 775, 734. 
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Mass Spectrum (70eV) m/z (%) 263 (M+H+, 4) , 215 (69), 173 (67) , 159 (84), 89 
( 5 5), 7 3 ( 100), 5 9 ( 44). 
HRMS calcd for C13H30O3Si (M+H+), 263.2043 . Found: (M+H+), 263.2047. 
Specific Rotation [a]D -3.6 (c 1.5). 
(2S, 3R, 4R )-4-(t-B u tyldimethylsiloxy )-3-methoxy-2-methylpen tan al 
(142) 
OMe 
~
: : OH 
. . 
- -
= = 
TBDMSO 141 
Parikh - Doering 
• 
oxidation 
OMe 
~o . . 
TBDMSO 
142 
A solution of triethylamine (1.72 ml, 12.4 mmol) and alcohol 141 (0.5 g, 1.9 mmol) in 
dichloromethane (5 ml) was added, dropwise, to a magnetically stirred solution of the 
sulphur trioxide/pyridine complex (1.2 g , 7.6 mmol) in dimethyl 
sulfoxide/dichloromethane (15.5 ml of a 3:2 v/v mixture) maintained at 0 °C (ice bath) 
under a nitrogen atmosphere. The reaction mixture was allowed to warm to room 
temperature and stirred for a further hour before being quenched with water (25 ml) and 
extracted with hexane (3 x 25 ml). The combined organic extracts were washed with 
brine (1 x 15 ml), then dried, filtered and concentrated under reduced pressure. The oily 
residue thus obtained was subjected to flash chromatography (silica, 1 :9 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.4) afforded 
the title aldehyde 142 (0.5 g, 94 % ) as a clear, colourless oil. Since this aldehyde is 
highly prone to epimerisation it was immediately subjected to the next step of the reaction 
sequence. 
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(3R, 4S, SR, 6R )-6-(t-B u tyldimethy lsiloxy )-2,4-dimethyl-5-methoxy-1-
penten-3-ol (143) 
OMe 
~o 
TBDMSO 
142 
H2C=C(Me)Br, t-BuLi, 
• 
CuBr.DMS, Et20 
TBDMSO 
OMe OH 
143 
Neat 2-bromopropene (6.23 ml, 70.1 mmol) was added, dropwise, to a magnetically 
stirred solution of t-butyllithium (83.3 ml of a 1.7 M solution in pentane, 141.65 mmol, 
ex ALDRICH) in ether (180 ml) maintained under a nitrogen atmosphere at -78 °C. The 
resulting mixture was stirred at this temperature for 0.75 h and then treated with a 
solution of copper(!) bromide-dimethylsulfide complex (7.3 g, 35.6 mmol) in dimethyl 
sulfide ( 45 ml). The resulting mixture was stirred at -78 °C for a further 0.5 h and then 
subjected to addition of a solution of aldehyde 142 (1.35 g, 5.18 mmol) in ether (20 ml). 
Stirring was continued at this temperature for 0.5 h then the reaction mixture was 
quenched with NH4Cl (50 ml of a saturated aqueous solution). The slurry obtained in 
this manner was warmed to room temperature and extracted with ether (3 x 50 ml). The 
combined organic extracts were then dried, filtered and concentrated under reduced 
pressure. The ensuing residue was subjected to flash chromatography (silica, 1.5:8.5 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rf= 0.4) 
afforded the title compound 143 ( 1. 10 g, 70%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.10 (s, lH), 4.92 (s, lH), 4.24 (s, lH), 3.98 (m, 
lH), 3.50 (s, 3H), 3.10 (dd, J = 6.4 and 4.2 Hz, lH), 1.86-1.81 (complex m, lH), 
1.68 (s, 3H), 1.14 (d, J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.84 (d, J = 7.1 Hz, 3H), 0.10 (s, 
6H). 
13c NMR (7 5 .5 MHz, CDCl3) 8 145 .0 (C), 111.2 (CH2), 89 .0 (CH), 77 .2 (CH), 
70.1 (CH), 60.3 (CH3), 36.1 (CH3), 25.9 (CH3), 19.5 (CH), 19.3 (CH3), 18.1 (C), 
7.3 (CH3), -4.6 (CH3), -4.7 (CH3). 
IR (KBr plate, cm-1) 3447, 2931, 1462, 1256, 1093, 988,900,835, 776. 
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Mass Spectrum (70eV) m/z (%) 245 [(M-C4H9-)+, 35], 227 (40), 159 (100), 89 
( 4 9), 7 3 ( 100), 5 9 ( 3 7). 
HRMS calcd for C12H25O3Si (M-C4H9-)+, 245.1573. Found: (M-C4H9-)+, 
245.1570. 
Specific Rotation [a]D +3.2 (c 1.2). 
(2'R, 3'S, 4'S, S'R )-6'-(t-Butyldimethylsiloxy)-2' ,4'-dimethyl-5'-
methoxy-1'-penten-3'-yl Propionate (144) 
OMe OH 
TBDMSO 
143 
(EtCOhO, DMAP 
• pyridine 
TBDMSO 
0 
OMe 0~ 
144 
A magnetically stirred solution of allylic alcohol 143 (150 mg, 0.5 mmol) in pyridine (4 
ml) was treated with propionic anhydride (0.16 ml, 1.2 mmol) and a catalytic amount of 
4-(N, N-dimethylamino)pyridine (2 mg, 0.02 mmol). The resulting mixture was stirred at 
18 °C for 16 h then poured onto crushed ice ( ca. 10 g) and extracted with ether (3 x 25 
ml). The combined organic extracts were then washed with HCl (10 ml of a 1 M aqueous 
solution) and brine (10 ml) before being dried, filtered and concentrated under reduced 
pressure. Subjection of this material to flash chromatography (silica, 1 :4 v/v ethyl 
acetate/hexane elution) gave, after concentration of the appropriate fractions (Rf= 0.6), 
the title ester 144 (160 mg, 90%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.25 (d, J = 8.0 Hz, lH), 5.02-5.00 (complex m, 2H), 
3.91 (m, lH), 3.43 (s, 3H), 2.92 (dd, J = 6.5 and 2.8 Hz, lH), 2.34 (q, J = 7.5 Hz, 
2H), 2.06-1.99 (complex m, lH), 1.70 (s, 3H), 1.14 (t, J = 7.6 Hz, 3H), 1.10 (d, J = 
6.4 Hz, 3H), 0.90 (s, 9H), 0.89 (d, J = 8.8 Hz, 3H), 0.08 (s, 6H). 
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13c NMR (75.5 MHz, CDCl3) 8 173.5 (C), 142.0 (C), 115.5 (CH2), 85.0 (CH), 
79.9 (CH), 70.2 (CH), 60.5 (CH3), 35.5 (CH3), 27.9 (CH2), 26.0 (CH3), 20.1 (CH), 
18.1 (C), 18.0 (CH3), 9.6 (CH3), 9.2 (CH3), -4.6 (CH3). 
IR (KBr plate, cm-1) 2931, 1741, 1463, 1256, 1184, 1095, 1006, 903,835,776. 
Mass Spectrum (70eV) m/z (%) 301 [(M-C4H9-)+, 4], 227 (14), 159 (70), 89 (62), 
73 (84). 
HRMS calcd for C15H29O4Si (M-C4H9-)+, 301.1835. Found: (M-C4H9-)+, 
301.1839. 
Specific Rotation [a]n -22 (c 1.6 ). 
( 2 S, 6S , 7 R , SR , 4E ) - 8 - ( t- But y Id i met h y Is i Io x y) - 7 - met ho x y - 2, 4, 6 -
trimethyl-4-nonenoic Acid (145) 
0 
OMe o¼ 
TBDMSO 
144 
LDA, HMPA, 
• THF, TBDMSCI 
TBDMSO 
OMe 
C02H 
145 
A magnetically stirred solution of diisopropylamine (27 µl, 0.2 mmol) in THF (1.5 ml) 
was cooled to -10 °C then treated with n-butyllithium (113 µl of a 1.6 M solution in 
hexane, 0.18 mmol, ex ALDRICH). The resulting mixture was stirred at -10 °C for 0.25 
h and then warmed to 18 °C and stirred for a further 0.25 h. After this time the mixture 
was cooled to -40 °C and THF (0.3 ml) then dry HMPA (0.15 ml) were added. 
Subsequently the reaction mixture was cooled to -78 °C and a solution of propionate ester 
144 (50 mg, 0.14 mmol) was added dropwise over a period of 0.16 h. After 0.25 h 
TBDMSCl (0.03 g, 0.19 mmol) in THF (0.1 ml) was added rapidly with vigorous 
stirring. The resulting mixture was stirred at -78 °C for 0.25 h and then allowed to warm 
to room temperature over a 0.75 h period. After heating to 60 °C for 6 h, the reaction 
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mixture was diluted with HCl (5 ml of a 1 M aqueous solution) and extracted with ether 
(3 x 10 ml). The combined organic phases were washed with brine (1 x 10 ml) then 
dried, filtered and concentrated under reduced pressure. Subjection of this material to 
flash chromatography (silica, 1.5:8.5 v/v ethyl acetate/hexane elution) gave, after 
concentration of the appropriate fractions (Rf= 0.2), the title acid 145 (38 mg, 75%) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.20 (d, J = 9.3 Hz, lH), 3.83 (t, J = 6.7 Hz, lH), 
3.43 (s, 3H), 2.80 (t, J = 5.4 Hz, lH), 2.65-2.53 (complex m, 2H), 2.41-2.35 
(complex m, lH), 2.08-2.01 (complex m, lH), 1.61 (s, 3H), 1.13 (d, J = 6.7 Hz, 3H), 
1.11 (d, J = 6.7 Hz, 3H), 1.00 (d, J = 6.7 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 
13c NMR (75.5 MHz, CDCl3) 8 182.4 (C), 131.8 (CH), 130.1 (C), 89.7 (CH), 70.1 
(CH), 60.8 (CH3), 43.7 (CH2), 37.9 (CH), 33.8 (CH), 25.9 (CH3), 20.1 (CH3), 18.1 
(C), 16.4 (CH3), 15.8 (CH3), 15.4 (CH3), -4.56 (CH3), -4.6 (CH3). 
IR (KBr plate, cm-1) 2958, 2931, 1709, 1254, 1093, 834,776. 
Mass Spectrum (70eV) m/z (%) 358 (M+H+, 3), 301 [(M-C4H9-)+, 14], 225 (8), 
203 (90), 159 (57), 133 (59), 89 (69), 73 (100). 
HRMS calcd for C15H29O4Si (M-C4H9-)+, 301.1835. Found: (M-C4H9-)+, 
301.1836. 
Specific Rotation [a]n +5.82 (c 2.15 ). 
( 2 S, 6S, 7 R , SR , SE) - 8 - ( t- But y Id i met h y Is i Io x y) - 7 -met ho x y - 2, 4, 6 -
trimethyl-4-nonen-1-ol (146) 
OMe OMe 
C02H 
LiAlH4 • OH 
TBDMSO 
145- TBDMSO 146 
LiAlH4 (0.28 ml of a 1 M solution in THF, 0.28 mmol, ex ALDRICH) was added, 
dropwise, to a magnetically stirred solution of the acid 145 (100 mg, 0.28 mmol) in ether 
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( 4 ml) maintained under a nitrogen atmosphere at O °C. The resulting mixture was allowed 
to warm to room temperature and stirred for a further 1 h then cooled and treated 
sequentially with water (2 ml), NaOH (2 ml of a 10% (w/v) aqueous solution) and water 
(5 ml). The resulting precipitate was filtered off and the solids thus retained were washed 
successively with ether (1 x 50 ml) and hot chloroform (1 x 25 ml). The combined 
filtrates were then dried, filtered and concentrated under reduced pressure to give a light 
-yellow oil. Subjection of this material to flash chromatography (silica, 1 :4 v/v ethyl 
acetate/hexane elution) gave, after concentration of the appropriate fractions (Rf= 0.4), 
the title alcohol 146 (63 mg, 66%) as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 5.20 (d, J = 9.2 Hz, lH), 3.83 (m, lH), 3.53-3.47 
(complex m, 2H), 3.44 (s, 3H), 2.80 (t, J = 5.7 Hz, lH), 2.58-2.55 (complex m, lH), 
2.10-2.03 (complex m, lH), 1.87-1.80 (complex m, 2H), 1.62 (s, 3H), 1.12 (d, J = 6.2 
Hz, 3H), 0.92 (d, J = 6.7 Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 
6H). 
13c NMR (75.5 MHz, CDCl3) 8 132.0 (C), 131.0 (CH), 89.7 (CH), 70.1 (CH), 68.6 
(CH2), 60.9 (CH3), 44.4 (CH2), 33.72 (CH), 33.69 (CH), 26.0 (CH3), 20.1 (CH3), 
18.1 (C), 16.9 (CH3), 16.1 (CH3), 15.4 (CH3), -4.56 (CH3), -4.60 (CH3). 
IR (KBr plate, cm-1) 3337, 2957, 2930, 1255, 1093, 834, 775. 
Mass Spectrum (70eV) m/z (%) 344 (M+·, 9), 312 (14), 287 [(M-C4H9-)+, 17], 255 
[(M-C4H9-MeOH·)+, 12], 203 (82), 159 (58), 133 (56), 89 (75), 73 (100), 59 (42). 
HRMS calcd for C19H40O3Si (M+·), 344.2747. Found: (M+·), 344.2750. 
Specific Rotation [a]D +6.4 (c 1.6). 
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[(2'R, 4'R)-(Dimethyl-tetrahydrofuran-2'-yl)]-(1R, 2R, 3R, 4R)-3-
methoxy-2-methyl-1,4-diol 159 and [(2'R, 4'R )-(Dimethyl-
tetrahydrofuran-2' -y I)]-( 1S, 2R, 3R, 4R )-3-methoxy-2-methy 1-1,4-diol 
(160) 
TBDMSO 
OMe 
TBDMSO 
OMe 
155 i HCI (trace) 
OMe OH 
- -
- -
- -. . 
. ' 
~ ~ ,, ' ./"--.... /l>o 
TBDMsb ~ . 
157 
ITBAF, THF 
t0 °Ctort 
OMe OH 
- -: : 
. ' 
·' , 
~ 
~,, ~ : )()''·. 0 
HO i 
159 · .. , ., 
,, 
OH 
146 
Dime thy ldioxirane, 
Acetone, -78 °C to rt 
OH + 
OMe 
TBDMSO 
156 i HCI (trace) 
OMe OH 
~ · ,, ~ '✓>o 
TBDMsb i . 
158 
I TBAF, THF f 0 °C to rt 
OMe OH 
. 
--~ 
T{'>c) 
160 --~ 
OH 
Dimethyldioxirane (2.2 ml of a 0.1 M solution in acetone, 0.22 mmol) was added to a 
magnetically stirred solution of alcohol 146 (75 mg, 0.22 mmol) in anhydrous acetone (1 
ml) maintained under a nitrogen atmosphere at -78 °C. The resulting mixture was stirred 
for 1 h at -7 8 °C and then allowed to warm to room temperature and concentrated under 
reduced pressure. TLC analysis of the yellow oil thus obtained (1 :4 v/v ethyl 
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acetate/hexane elution on silical gel) revealed two spots of Rf 0.2 and 0.25 which are 
attributed to the presence of the diastereoisomeric epoxides 155 and 156. However, the 
instability of these compounds prompted their immediate subjection to acid-catalysed 
cyclisation so as to form tetrahydrofurans 157 and 158. Thus, a solution of epoxides 
155 and 156 in dichloromethane (4 ml) was treated with 1 M aqueous HCl (1 drop) and 
the resulting mixture stirred at room temperature for 0.5 h then diluted with 
dichloromethane (10 ml) and water (10 ml). The separated organic phase was then dried, 
filtered and concentrated under reduced pressure to give a light-yellow oil which by 1 H 
NMR analysis contained two major products 157 and 158. Tetra-n-butylammonium 
fluoride (308 µl of a 1 M solution in THF, 0.15 mmol) was added, dropwise, to a 
magnetically stirred solution of compounds 157 and 158 (56 mg, 0.15 mmol) in THF 
(2 ml) maintained under a nitrogen atmosphere at 0 °C. The resulting mixture was allowed 
to warm to room temperature and stirred for a further 3 h then water (5 ml) was added 
and the phases separated. The aqueous layer was extracted with dichloromethane (3 x 10 
ml) and the combined organic phases were washed with brine (1 x 5 ml), dried, filtered 
and concentrated under reduced pressure to give a light-yellow oil. Subjection of this 
material to flash chromatography (silica, 1: 1 v/v ethyl acetate/hexane elution) gave, after 
concentration of the appropriate fractions (Rf= 0.4 ), the mixture of diols 159 and 160 
as a clear, colourless oil. This mixture of diols was subjected to semi-preparative HPLC 
(2,3-propane diol column, 3:7 v/v ethyl acetate/hexane elution, flow rate 2 ml/min) and 
two fractions A and B were obtained in a ratio of 3 : 1. 
Concentration of fraction A (Rt 20 min) afforded compound 160 ( 18 mg, 50%) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 3.94 (t, J = 8.0 Hz, 2H), 3.81 (s, lH), 3.50 (s, 3H), 
3.30 (t, J = 8.9 Hz, lH), 2.88 (dd, J = 5.l and 1.8 Hz, lH), 2.50-2.30 (complex m, 
4H), 1.80-1.70 (complex m, lH), 1.60-1.50 (complex m, lH), 1.26 (d, J = 6.6 Hz, 
3H), 1.23 (s, 3H), 1.04 ( d, I = 6.6 Hz, 3H), 0.95 ( d, I = 7 .2 Hz, 3H). 
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13c NMR (75.5 MHz, CDCl3) 8 87.5 (CH), 86.2 (C), 73.3 (CH2), 72.8 (CH), 65.8 
(CH), 58.6 (CH3), 42.9 (CH2), 35.2 (CH), 33.0 (CH), 24.1 (CH3), 21.1 (CH3), 17.4 
(CH3), 10.1 (CH3). 
Concentration of fraction B (Rt 21 min) afforded compound 159 (7 mg, 16%) as a clear, 
colourless oil. 
lH NMR (300 MHz, CDCl3) 8 4.05-3.90 (complex m, lH), 3.90-3.80 (complex m, 
lH), 3.57 (s, 3H), 3.38-3.20 (complex m, 2H), 2.50-2.20 (complex m, 2H), 1.80-1.70 
(complex m, 2H), 1.64-1.60 (complex m, lH), 1.21 (s, 3H), 1.20 (d, J = 5.6 Hz, 3H), 
1.04 (d, J = 6.5 Hz, 3H), 0.95 (d, I= 6.9 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 87.8 (CH), 86.2 (C), 75.2 (CH2), 72.8 (CH), 65.3 
(CH), 59.2 (CH3), 44.0 (CH2), 35.2 (CH), 33.7 (CH), 23.1 (CH3), 20.4 (CH3), 16.2 
(CH3), 14.1 (CH3). 
( 2 S , 6S , 7 R , SR , SE ) -8 - ( t- B u t y Id i met h y Is i Io x y) - 7 - met ho x y - 2 , 4 , 6 -
trimethyl-4-nonenal (12-epi-94) 
OMe OMe 
Dess-Martin 
OH .d . • 
OXl at10n 
TBDMSO TBDMSO 
146 12-epi-94 
The Dess-Martin periodinane (90 mg, 0.22 mmol) was added to a magnetically stirred 
solution of alcohol 146 (51 mg, 0.15 mmol) in dichloromethane (1.5 ml) maintained at 
18 °C under a nitrogen atmosphere. Stirring was continued for 0.75 h then the reaction 
mixture was diluted with diethyl ether (2 ml), NaHCO3 (2 ml of a saturated aqueous 
solution) and Na2S2O3 (2 ml of a 1 M aqueous solution) and stirring was continued until 
two clear layers were observed. The separated aqueous layer was extracted with diethyl 
ether (2 x 15 ml) and the combined organic fractions were dried, filtered and concentrated 
under reduced pressure to give a light-yellow oil. Subjection of this material to flash 
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chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution) gave, after concentration of 
the appropriate fractions (Rf= 0.7), the title compound 12-epi-94 (31 mg, 62%) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 9.61 (d, I= 2.3 Hz, lH), 5.22 (d, J = 9.3 Hz, lH), 
3.83 (m, lH), 3.43 (s, 3H), 2.80 (t, J = 5.5 Hz, lH), 2.59-2.51 (complex m, lH), 
2.50-2.38 (complex m, lH), 2.04-1.94 (complex m, lH), 1.61 (s, 3H), 1.11 (d, J = 6.7 
Hz, 3H), 1.04 ( d, I = 7 .0 Hz, 3H), 0.91 ( d, I = 6.6 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 
6H). 
This compound is unstable and was not, therefore, subjected to full characterisation but, 
rather, immediately subjected to the next step of the reaction sequence. 
Chapter Five 
5. 4 Experimental Procedures Associated with Work Described in 
Chapter Four 
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Methyl (2S, 3S, 6R )-{[lE, 3E, 7E, llR, lOR, 9R, SS )-11-t-
Butyldimethylsiloxy-10-methoxy-1,5, 7 ,9-tetramethyldodeca-1,3, 7-
trienyl]-3-methyloxan-6-yl}ethanoate (161) and Methyl (2S, 3S, 6R )-
{ [ 1 E, 3E , 7 E , 1 lR , 1 OR , 9 R , SR ) -11- t- But y Id i met h y Is ii ox y -10 -met ho x y -
1,5, 7 ,9-tetramethyldodeca-1,3, 7-trienyl]-3-methyloxan-6-yl}ethanoate 
(162) 
OMe 
TBDMSO 
12-epi-94 
OMe 
OR 
161 CO2Me 
I R=TBDMS I 
+ 
(i) NaH, THF, 55 °C 
then CH2N2 
OMe 
+ 
-
OR 
95 CO2Me 
162 CO2Me 
A solution of phosphine oxide 95 (62 mg, 0.15 mmol) in THF (2 ml) was added, via 
syringe, to a magnetically stirred suspension of NaH (60 mg of a 35% w/w dispersion in 
mineral oil, 1.5 mmol) in anhydrous THF (10 ml) maintained under a nitrogen 
atmosphere. The resulting mixture was stirred at room temperature for 0.5 h and then 
treated with compound 12-epi-94 (50 mg, 0.15 mmol). The reaction mixture was then 
heated to 55 °C and stirring was continued for 2 h. The cooled reaction mixture was then 
poured onto crushed ice and the resulting melt was acidified with concentrated HCl to 
pH~2-3. The mixture thus obtained was extracted with ether (3 x 20 ml) and the 
combined organic extracts were then dried, filtered and concentrated under reduced 
pressure to give a clear, colourless oil. This material was treated with diazomethane (8 ml 
Chapter Five 131 
of a 0.35 M solution in ether, 2.8 mmol) at 0 °C and the resulting mixture was allowed to 
warm to room temperature and left stirring for 0.5 h. The light-yellow solution thus 
obtained was poured into water (10 ml) and extracted with ether (3 x 10 ml). The 
combined organic extracts were then dried, filtered and concentrated under reduced 
pressure to give a pale-yellow oil. This material was subjected to semi-preparative HPLC 
(2,3-propane diol column, 1 :99 v/v MTBE/hexane elution, flow rate 2 ml/min) and two 
fractions A and B were obtained in a ratio of 1.5: 1. 
Concentration of fraction A (Rt 30 min) afforded the title compound 161 (30 mg, 38%) 
as a clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 6.24-6.13 (complex m, lH), 5.92-5.87 (complex m, 
lH), 5.60-5.50 (complex m, lH), 5.15-5.10 (complex m, lH), 3.86-3.72 (complex m, 
2H), 3.66 (s, 3H), 3.44 (s, 3H), 3.32 (d, J = 9.7 Hz, lH), 2.80-2.75 (complex m, lH), 
2.65-2.48 (complex m, 2H), 2.43-2.33 (complex m, 2H), 2.07-1.95 (complex m, lH), 
1.93-1.76 (complex m, 2H), 1.70 (s, 3H), 1.58 (s, 3H), 1.55-1.20 (complex m, 4H), 
1.12 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.7 Hz, 3H), 0.90 (d, I= 12.1 Hz, 3H), 0.68 (d, 
J = 6.5 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 
13c NMR (75.5 MHz, CDCl3) 8 171.9 (C), 140.6 (CH), 134.2 (C), 131.5 (C), 130.8 
(CH), 128.5 (CH), 123.8 (CH), 90.6 (CH), 89.8 (CH), 73.8 (CH), 70.1 (CH), 61.0 
(CH3), 51.6 (CH3), 47.5 (CH2), 41.3 (CH2), 35.1 (CH), 33.7 (CH), 32.3 (CH2), 
32.1 (CH), 31.7 (CH2), 26.0 (CH3), 20.2 (CH3), 20.1 (CH3), 18.1 (C), 17.7 (CH3), 
16.2, (CH3), 15.5 (CH3), 12.0 (CH3), -4.60 (CH3). 
IR (KBr plate, cm-1) 2954, 1743, 1455, 1254, 1197, 1067, 834, 775. 
Mass Spectrum (70eV) m/z (%) 550 (M+·, 22), 493 [(M-C4H9·)+, 2], 449 (7), 347 
(6), 265 (98), 203 (100), 159 (40), 133 (32), 95 (48), 73 (70), 59 (16). 
HRMS calcd for C32H53O5Si (M+·), 550.4054. Found: (M+·), 550.4060. 
Specific Rotation [a]D +0.35 (c 2.3) 
UV (A,max) 239 nm(£ 21 080). 
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Concentration of fraction B (Rt 26 min) afforded the compound 162 (20 mg, 25%) as a 
clear, colourless oil. 
lH NMR (300 MHz, CDCl3) 8 6.24-6.10 (complex m, lH), 5.90 (d, J = 11.0 Hz, 
lH), 5.60 (dd, J = 15.1 and 7.3 Hz, lH), 5.13 (d, J = 9.5 Hz, lH), 3.84-3.74 (complex 
m, 2H), 3.66 (s, 3H), 3.43 (s, 3H), 3.31 (d, J = 9.8 Hz, lH), 2.80-2.74 (complex m, 
lH), 2.64-2.51 (complex m, 2H), 2.44-2.36 (complex m, 2H), 2.07-2.00 (complex m, 
lH), 1.95-1.81 (complex m, 2H), 1.70 (s, 3H), 1.58 (s, 3H), 1.57-1.20 (complex m, 
4H), 1.12 (d, J = 6.4 Hz, 3H), 0.93 (d, J = 3.9 Hz, 3H), 0.91 (d, J = 4.l Hz, 3H), 
0.69 (d, J = 6.6 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 
13c NMR (75.5 MHz, CDCl3) 8 171.9 (C), 140.7 (CH), 134.2 (C), 131.5 (C), 130.9 
(CH), 128.4 (CH), 123.7 (CH), 90.8 (CH), 89.7 (CH), 73.8 (CH), 70.1 (CH), 60.9 
(CH3), 51.5 (CH3), 47.5 (CH2), 41.3 (CH2), 34.8 (CH), 33.7 (CH), 32.3 (CH2), 
32.3 (CH2), 32.2 (CH), 31.6 (CH2), 26.0 (CH3), 20.2 (CH3), 19.5 (CH3), 18.1 (C), 
17.7 (CH3), 16.2, (CH3), 15.5 (CH3), 12.3 (CH3), -4.60 (CH3). 
IR (K.Br plate, cm-1) 2954, 1743, 1455, 1254, 1197, 1067, 834, 775. 
Mass Spectrum (70eV) rn/z (%) 550 (M+·, 40), 493 [(M-C4H9-)+, 2], 449 (11), 347 
(10), 265 (90), 203 (100), 159 (50), 133 (42), 95 (56), 73 (74), 59 (22). 
HRMS calcd for C32H58O5Si (M+·), 550.4054. Found: (M+·), 550.4049. 
UV (Amax) 239 nm(£ 21 080). 
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Methyl (2S, 3S, 6R)-{[1E, 3E, 1E, llR, lOR, 9R, SS)-11-Hydroxy-10-
methoxy-1,S, 7 ,9-tetramethyldodeca-1,3, 7-trienyl]-3-methyloxan-6-
yl}ethanoate (163) 
OMe 
TBDMSO 
161 
C02Me 
TBAF 
OMe 
OH 
163 C02Me 
Tetra-n-butylammonium fluoride (61 µl of a 1 M solution in THF, 61 µmol) was added, 
dropwise, to a magnetically stirred solution of the compound 161 (23 mg, 0.04 mmol) in 
THF (2 ml) maintained at 0 °C under a nitrogen atmosphere. The resulting mixture was 
allowed to warm to room temperature and stirred for a further 6 h then water (5 ml) was 
added and the phases separated. The aqueous layer was extracted with dichloromethane 
(3 x 10 ml) and the combined organic phases were washed with brine (1 x 5 ml) then 
dried, filtered and concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica, 3:7 v/v ethyl acetate/hexane 
elution) gave, after concentration of the appropriate fractions (Rf= 0.4 ), the title 
compound 163 (12 mg, 68%) as a clear, colourless oil. 
1H NMR (300 MHz, CDCl3) 8 6.23-6.13 (complex m, lH), 5.92-5.88 (complex m, 
lH), 5.60-5.50 (complex m, lH), 5.00-4.95 (complex m, lH), 3.80-3.70 (complex m, 
2H), 3.66 (s, 3H), 3.50 (s, 3H), 3.32 (d, J = 9.7 Hz, lH), 2.72-2.56 (complex m, 3H), 
2.43-2.36 (complex m, 2H), 2.10-1.80 (complex m, 3H), 1.70 (s, 3H), 1.61 (s, 3H), 
1.57-1.23 (complex m, 4H), 1.19 (d, J = 6.5 Hz, 3H), 0.95 (d, J = 6.5 Hz, 3H), 0.70 
(d, I= 4.5 Hz, 3H), 0.68 (d, J = 4.5 Hz, 3H). 
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Methyl (2S, 3S, 6R)-{[1E, 3E, llR, lOR, 9R, SR, 7R, SS)-7,8-Epoxy-
11-hydroxy-1 0-methoxy-1,5, 7 ,9-tetramethyldodeca-1,3-dienyl]-3-
methyloxan-6-yl}ethanoate (163) and Methyl (2S, 3S, 6R )-{ [ lE, 3E, 
1 lR, lOR, 9R, 8S, 7S, SS)-7,8-Epoxy-11-hydroxy-10-methoxy-l,5, 7,9-
tetramethyldodeca-1,3-dieny l]-3-methy loxan-6-y l }ethanoate ( 164) 
OMe 
OH 
OMe 
OH 
5 
163 CO2Me 
+ 
CO2Me 
t-BuOOH, VO(acach 
DCM, -8 °C 
OMe 
,,, 0 
164 CO2Me 
A magnetically stirred solution of compound 163 (20 mg, 0.047 mmol) in anhydrous 
dichloromethane (0.4 ml) maintained at -8 °C using cryobath under nitrogen atmosphere 
was treated with vanadyl bis(acetylacetonate) (0.12 mg, 0.5 µmol) followed by the slow 
addition of a solution of tert-butyl hydroperoxide (TBHP) (28 µl of a 5.0 M solution in 
decane, 0.14 mmol) in anhydrous dichloromethane (0.4 ml) via a syringe pump over 48 
h. After the complete addition of the stoichiometric oxidant the colourless solution was 
allowed to stir for a further 24 h at -8 °C. After this time the mixture was diluted with 
ether (5 ml) and water (5 ml) and the layers shaken well and then separated. The aqueous 
phase was then extracted with dichloromethane (3 x 5 ml) and the combined organic 
extracts were washed with brine ( 1 x 5 ml), dried, filtered under reduced pressure. This 
material was subjected to semi-preparative HPLC (2,3-propane diol column, 1.5:8.5 v/v 
MTBE/hexane elution, flow rate 1 ml/min) and two fractions A and B were obtained. 
Chapter Five 135 
Concentration of fraction A (Rt 35 min) afforded compound 59 (13 mg, 63%) as a clear, 
colourless oil. 
lH NMR (300 MHz, CDCl3) 8 6.23 (dd, J = 15.3 and 10.56 Hz, lH), 5.90 (d, J = 
10.9 Hz, lH), 5.43 (dd, J = 14.9 and 8.8 Hz, lH), 3.86-3.77 (complex m, lH), 3.76-
3.75 (complex m, lH), 3.66 (s, 3H), 3.54 (s, 3H), 3.32 (d, J = 9.8 Hz, lH), 2.97 (t, J 
= 5.4 Hz, lH), 2.63-2.54 (complex m, 2H), 2.43-2.36 (complex m, 2H), 1.92 (dd, J = 
13.7 and 4.7 Hz, lH), 1.86-1.81 (complex m, lH), 1.70 (s, 3H), 1.67-1.56 (complex 
m, 3H), 1.54-1.30 ( complex m, 3H), 1.28 (s, 3H), 1. 18 ( d, J = 6.4 Hz, 3H), 1.04 ( d, I 
= 6.7 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H), 0.66 (d, J = 6.6 Hz, 3H). 
13c NMR (75.5 MHz, CDCl3) 8 171.8 (C), 139.2 (CH), 135.2 (C), 128.1 (CH), 
125.2 (CH), 90.6 (CH), 87.6 (CH), 73.8 (CH), 68.2 (CH), 66.0 (CH), 61.4 (CH3), 
61.3 (C), 51.6 (CH3), 46.9 (CH2), 41.3 (CH2), 35.3 (CH), 35.2 (CH), 32.2 (CH2), 
32.0 (CH), 31.6 (CH2), 22.1 (CH3), 18.9 (CH3), 17.6 (CH3), 16.5 (CH3), 11.9 
(CH3), 11.9 (CH3). 
IR (KBr plate, cm-1) 3454, 2917, 2849, 1738, 1455, 1068. 
Mass Spectrum (70eV) m/z (%) 452 (M+·, 10), 434 (4), 351 (4), 305 (4), 278 (12), 
265 (12), 237 (5), 197 (14), 169 (58), 143 (34), 129 (90), 100 (80), 69 (100). 
HRMS calcd for C26H44O6 (M+·), 452.3138. Found: (M+·), 452.3137. 
Specific Rotation [a]D + 1.3 (c 0.2), {lit.9 [a]D = +0.9 (c 0.7)} 
UV (Amax) 246 nm(£ 21 000). 
Concentration of fraction B (Rt 36 min) afforded trace amounts ( < 0.5 mg) of a light-
yellow oil which is tentatively identified as compound 164, the diastereoisomer of 
herboxidiene me thy 1 ester. 
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Throughout this thesis several different representations, as shown below, have been used to illustrate 
the structure of herboxidiene and various key sub-structures. These varying representations reflect the 
different ways in which such compounds have been portrayed in the literature. 
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Scheme 1.7: Kocienski's Synthesis of the Herboxidiene A Core 41. 
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Scheme 1.7: Kocienski's Synthesis of the Herboxidiene A Core 41. 
Reagents and conditions: (a) TESCl, DMAP, imidazole/CH2Cl2, rt, 2 h; (b) DIEAL/toluene-CH2Cl2, -80 °C (c) EuLi, 
(-)-sparteine/cyclohexane-pentane, -80 °C, 3 h; (d) Ti(O-i-Pr)4/pentane, -80 °C, 20 min; (e) 43 and 45, -80 °C (1.5 h) to 
rt (1 h); (f) PMEO-C(=NH)CCl3, TMSOTf/Et2O, rt; (g) t-EuLi/Et2O, -20 °C; (h) EuLi/THF, -80 °C then ClCO2Me; 
(i) H2 (1 atm), Pd-C/EtOAc, rt; U) DIEAL/CH2Cl2, -80 °C; (k) (EtO)2P(=O)CH2CO2All, NaH/THF, -10 °C; (1) 
DDQ/CH2Cl2-H2O, rt; (m) t-EuOK/THF, -65 °C; (n) TEAF, 4 A molecular sieves/THF, rt; (o) PCC, 4 A molecular 
sieves/CH2Cl2, rt; (p) (EtO)2P(=O)CH2CO2Eut, NaH/THF, 0 °C to rt; (q) TFA, PhSMe/CH2Cl2; (r) 
[Me2N=CHCl]Cl/THF-MeCN then LiAlH(OEut)3. 
Scheme 1.8: Kocienski's Synthesis of the Herboxidiene A Side Chain 40. 
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Scheme 1.8: Kocienski's Synthesis of the Herboxidiene A Side Chain 40. 
Reagents and conditions: (a) 4-Me-2,6-di-t-Bupyr, MeOTf/toluene, 70 °C; (b) t-BuLi/THF, -85 °C, rt; (c) Me3SnCl, -85 
°C, rt; (d) TESCl, DMAP, imidazole/CH2CI2, rt; (e) DIBAL/toluene, -78 °C; (f) I2, PPh3, imidazole/CH2Cl2, rt; (g) t-
BuLi/Et2O-pentane, -80 °C; (h) CuBr.Me2S, Me2S-THF; (i) 53, -35 to O °C; (j) Mel, HMPA/THF, -20 °C; (k) HF-
pyridine/pyridine-THF, 0 °C to rt, 1 h; (1) 2-mercaptobenzothiazole, PPh3, DEAD/THF, rt, 30 min; (m) Mo(NH4)6, 
H2O2/EtOH-H2O, 0 °C to rt 5 h, rt, 24 h. 
Scheme 1.9: Final Stages of Kocienski's Synthesis of Herboxidiene A (39): Union of the Core 41 
and the Side Chain 40. 
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Scheme 1.9: Final Stages of Kocienski's Synthesis of Herboxidiene A (39): Union of the Core 41 
and the Side Chain 40. 
Reagents and conditions : (a) THF, -78 °C; (b) HF.pyr/THF-pyridine, rt; (c) VO(acac)2, t-BuOOH/CH2Cl2, 0 °C; (d) 
Pd(PPh3)4, morpholine/THF, rt. 
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Scheme 1.10: Kocienski's Synthesis of the C-1 to C-10 Core Fragment 41 of 
Herboxidiene (1). 
Appendix 1 147 
,,, t~~_.,,,, .•' b a I 
• • 
0 X ,,, ........ -0 X,,, C 
'O C 
61 62 63 i c,d 
~~,,,, f t~/' • e t~~_.,,,, 0 .•• • 
- l -67 - 66 OH 64 
tg 
............. 
,,, fl,,, 
·' 1 ~.'' j,k 
:•- • 
R10AO~ 
~ 
HO 
- -
OR2 
-
-
OPMB CO2All 
68 R 1 = Me, R 2 = H 70 Ii- 71 R=PMB 
hi • 69 R 1=Me,R2 =PMB 
---72 R=H tm 
I _._ CU All ' 2 ./"'-
10 
~ ~ .,,.0, ~ 
-
/,N N-N 41 
I 
Xe= O:tS 
// \\___ 
N, ✓ --sO2Et 
I 
Ph 
65 
~ 0 
OR 
Scheme 1.10: Kocienski's Synthesis of the C-1 to C-10 Core Fragment 41 of Herboxidiene (1) 
Reagents and conditions: (a) (i) BuLi, THF, -80 °C, 2 h; (ii) Mel, DMPU, -80 °C to rt, 12 h; (b) (i) 03, MeOH-
CH2Cl2 (1 :3), -78 °C, 2 h; (ii) Me2S, -78 °C to rt, 12 h; (iii) 2,2-dimethylpropane-1,3-diol, p-TsOH, PhMe, heat, (-
H2O), 12 h; (c) LiAlH4, Et2O, rt, 12 h; (d) Pyr.SO3, Et3N, DMSO, rt, 30 min; (e) sulfone 65, KHMDS, DME, -60 
°C, 45 min; (f) AD-mix a, MeSO2NH2, t-BuOH-H20 (2:3), 0 °C, 18 h; (g) p-TsOH, MeOH, rt, 3d, a:~= 3 :1; (h) 
(i) KHMDS, THF, 0 °C, 20 min; (ii) PMBCl, TBAI, 0 °C to rt, 24 h; (i) AcOH-THF-H2O (3 : 2 : 2), 65 °C, 2 h, a : 
~ = 3 :2; U) allyl diethyl phosphonoacetate, Cs2CO3, THF, heat, 18 h; (k) t-BuOK, THF, -65 °C, 10 min, pure cis 
isomer; (1) DDQ, 1:15 v/v H2O/CH2Cl2, rt, 30 min; (m) 4 steps (see ref.10). 
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Scheme 1.11: Kocienski's Synthesis of the C-11 to C-19 Side Chain Fragment 86 Associated 
with Herboxidiene (1). 
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Scheme 1.11: Kocienski's Synthesis of the C-11 to C-19 Side Chain Fragment 86 Associated with 
Herboxidiene (1). 
Reagents and conditions : (a) (i) Et2BOTf, CH2CI2, -5 °C; (ii) i-Pr2NEt, 30 min; (iii) 7 4, -78 °C, 3 h; (b) MeOTf, 
proton sponge, PhMe, 80 °C, 24 h; (c) LiAIH4, Et2O, 0 °C, 15 min; (d) Dess-Martin periodinane, CH2CI2, 0 °C to rt, 
2 h; (e) (i) CH2=C(Me)MgBr, Et2O, 0 °C, 1 h; (ii) DMP, CH2CI2, rt, 4 h; (f) LiAIH4, Lil, Et2O, -100 °C, 1 h; (g) 
(EtCO)2O, DMAP, pyridine, rt, 16 h; (h) (i) LDA, THF, -78 °C, 30 min; (ii) TBSCI, DMPU; (iii) -78 °C~Li, 1 h; 
(iv) aq. HCI; (i) LiAIR4, Et2O, 0 °C, 10 min; U) BTSH, Ph3P, DIAD, THF, 0 °C to rt, 2 h; (k) TBAF.3H2O, THF, 
rt, 32 h; (1) Mo(vi), H2O2, H2O-EtOH, rt, 24 h; (m) VO(acac)2, TBHP, CH2CI2, -8 °C, 72 h; (n) (i) Ph3P, DMAD, 
THF, 0 °C; (ii) PCBOH, 0 °C to rt, 3 h. 
Scheme 1.12: Completion of Kocienski's Synthesis of Herboxidiene - Union of Core 41 and 
Side Chain 86. 
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Scheme 1.12: Completion of Kocienski's Synthesis of Herboxidiene - Union of Core 41 and Side 
Chain 86. 
Reagents and conditions : (a) (i) LDA, THF, -78 °C, 15 min; (ii) 41, -78 °C to -20 °C, 1.5 h; (b) K2CO3, MeOH, 11, 2 
h; (c) K2CO3, H2O-MeOH (1 : 4), 11, 1 h. 
Scheme 1.15: Enantioselective Route from Nerol (97) to Phosphine Oxide 95. 
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Scheme 1.15: Enantioselective Route from Nerol (97) to Phosphine Oxide 95. 
Reagents and conditions: (a) KSAE, diethyl D-(-)-tartrate/CH2Cl2; (b) NaBH3CN, BF3.OEt2/THF; (c) Ac2O, DMAP 
(trace)/pyridine, 18 °C; (d) O3/CH2Cl2, -78 °C then PPh3; (e) MeO2CCH2P(O)(OCH2CF3)2, l8-crown-6/CH3CN-
complex, KHMDS/THF, -78 °C; (f) K2CO3/MeOH, rt, then MeOH, H2SO4 (trace), rt; (g) PCC, NaOAc/CH2Cl2, 18 
°C; (h) MeMgCl/THF, 0 °C; (i) PCC, NaOAc/CH2Cl2, 18 ° C; U) H2C=C(H)MgBr/THF, -78 °C; (k) PBr3/Et2O, 0 
°C; (1) Ph2POEt/THF, reflux, 2 h. 
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Scheme 1.16: Bui's Synthesis of an Isomer, 122, of the Herboxidiene Side Chain. 
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Scheme 1.16: Bui's Synthesis of an Isomer, 122, of the Herboxidiene Side Chain. 
Reagents and conditions: (a) BnOC(NH)CCl3, CF3SO3H (cat.)/CH2Cl2, 0 to 18 °C; (b) LiAlH4/Et2O, 0-5 °C; (c) 
Me2SO, Cl(CO)2Cl/CH2Cl2, -60 °C then NEt3; (d) CH2=C(H)MgBr/THF, 0 °C; (e) Mel, KH/THF, 0 to 18 °C; (f) 
O3/CH2Cl2, -78 °C then Me2S; (g) MeMgCl/THF, -78 °C; (h) TBDMSCl, imidazole/DMF, 60 °C; (i) H2 (1 atm), 
10% Pd on C/EtOH, rt; (j) Me2SO, Cl(CO)2Cl/CH2Cl2, -60 °C then NEt3; (k) H2C=C(Me)Br, t-BuLi, 
CuBr.DMS/Et2O, -78 °C; (1) (EtCO)2O, DMAP, pyridine, rt; (m) KN(TMS)2/THF, then TMSCl-Et3N, HMPA then 
heat at 45 °C; (n) LiAIH4/Et2O, 0 °C; (o) Me2SO, Cl(CO)2CI/CH2Cl2, -60 °C then NEt3. 
mt UkidlllPP rem nn:nna:cmNMe__..,,.: 
Scheme 2.1 and 2.2: Enantio- and Diastereo-selective Route to Herboxidiene Core Molecule 95. 
-----··-------
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Scheme 2.1 and 2.2: Enantio- and Diastereo-selective Route to the Herboxidiene Core 
Molecule 95. 
Reagents and Conditions: (i) Swern oxidation then Ph3P=C(H)CO2Et/CH2Cl2, 2 h; (ii) DIBAL/ CH2Cl2, 2 h, -78 °C; 
(iii) KSAE, diethyl D(-)-tartrate/CH2Cl2; (iv) DMAP, NEt3/CH2Cl2 then 119 and Mosher chloride; (v) 
Me3Al/CH2Cl2, 0 °C to rt, 10 h; (vi) Ac2O, DMAP(trace)/pyridine, 18 °C, 3 h; (vii) O3/CH2Cl2 then PPh3; (viii) 
MeO2CCH2P(O)(OCH2CF3)2, l8-crown-6/CH3CN-complex, KN(TMS)2/THF, -78 °C; (ix) K2CO3/MeOH, rt, then 
MeOH, H2SO4 (trace), rt; (x) pyridine.SO3 complex/DMSO, CH2Cl2, 0 °C; (xi) MeMgCl/THF, -78 °C to O °C; (xii) 
Dess-Martin periodinane/CH2Cl2, rt, 1 h; (xiii) H2C=C(H)MgBr/THF, -78 °C; (xiv) PBr3/Et2O, 0 °C; (xv) 
Ph2POEt/THF, reflux, 2 h. 
-Scheme 3.1: Diastereoselective Synthesis of Herboxidiene Side Chain Synthon 12-epi-94. 
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OH 
Reagents and conditions: (i) BnOC(NH)CCl3 , CF3SO3H (cat.)/CH2Cl2, 0 to 18 °C; (ii) Me(MeO)NH.HCl, i-
PrMgClffHF, -15 °C; (iii) H2C=C(H)MgBr/THF, 0 °C; (iv) Zn(BH4)2/CH2Cl2, -78 °C; (v) Mel, KHffHF, 0 to 18 
°C; (vi) O3/CH2Cl2, -78 °C then Me2S; (vii) Me2Zn, TiCl4/CH2Cl2, -78 °C; (viii) TBDMSCl, imidazole/DMF, 60 
°C; (ix) H2 (1 atm), Pd(OH)2 on Cl THF, rt; (x) SO3.pyridine complex/DMSO, CH2Cl2, rt; (xi) H2C=C(Me)Br, t-
BuLi, CuBr.DMS/Et2O, -78 °C; (xii) (EtCO)2O, DMAP, pyridine, rt; (xiii) LDA, HMPA/THF, TBDMSCl, -78 °C 
to 50 °C; (xiv) LiAlH4/Et2O, 0 °C; (xv) Dess-Martin periodinane/CH2Cl2, rt. 
Scheme 4.1: Union of Core and Side Chain with Subsequent Regio-and Diastereo-
controlled Epoxidation of the Resulting Triene 163: Formation of Herboxidiene 
Methyl Ester (5). 
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Scheme 4.1: Union of Core and Side Chain with Subsequent Regio- and Diastereo-controlled 
Epoxidation of the Resulting Triene 163: Formation of Herboxidiene Methyl Ester (5). 
Reagents and Conditions : (i) NaH/THF, 55 °C then CH2N2; (ii) TBAF/THF, 0 °C to rt.; (iii) t-BuOOH, 
VO(acac)2/CH2CI2, -8 °C, 72 h. 
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The Total Synthesis of Herboxidiene, a Complex 
Polyketide from Streptomyces Species A7847. 
Martin Banwell,* a Malcolm Mcleod,a Rajaratnam Premraja and 
Gregory Simpsonb 
a Research School of Chemistry, Institute of Advanced Studies, The Australian 
National University, Canberra, ACT 0200, Australia. b CS/RO Molecular Science, 
Bag 10, Clayton South, Victoria 3169, Australia. 
Abstract: A formal total synthesis of the polyketide herboxidiene (J) has been 
achieved by Homer-Wittig coupling of the side-chain fragment 12-epi-(2) with the 
tetrahydropyran-2-acetic acid derivative (3) followed by desilylation of the resulting 
triene (19) and hydroxyl-directed mono-epoxidation of the ensuing bis-homoallylic 
alcohol (20). 
In 1992 a group at Monsanto (USA) detailed (ref. 1) the near complete structural elucidation of the 
polyketide herboxidiene (J, a.k.a. TAN-1609) which they had isolated from Streptomyces chromofuscus 
A 7847. The same group also revealed (ref. 1) that the molecule displays potent and highly selective 
phytotoxic properties such that at application rates of 35 g/acre it selectively controls various crop pests such 
as oilseed rape, wild buckwheat and morning glory while being harmless to wheat. Such properties, which 
are remarkable for a polyketide, prompted efforts by Edmund's group at Novartis AG (ref. 2) to re-isolate 
herboxidiene and then, through a combination of X-ray crystallographic, chemical degradation and chemical 
synthesis studies, to establish the full stereochemistry associated with compound (1). Such studies were 
accompanied by extensive SAR-work (ref. 3) as well as, thus far, unsuccessful efforts (ref. 2,3) to develop a 
total synthesis of the compound. At about the same time three Japanese groups (ref. 4-6) reported isolating 
herboxidiene from various fermentation processes. One of these groups (ref. 4) reported that the compound 
up-regulates gene expression of low density lipoprotein receptors (and thereby lowering cholesterol levels in 
blood plasma) while another has reported (ref. 6) that it blocks the cell-cycle at the G2 phase in human and 
murine tumour cells by inducing apoptosis. 
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The first total synthesis of herboxidiene was reported recently by Kocienski and co-workers (ref. 7) who 
adapted elegant earlier work (ref. 8) that had culminated in the preparation of herboxidiene A, a 
diastereoisomer of the natural product. We now report a (formal) total synthesis of the title compound that 
differs, in a number of respects, from that described by the Glasgow group (ref. 7). The present work exploits 
the Katsuki-Sharpless epoxidation reaction, a chiral-pool starting material and substrate-directed 
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transformations for establishing the correct stereochemistry associated with eight of the nine centres of 
chirality contained in the target molecule (1). 
As enunciated previously, (ref. 9,10) an obvious disconnection of target (1) is between CI0 and Cl I so as 
to create substructures such as the side-chain molecule (2) and phosphine oxide core (3) that could be coupled 
to one another through a Homer-Wittig (HW) reaction. It was anticipated that the epoxide moiety associated 
with herboxidiene could be introduced via CI 8-hydroxyl-directed epoxidation after the HW-coupling step 
(ref. 7,11). We have recently detailed (ref. 9) a synthesis of compound (3), that starts with the Katsuki-
Sharpless asymmetric epoxidation of nerol, and shown that this phosphine oxide does couple in the 
appropriate fashion (ie with high E-selectivity) with model aldehydes. A highly diastereoselective synthesis 
of the herboxidiene side-chain is shown in Fig. 1 and starts with the commercially available methyl (2S)-3-
hydroxy-2-methylpropionate ( 4) (ALDRICH, 99% ee ). Compound ( 4) was O-benzylated under conditions 
which avoid racemisation (ref. 12) and the resulting ether (5) (ref.13) (97%) converted into the corresponding 
Weinreb amide (6) (98%) {[a]n = +4.6 (c = 2.0)} using i-propylmagnesium chloride as base. Treatment of 
the latter compound with vinylmagnesium bromide afforded, after acidic workup, the expected conjugated 
ketone (7) (92%) which underwent a chelation controlled 1,2-reduction with zinc borohydride (ref. 14) at 
-78jC to give a ca. 8:1 mixture of allylic alcohol (8) (ref. 15) (83%) {[a]n = -9.6 (c = 2.8)} and the 
corresponding anti-isomer (ca. 10%) {[a]n = +28.2 (c = 2.5)} which could be readily separated from one 
another by preparative HPLC. O-Methylation of compound (8), to give (9) (85%) {[a] 0 = +12.2 (c = 1.3)}, 
followed by ozonolytic cleavage of the carbon-carbon double bond afforded the unstable aldehyde (10) (90%) 
{[a]n = +22.5 (c = 2.2)} which was immediately reacted with dimethylzinc in the presence of TiCl4 (ref. 
16) to give alcohol (11) (70%) {[a]n = +8.6 (c = 2.8)} as the only isolable reaction product. The readily 
derived TBDMS-ether (12) (80%) {[a]o = + 10.4 ( c = 2.5)} was subjected to hydrogenolytic debenzylation 
and the ensuing I j-alcohol (13) (80%) oxidised to the aldehyde (14) using the Parikh-Doering reagent (ref. 
17). Reaction of the last compound with the Gilman reagent obtained from 2-bromopropene then gave, via a 
chelation controlled process, the allylic alcohol (15) [70% from (13)] {[a]n = +3.2 (c = 1.2)}. The derived 
propionate ester (16) (90%) {[a]n = -22.0 (c = i.6)} was subjected to an Ireland-Claisen rearrangement (ref. 
10, 18) involving sequential treatment with LDA then TBDMSCl in HMPA/THF from -78 to 50 jC. The 
(12R)-stereochemistry and the (E)-geornetry about the double-bond in the ensuing y))-unsaturated carboxylic 
acid (17) (75%) {[a]n = + 5.8 (c = 2.2)} were initially proposed on the basis of the well-defined outcomes 
associated with the Ireland-Claisen rearrangements of related substrates under the same reaction conditions 
(ref. 7,10). LiAlH4-prornoted reduction of compound (17) afforded the corresponding alcohol (18) (80%) 
{[a]n = +6.4 (c = 1.6)} which was converted, using the Dess-Martin periodinane, into the unstable C12-
epimer (80%) of the target aldehyde (2), viz. 12-epi-(2). 
The stage was now set for the crucial HW-reaction involving phosphine oxide (3) (ref. 9) and, thence, the 
final stages of the total synthesis. In the event coupling of aldehyde 12-epi-(2) and phosphine oxide (3) could 
be effected with sodium hydride. The reaction was accompanied by epimerisation of the former compound 
with the result that a 3:2 mixture of triene (19) (39%) {[a]o = +0.4 (c = 2.3)} and its C12-epimer (26%) 
{ [a]n = +18.4 (c = 1.5)} was obtained. These products could be separated from one another using semi-
preparative HPLC techniques and desilylation of the chromatographically less-mobile compound (I 9) was 
accomplished using tetra-n-butylammonium fluoride (TBAF) in THF. 
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Fig. 1 Reagents and conditions: (i) BnOC(NH)CCl3 (1.2 mole equiv.), CH2Cl2, CF3SO3H (cat.), ca. 0 tol8 jC, 16 h; 
(ii) Me(MeO)NH.HCI (1.55 mole equiv .), i-PrMgCI (3.0 mole equiv.), THF, -15 jC, 0.5 h; (iii) H2C=C(H)MgBr (1.5 
mole equiv.), THF, 0 jC, 0.5 h; (iv) Zn(BH4)2, CH2Cl2, -78 to O jC, 4.5 h; (v) Mel (2.5 mole equiv.), KH (2.5 mole 
equiv.), THF, 0-18 jC, 6 h; (vi) 03 (excess) , CH2CI2, -78 jC, 1 h then DMS (1.0 mole equiv .), -30-18 jC, 0.5 h; (vii) 
Me2Zn (1.0 mole equiv.), TiCl4 (1.0 mole equiv.), THF, -78 jC, 0.5 h; (viii) TBDMSCl (2.0 mole equiv.), imidazo le 
(3.0 mole equiv.) , DMF, 60 jC, 3 h; (ix) H2 (1 atm.) , Pd(OH)2 , THF, 18 jC, 1 h; (x) SO3 /pyridine (3.0 mole equiv.), 
DMSO, CH2Cl2, 0 to 18 jC, 4 h then Et3N, 0 iC , 1.0 h; (xi) H2C=C(Me)Br (13 .5 mole equiv.), t-BuLi (27 mole 
equiv.), CuBr.DMS (6.9 mole equiv.), Et2O, -78 jC, 3 h; (xii) (EtCO)2O (2.5 mole equiv.), DMAP (cat.), C6H5N, 18 
jC, 16 h; (xiii) LDA (1.3 mole equiv.), HMPA/THF (1:2 v/v), -78 jC, 0.5 h then TBDMSCl (1.3 mole equiv) then heat 
at 50 jC, 6 h; (xiv) LiAlH4 (1.0 mole equiv.) , THF, 0 to 18 jC, 6 h; (xv) Dess-Martin periodinane (2.5 mole equiv.), 
CH2Cl2, 0 to 18 jC, 4 h; (xvi) Compound 3 (l.0 mole equiv.) NaH (10 mole equiv.), THF, 55 jC, 2 h then CH2N2 
(excess), CH2CI2, 18 jC, 16 h; (xvii) TBAF (1.5 mole equiv.), THF, 0-18 jC, 6 h; (xviii) t-BuOOH (3.0 mole equiv.), 
VO(acac)2 (1.0 mole %), CH2Cl2, -8 jC, 72 h. 
The resulting alcohol (20) (68%) was then reacted with tert-butylhydroperoxide in the presence of VO(acac)2 
and in this way a ca. 4: 1 mixture of herboxidiene methyl ester (21) (73%) {[ a]o = + 1.3 ( c = 0.2) , lit. (ref. 
7) [a]o = + 0.9 (c = 0.7)} and an isomer was obtained. These epoxides could also be separated from one 
another by semi-preparative HPLC and the spectral data obtained on the former product matched, in all 
respects, those reported by Kocienski and co-workers (ref. 7). 
The acquisition of herboxidiene methyl ester constitutes a formal total synthesis of herboxidiene because it 
has been shown that the former material can be converted into compound (1) by conventional hydrolysis (ref. 
7). In principle the problems of controlling C-12 stereochemistry could be addressed by effecting Ireland-
Claisen rearrangement of the (E)-silylketene acetal derived from propionate ester (16) so as to give 12-epi-(l 7) 
and, thence, aldehyde (2) (ref. 7,18b). Furthermore, there are indications in the literature (ref. 18b) that a-
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chiral aldehydes can participate in HW-reactions without epimerisation/racemisation when NaN(SiMe3)2 is 
used as base. Efforts to exploit such possibilities are currently underway in our laboratories. 
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Abstract 
The phosphine oxide (2), which embodies the tetrahydropyranylacetic acid core associated with the 
phytotoxic polyketide herboxidiene (1) and which is a key intermediate in a projected synthesis of 
this natural product , has now been prepared in a highly enantio- and diastereo-selective manner. 
The pivotal steps in this new and improved synthesis of compound (2) involve Sharpless 
asymmetric epoxidation of the allylic alcohol (4) to give epoxide (7) and subsequent ring-cleavage 
of the latter compound with trimethylaluminium to give dial (9) . The derived acetate (10) is then 
readily ozonolysed to give the previously reported aldehyde ( 11) , although now in high 
enantiomeric excess. Compound (11) can be elaborated , by established chemistry , to the target 
oxide (2). 
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Introduction 
In 1992 a group at Monsanto (USA) detailed 1 the near complete structural elucidation of 
the polyketide herboxidiene (1, a.k.a. TAN-1609) which they had isolated from 
Streptomyces chromofuscus A7847. The same group also revealed1 that the molecule 
displays potent and highly selective phytotoxic properties such that at application rates of 
35 g/acre it selectively controls various crop pests such as oilseed rape, wild buckwheat 
and morning glory while being harmless to wheat. Such properties, which are remarkable 
for a polyketide, prompted efforts by Edmund's group at Novartis AG2 to re-isolate 
herboxidiene and then, through a combination of X-ray crystallographic, chemical 
degradation and chemical synthesis studies , to establish the full stereochemistry associated 
with compound (1 ). Several Japanese groups3-5 have also isolated herboxidiene and one 
has determined5 that the compound up-regulates the gene expression of the low-density 
lipoprotein receptor while another has reported3b that it inhibits the growth of various 
murine and human tumour cell lines . The interesting biological profile of this natural 
product has prompted various attempts to effect its preparation by total synthesis.2,6-9 In 
connection with our own efforts in this areaB ,9 we have reported9 a twelve step route to 
phosphine oxide (2) which embodies the tetrahydropyranylacetic acid core associated with 
compound (1 ). However, a deficiency associated with our synthesis of (2) is the need to 
carry out, at the initial stage , a Sharpless asymmetric epoxidation (SAE) of nerol (3) 
which delivers the corresponding epoxy-alcohol in only ca. 50% enantiomeric excess 
(ee).9 Since, with the exception of target (2) , all the compounds in the reaction sequence, 
including the initially formed epoxy-alcohol , are oils the only opportunity to obtain 
enantiopu re phosphine oxide (2) was by repeated recrystallisation of this compound. 
However, the attendant loss of material was significant thus prompting us to examine 
alternate routes to this compound. As a consequence , we now describe a new synthesis of 
phosphine oxide (2) that circumvents the above-mentioned problems. 
Appendix 2 162 
Results and Discussion 
In contrast to the situation with (Z)-1,2,2-trisubstituted alkenes (e.g. nerol), the SAE of 
allylic alcohols proceeds in high enantiomeric excess (ee) when (E)-1,2-disubstituted 
alkenes are employed as substrates. 1 O Consequently, the allylic alcohol (4) was chosen as 
the substrate for SAE on the basis that the product epoxide would be obtained in high ee. In 
addition, it was anticipated that nucleophilic methylation of the product epoxide could be 
achieved in a regio- and diastereo-selective manner so as to install the methyl group 
required at C6 in the target molecule (2). The pivotal alkene (4) was readily prepared 
(Scheme 1) by a one-pot procedure involving initial oxidation of commercially available 
(ALDRICH) alcohol (5) to the corresponding aldehyde. Using a modification of procedures 
reported by Barrett, 11 Lee 12 and Taylor, 13 this latter compound was subjected to in situ 
Wittig olefination with (carbethoxymethylene)-triphenylphosphorane. In this manner the 
a,~-unsaturated ester (6) (98%) was obtained and the illustrated (E)-configuration about 
the ~2-double-bond was established by 1 H n.m.r. analysis (JH2 ,H3 = 15.6 Hz). DIBALH-
promoted 1,2-reduction of compound (6) proceeded smoothly to give the target alcohol (4) 
in 85% yield and the various spectral data derived from this material were in full accord 
with the assigned structure. SAE of compound (4) was effected under standard conditions 
using catalytic quantities of diethyl O-(-)-tartrate and in this manner the anticipated 
epoxy-alcohol (7) (70%) was obtained. This latter material was converted , under standard 
conditions, into the corresponding Mosher ester (8) (42%) which was obtained as a single 
diastereoisomer (as determined by 1 H n.m.r. analysis) and thus suggesting that the 
precursor alcohol was of >95% ee. This interpretation was confirmed by , inter alia , 
converting the racemic modification of epoxide (7) [prepared by treating alkene ( 4) with 
m-chloroperbenzoic acid] into the corresponding 1: 1 mixture of compound (8) and its 
diastereoisomer and observing that these Mosher esters were readily differentiated from 
one another by 300 MHz 1 H n.m.r. spectroscopy (see Experimental Section). 
Treatment of epoxy-alcohol (7) with three molar equivalents of trimethylaluminium 14 in 
CH2Cl2 at 18 °C for 10 h resulted in its smooth conversion into dial (9) (83%) the 
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structure of which follows from its transformation into the previously reported9 aldehyde 
(11 ). Thus, two-fold acetylation of compound (9) was achieved under standard conditions 
and the resulting diacetate (10) (96%) was subjected to ozonolytic cleavage followed by 
reductive work-up with triphenylphosphine to give the aldehyde (11) (79%). This last 
compound proved identical (as judged by 1 H n.m.r., 13c n.m .r. , i.r. and mass spectral 
analysis) with the samples of the aldehyde obtained by our previous route.9 As expected , 
however, the specific rotation of the material generated by the present route was effectively 
double {[a] o = + 7 .3 vs [a] o = +3 .8} that observed for the sample of aldehyde (11) 
obtained earlier. 
The completion of the synthesis of the target phosphine oxide (2) followed the route 
established earlier although various minor modifications to the previously reported 
methods9 are detailed here-in. Thus , subjection of compound (11) to Still-Gennari 
modification 15 of the Wadsworth-Emmons reaction afforded the alkene (12) (80%) as the 
only isolable product of reaction. The (Z)-configuration about the double-bond in this 
product follows from the magnitude of the vicinal spin-spin coupling (J = 11 .5 Hz) 
observed between H-2 and H-3 in the 1 H n.m.r. spectrum of this material. Treatment of 
compound (12) with potassium carbonate in methanol resulted in removal of the acetate 
groups and a subsequent intramolecular Michael addition reaction to give the 
tetrahydropyranylacetic acid ester (13) which was accompanied by varying quantities of 
the corresponding acid. Consequently, the crude reaction mixture was treated with acidic 
methanol and in this manner compound (13) was obtained in 71 % yield . Oxidation of 
hydroxy-ester (13) under Parikh-Doering conditions (pyridine-SO3 activated DMSO) 1 6 
afforded the corresponding aldehyde (14) (60%) which proved spectroscopically identical 
with the sample we had obtained by our previous route . In addition , the optical rotation of 
this material effectively matched that reported2 by Edmunds for enantiomerically pure 
material. The conversion of aldehyde (14) into methyl ketone (15) proved especially 
troublesome and, thus far, we have not been able satisfactorily resolve these difficulties . 
After considerable experimentation with a range of nucleophilic methylating agents , methyl 
magnesium chloride proved to be most effective in adding to the aldehyde moiety associated 
Appendix 2 164 
with compound (14). The resulting mixture of diastereoisomeric 2°-alcohols was 
immediately oxidised with the Dess-Martin periodinane 17 and the corresponding methyl 
ketone (15) thereby obtained albeit in only 17% yield. Nevertheless, the optical rotation of 
this compound matched that reported for a sample obtained by ozonolytic cleavage of 
herboxidiene itself. 2 
Elaboration of ketone (15) to the target phosphine oxide (2) followed previously 
established procedures9 and involved initial reaction of the former compound with vinyl 
magnesium bromide. This resulted in generation of the desired 3°-alcohol (60%) which 
was treated with phosphorous tribromide to afford the allylic bromide (16) (93%). The 
latter compound engaged in a Michaelis-Arbuzov reaction with diphenylethoxyphosphine to 
deliver the target compound (2) (85%) as a crystalline solid after flash chromatography. 
The melting point of this compound (m.p. = 125-126 °C) matched that reported for the 
multiply recrystallised material obtained by the previous route . 9 However, the specific 
rotation of compound (2) produced by the method described here was much lower {[cx]o = 
-0.4 vs [ ex] o = -33} than that reported 9 for material generated using the earlier route. 
Fortunately a sample of compound (2) derived by the earlier sequence was still available 
and a re-determination of the specific rotation resulted in a value identical to that observed 
for the newly prepared sample. Consequently , we believe that our earlier determination9 of 
optical rotation for compound (2) to be in error. Given the absence of any racemisation 
pathways in the synthetic sequence just described as well as the high levels of 
enantioselectivity obtained in the SAE reaction leading to compound (7) we conclude that 
phosphine oxide (2) produced by the method described here has been obtained in >95% ee. 
Efforts are now underway to exploit compound (2) as a key building block in the total 
synthesis of herboxidiene.8 Results will be described in due course. 
Appendix 2 165 
Experimental 
Melting points were recorded with a Kofler hot stage apparatus and are uncorrected. Proton 
(1 H) and carbon (13 c) n.m.r. spectra were recorded with a Varian Gemini 300 
spectrometer operating at 300 MHz for proton and 75 MHz for carbon. All such spectra 
were recorded in deuterochloroform (chloroform-d) solution at 22 °c. The protonicities of 
the carbon atoms observed in 13c n.m.r. spectra were determined by attached proton test 
(a.p .t.) experiments. Infrared spectra (umax) were recorded with either a Perkin-Elmer 
983G infrared spectrophotometer or a Perkin-Elmer 1800 Series FTI R spectrophotometer. 
Unless otherwise specified, samples were analysed as thin liquid films on potassium 
bromide plates. Low resolution electron-impact mass spectra (m/z) were recorded at 70 eV 
on a VG Micromass 7070F mass spectrometer. High resolution mass spectra were recorded 
with the same instrument. Unless otherwise stated , optical rotations were measured in 
spectroscopic grade chloroform at 22 °C using a Perkin-Elmer 241 Polarimeter. Diethyl 
ether (Et2O) and tetrahydrofuran (thf) were distilled under nitrogen from sodium 
benzophenone ketyl. Dichloromethane (CH2Cl2) , ethyl acetate (EtOAc) and hexane were 
each distilled from calcium hydride. Ethanol and methanol (CH3OH) were distilled from 
their respective magnesium alkoxide salts. Ozonolyses were performed using a Wallace and 
Tiernan Ozonator with the oxygen flow rate and power set at approximately 25 I/h and 200 
V, respectively. Flash chromatographic separations were conducted according to the method 
of Still et al. 1 8 
Ethyl (E)-2, 6-Heptadienoate (6). 
DMSO (23.7 ml, 334 mmol) was added to a magnetically stirred solution of oxalyl chloride 
(13.4 ml, 153 mmol) in CH2Cl2 (480 ml) maintained under a nitrogen atmosphere at -78 
°C. After 0.1 h 4-penten-1-ol (5) (12.0 g, 139 mmol , ex ALDRICH) was added , dropwise , 
followed, after a further 0.25 h, by triethylamine (134 ml, 961 mmol). The resulting 
mixture was stirred for 0.5 h at -78 °C then warmed to room temperature and treated with 
( carbethoxymethylene )triphenylphosphorane 19 (72.8 g, 209 mmol) in dry CH2Cl2 (110 
ml). After 2 h at 18 °C the reaction mixture was quenched with water (200 ml) and the 
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separated aqueous layer was extracted with CH2Cl2 (3 x 100 ml) . The combined organic 
layers were washed with brine (1 x 75 ml) then dried (MgSO4), filtered and concentrated 
under reduced pressure to give a light-yellow oil. An ethyl acetate/hexane (1 :9 v/v) 
solution of this material was filtered through a short pad of t.l.c. grade silica gel to afford , 
after concentration of the filtrate , the title ester (6)12,20 (21.0 g, 98%) as a light-
yellow oil. vmax 3078, 2980 , 2933, 1721 , 1655, 1446, 1367, 1315, 1266, 1206, 
1176, 1044, 989,914 and 852 cm- 1 . 1H n.m .r. 86.93 (dt, J= 15.6 and 5.7 Hz, 1H) , 
5.84-5.73 (complex m, 2H), 5.06-4.96 (complex m, 2H), 4.15 (q , J = 7.1 Hz, 2H), 
2.32-2.17 (complex m, 4H), 1.26 (t , J = 7.1 Hz, 3H). 13c n.m.r. 8 166.5 (C), 148.2 
(CH), 137.0 (CH), 121.6 (CH), 115.4 (CH2), 60.1 (CH2), 32.0 (CH2), 31.4 (CH2), 
14.2 (CH3). Mass spectrum m/ z 154 (6%, M+·) , 109 [30 , (M -C2H5O·)+] and 81 
[100, (M -C2H5OCO·)+]. This material was of sufficient purity for use in the next step of 
the reaction sequence. 
(E)-2,6-Heptadien-1-ol (4) . 
Di-isobutylaluminium hydride (325 ml of a 1.0 M solution in hexane , 325 mmol , ex 
ALDRICH) was added dropwise (via syringe) to a magnetically stirred solution of ethyl (E)-
2,6-heptadienoate (6) (20.0 g, 130 mmol) in CH2Cl2 (650 ml) maintained under a 
nitrogen atmosphere at -78 °C. The resulting mixture was stirred for 2 h at -78 °C then 
warmed to 18 °C and quenched with tartaric acid (200 ml of a 1 M aqueous solution) . 
Stirring was continued until two distinct layers were observed (0.25 h) . The separated 
aqueous layer was extracted with CH2Cl2 (3 x 200 ml) and the combined organic phases 
were washed with brine (1 x 200 ml) then dried (MgSO4) , filtered and concentrated under 
reduced pressure. Subjection of the material thus obtained to flash chromatography (silica 
gel, 1 :4 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions 
(Rt= 0.25) afforded the title compound (4)12 ,21 (12 .4 g, 85%) as a light-yellow oil . 
vmax 3326, 2923, 1641, 1437, 1087, 1000, 970 and 911 cm- 1 . 1 H n.m.r. 8 5.85-
5.65 (complex m, 3H), 5.04-4.94 (complex m, 2H), 4.07 (d, J = 4.4 Hz, 2H), 2.15-
2.13 (complex m, 4H) and 1.67 (s, 1 H). 13 c n.m.r. 8 138.0 (CH), 132.4 (CH), 129.3 
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(CH), 114.8 (CH2), 63.7 (CH2), 33.2 (CH2) and 31.5 (CH2). Mass spectrum m/z 111 
[1%, (M-H·)+], 94 [13, (M -HO·)+] and 79 (100). 
(2R -trans)-2,3-0xiranehept-6-en-1-o/ [(+)-(7)). 
SAE of al lyl ic alcohol ( 4), so as to afford epoxide ( + )-(7), was carried out according to the 
method of Sharpless et at.22 Thus, a magnetically stirred suspension of finely powdered and 
activated 4 A molecular sieves (1.0 g) in dry CH2Cl 2 (137 ml) was cooled to -40 °c then 
treated, sequentially, with diethyl O-(-)-tartrate (0.92 ml , 5.38 mmol) , Ti(O-i-Pr)4 
(1.32 ml, 4.50 mmol) and tert-butyl hydroperoxide (17.2 ml of a 5.2 M solution in 
isooctane, 89 mmol - prepared by extraction of 70% aqueous tert-butylhydroperoxide ex 
ALDRICH 22 ). The resulting mixture was stirred at -40 °C for 0.5 h then a solution of 
compound (4) (5.0 g, 44.6 mmol) in CH2Cl2 (20 ml) was added , via cannula, at such a 
rate as to maintain the reaction temperature below -20 °C. After an additional 3 h at -20 °C 
the reaction mixture was warmed to O °C then treated with water (26 ml) . The reaction 
mixture was then warmed to 18 °C and after a further 1 h treated with NaOH (6.0 ml of a 
30% aqueous solution saturated with sodium chloride) and stirred vigorously. After ca . 0.2 
h of stirring, the mixture was filtered through a small pad of Celite™ then the separated 
aqueous layer was extracted with CH2Cl2 (3 x 150 ml). The combined organic layers were 
dried (MgSO4), filtered and concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica gel , 3:7 v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (Rf = 0.3) afforded 
the title compound (7) (4.00 g, 70%) as a clear colourless oil , [cx ]o = +33 (c 1.2). v max 
3401, 3078, 2979, 2928, 1641, 1449, 1088, 1030, 997 , 914 , 882 and 642 cm- 1 . 
1 H n.m.r. 8 5.90-5.73 (complex m, 1H), 5.10-4 .95 (complex m, 2H), 3.94-3.88 
(complex m, 1 H), 3.66-3.58 (m , 1 H), 3 .01-2.90 (complex m, 2H) , 2.20 (m , 2H) , 1.76 
(t, J = 6.5 Hz, 1 H) and 1.71-1.64 (complex m, 2H); 13 c n.m.r. 8 137.4 (CH) , 115.3 
(CH2), 61.7 (CH2), 58.6 (CH), 55.4 (CH), 30.8 (CH2) and 30.1 (CH2). Mass spectrum 
mlz 97 [18%, (M -HOCH2 · )+] and 67 (100). 
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( ±)-trans -2, 3-0xira nehept-6-en-1-ol [( ±)-(7)). 
A magnetically stirred solution of allylic alcohol (4) (50 mg, 0.45 mmol) in CH2Cl2 (2.5 
ml) was treated, portion-wise, with m-chloroperbenzoic acid (132 mg of technical grade 
material containing ca. 70% peracid, ca. 0.54 mmol). After 2 h the reaction mixture was 
quenched with Na2S2O5 (5 ml of a 1 M aqueous solution). The separated organic phase was 
washed with NaHCO3 (1 x 5 ml) and water (1 x 5 ml) then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a light-yellow oil. Subjection of this material 
to flash chromatography (silica gel, 1 :4 v/v ethyl acetate/hexane elution) followed by 
concentration of the appropriate fractions (Rt = 0.3) then afforded the title compound (±)-
(7) (25 mg, 44%) as a clear, colourless oil. This material was identical, as judged by 1 H 
n.m.r., 13c n.m.r., mass spectral and infra-red analysis, with the material obtained using 
the SAE protocol described above. 
Mosher Ester Analysis of Epoxides (+)-(7) and (±)-(7). Formation of Ester (8) and a 
Diastereoisomer there-of. 
A nitrogen atmosphere was established over a magnetically stirred solution of DMAP (18 
mg, 0.15 mmol) and triethylamine (0.1 ml) in CH2Cl2 (0.5 ml) which was then treated 
with epoxide (+)-(7) (19.2 mg, 0.15 mmol) and (+)-a-methoxy-a-
(trifluoromethyl)phenylacetyl chloride22 (0.04 ml, 0.20 mmol). The resulting solution 
became warm and turned orange in colour. After 0.1 h the reaction mixture was treated with 
NaHCO3 (5 ml of a saturated aqueous solution) and extracted with CH2Cl2 (2 x 10 ml). The 
combined organic extracts were washed with brine (1 x 5 ml) then dried (MgSO4), filtered 
and concentrate under reduced pressure to afford a pale-yellow oil which was subjected to 
flash chromatography (silica, 1 :4 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rt = 0.4) afforded Mosher ester (8) (22 mg, 42%) as a clear, 
colourless oil. 1 H n.m.r. (C5D5) 8 7.82 (d, J = 7.6 Hz, 2H), 7.35-7.05 (complex m, 3H), 
5.69 (m, 1 H), 5.00 (m, 2H), 4.30 (dd, J = 12.2 and 3.2 Hz, 1 H), 3.80 (dd, J = 12.2 and 
5.8 Hz, 1 H), 3.54 (s, 3H), 2.63 (m, 1 H), 2.53 (m, 1 H), 1.97 (m, 2H), 1.32 (m, 2H). 
Appendix 2 169 
The racemic epoxide (±)-(7) (25 mg, 0.20 mmol) was converted into the corresponding 
mixture of diastereoisomeric Mosher esters by reaction with (+)-cx-methoxy-cx-
(trifluoromethyl)phenylacetyl chloride under the conditions described immediately above. 
1 H n.m.r. analysis of this material revealed it to be a 1 :1 mixture of compound (8) and the 
diastereoisomeric ester derived from ent-(7). The most diagnostic 1 H n.m.r. signals due to 
the (R)-MTPA ester derivative of ent-(7) appear (in C5D5) at 8 4.14 (dd, J = 12.2 and 
3.2 Hz, 1 H) and 3.90 (dd, J = 12.2 and 5.8 Hz, 1 H) [the corresponding signals for (8) 
appear at 8 4.30 and 3.80 respectively (see preceding paragraph)]. 
(2S, 3S )-3-Methyl-6-heptene-1,2-diol (9). 
Trimethylaluminium (131 ml of a 2.0 M solution in hexane, 262 mmol, ex ALDRICH) was 
added, dropwise, to a magnetically stirred solution of epoxide (7) (11.15 g, 87 mmol) in 
CH 2CI 2 (90 ml) maintained at O °C under a nitrogen atmosphere. After addition was 
complete, the reaction mixture was stirred at 18 °C for 10 h and then chilled (0 °C) and 
quenched (CAUTION) with HCI (75 ml of 1 M aqueous solution). The aqueous layer was 
extracted with CH2Cl2 (3 x 150 ml) and the combined organic layers washed with water (1 
x 100 ml) then dried (MgSO4), filtered and concentrated under reduced pressure to give a 
light-yellow oil. Subjection of this material to flash chromatography (silica gel, 1 :1 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rt = 0.4) 
afforded the title compound (9) (10.4 g, 83%) as a clear, colourless oil, [cx]o = -5.7 (c 
1.2) [Found: (M-H·)+, 143.1070. C8H15O2 requires (M-H·)+, 143.1072]. vmax 3368, 
3077, 2962, 2928, 1640, 1458, 1380, 1073, 995, 909 and 880 cm- 1 . 1 H n.m.r. 8 
5.78 (m, 1 H), 5.03-4.88 (complex m, 2H), 3.70-3.60 (complex m, 1 H), 3.53-3.40 
(complex m, 2H), 3.20 (br s, 2H), 2.20-2.08 (complex m, 1 H), 2.05-1.90 (complex m, 
1H), 1.70-1.54 (complex m, 2H), 1.29-1.18 (complex m, 1H) and 0.88 (d, J = 7.0 Hz, 
3H). 1 3c n.m.r. 8 138.8 (CH), 114.5 (CH2), 76.1 (CH), 64.6 (CH2), 35.5 (CH), 31.6 
(CH2), 31.1 (CH2) and 15.1 (CH3). Mass spectrum m/z 145 [3%, (M +H)+], 144 (3, 
M+·), 143 [2, (M -H·)+], 95 (100) and 71 (53). 
t 
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{2S, 3S )-3-Methyl-6-heptene-1 ,2-diol Oiaceta te (10). 
A magnetically stirred solution of diol (9) (5.54 g, 38.5 mmol) in pyridine (21 ml) was 
treated with acetic anhydride (12.7 ml, 134 mmol) and 4-(N,N-dimethylamino)pyridine 
(10 mg, 0.08 mmol). The resulting mixture stirred at 18 °C for 3 h then poured onto ice 
(ca. 50 g) and extracted with ether (1 x 100 ml). The separated organic phase was washed 
with HCI (2 x 20 ml of a 1 M aqueous solution), NaHCO3 (2 x 20 ml of a saturated aqueous 
solution) and brine (1 x 20 ml) then dried (MgSO4) , filtered and concentrated under 
reduced pressure to give a light-yellow oil. Subjection of this material to flash 
chromatography (silica gel , 3:7 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.7) afforded the title compound (10) (8.40 g, 96%) as a 
clear, colourless oil , [cx]o = +5 .24 (c 1.3) [Found : (M+H)+ , 229.1440. C12 H 200 4 
requires (M+H)+ , 229.1440]. Ymax 2973 , 2937 , 1744, 1641 , 1458, 1371 , 1227, 
1048, 1020, 913 and 605 cm-1. 1 H n.m .r. 8 5.76 (m , 1 H), 5 .03-4.90 (complex m, 
3H) , 4.27 (dd, J = 12.0 and 3.0 Hz, 1 H) , 4.05 (dd , J = 12.0 and 4.2 Hz, 1 H), 2.15-1.90 
(complex m, 2H), 2.06 (s, 3H) , 2.03 (s , 3H) , 1.85-1.73 (complex m, 1 H) , 1.50 (m , 
1 H), 1.23 (m, 1 H) and 0.92 (d , J = 6.9 Hz, 3H). 13c n.m.r. 8 170.8 (C) , 170.6 (C) , 
138.2 (CH) 114.8 (CH2), 74.9 (CH), 63.6 (CH2) , 33.6 (CH) , 31 .3 (CH2) , 31.0 (CH2) , 
21.0 (CH3), 20.9 (CH3) and 15.0 (CH3). Mass spectrum m/ z 229 [2% , (M+H)+], 213 
[24, (M -H3C·)+], 115 (76), 114 (78) , 108 (90) , 95 (100) , 93 (96) and 79 (70). 
[S -(R *, R *) J-5, 6-bis ( Ace tyloxy )-4-me thy/ hexenal ( 11) . 
A magnetically stirred solution of diacetate (10) (10 .50 g, 45 .65 mmol) in CH2Cl 2 (575 
ml) was cooled to -78 °C then treated with a stream of ozone gas until a blue colour 
persisted. The reaction mixture was then warmed to -30 °C and triphenylphosphine (12.0 
g, 45.65 mmol) was carefully added in portions . After the addition was complete , the 
reaction mixture was allowed to warm to room temperature. The solvent was then removed 
under reduced pressure and the residue there-by obtained was subjected to flash 
chromatography (silica gel, 3:7 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.3) gave the title compound (11 )9 (8.40 g, 79%) as a pale-
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yellow oil, [a]o = +7.3 (c 2.0 in MeOH) [Found: (M+H)+, 231.1232. Calcd for 
C11H18O5 (M+H)+, 231.1232]. vmax 2967, 2727, 1744, 1371, 1227, 1048, 959 
and 605 cm- 1. 1 H n.m.r. 8 9.77 (s, 1 H), 4.94 (m, 1 H), 4.31 (dd, J = 12.1 and 2.9 Hz, 
1 H), 4.05 (dd, J = 12.1 and 6.8 Hz, 1 H), 2.60-2.30 (complex m, 2H), 2.07 (s, 3H), 
2.04 (s, 3H), 1.90-1.72 (complex m, 2H), 1.54-1.44 (complex m, 1 H) and 0.93 (d, J = 
6.8 Hz, 3H). 13c n.m.r. 8 201.8 (CH), 170.8 (C), 170.6 (C), 74.5 (CH), 63.4 (CH2), 
41.2 (CH2), 33.5 (CH), 24.1 (CH2), 21.0 (CH3), 20.8 (CH3) and 15.1 (CH3); Mass 
spectrum m/z 231 [15%, (M+H)+], 115 (60), 103 (53), 97 (100) and 84 (48). 
Meth y I {S -[R *, R * - (Z ) }} - 7, 8 -bis ( A c e t y Io x y) -6 -me thy I -2-o ct en o a t e ( 1 2). 
KN(TMS)2 (73.0 ml of a 0.5 M solution in toluene, 36.5 mmol) was added, dropwise, to a 
magnetically stirred solution of bis (2, 2, 2-
trifluoroethyl)(methoxycarbonylmethyl)phosphon -ate (7.73 ml, 36.5 mmol) and 18-
crown-6/CH3CN complex23 (48.3 g, 183 mmol) in dry thf (140 ml) maintained at -78 
~C under an atmosphere of nitrogen. The reaction mixture was stirred at -78 °C for 0.5 h 
then treated with aldehyde (11) (8.4 g, 36.52 mmol). After 1 h at this temperature, the 
reaction mixture was quenched with NH4CI (60 ml of a saturated aqueous solution) then 
allowed to warm to room temperature. The resulting mixture was extracted with ether (3 x 
50 ml) and the combined organic phases were washed with water (1 x 100 ml) then dried 
(MgSO4), filtered and concentrated under reduced pressure. Subjection of the material thus 
obtained to flash chromatography (silica gel, 3:7 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.4) afforded the title ester (12)9 (8.35 
g, 80%) as a pale-yellow oil, [a]o = +9.9 (c 5.4) [Found: (M+H)+, 287.1495. Calcd for 
C14H22O5 (M+H)+, 287.1495]. vmax 2953, 1743, 1645, 1439, 1371, 1226, 1176, 
1048 and 821 cm-1. 1 H n.m.r. 8 6.18 (m, 1 H), 5.78 (br. d, J = 11.5 Hz, 1 H), 4.95 (td, 
J = 6.8 and 2.9 Hz, 1 H), 4.29 (dd, J = 12.0 and 2.9 Hz, 1 H), 4.06 (dd, J = 12.0 and 7.1 
Hz, 1 H), 3.70 (s, 3H), 2.68 (m, 2H), 2.07 (s, 3H), 2.04 (s, 3H), 1.82 (m, 1 H), 1.65-
1.50 (complex m, 1 H), 1.35-1.20 (complex m, 1 H) and 0.96 (d, J = 7.0 Hz, 3H). 13c 
n.m.r. 8 170.8 (C), 170.6 (C), 166.7 (C), 149.8 (CH), 119.7 (CH), 74.9 (CH3), 63.5 
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(CH2), 51.0 (CH), 33.9 (CH), 31.3 (CH2), 26.3 (CH2), 21.0 (CH3), 20.8 (CH3) and 
15.0 (CH3). Mass spectrum m/z 287 [5%, (M+H)+], 166 (52), 153 (70), 139 (100), 
107 (74) and 81 (90). 
Methyl {2R-(2a,5f3,6a)J-Tetrahydro-6-(hydroxymethy/)-5-methyl-2H -pyran-2-
acetate (13). 
A mixture of ester (12) (8.35 g, 29.20 mmol), K2CO3 (20.2 g, 146 mmol) and methanol 
(42 ml) was stirred at 18 °C for 24 h then filtered through a sintered glass funnel. Water 
(100 ml) was added to the filtrate which was acidified to pH 2-3 with HCI (concentrated 
aqueous solution). The resulting mixture was extracted with diethyl ether (3 x 50 ml) and 
the combined extracts dried (MgSO4), filtered and then concentrated under reduced 
pressure. The light-yellow oil obtained in this manner was suspended in methanol (50 ml) 
containing H2SO4 (six drops of 98% acid) and the resulting mixture stirred at 18 °C for 
16 h then poured onto ice (50 g) and extracted with diethyl ether (3 x 50 ml). The 
combined organic extracts were washed with NaHCO3 (1 x 50 ml of a saturated aqueous 
solution) then dried (MgSO4), filtered and concentrated under reduced pressure to afford a 
light-yellow oil. Subjection of this material to flash chromatography (silica gel, 3:7 v/v 
ethyl acetate/hexane elution) and concentration of the appropriate fractions (Rt = 0.25) 
afforded the title compound (13)9 (4.18 g, 71 %) as a clear colourless oil, [cx]o = +9.8 (c 
1.0) {lit.2 (a]o = +9.4} [Found: (M -H2O)+·, 184.1097. Calcd for C1oH18O4 ( M 
-H2O)+·, 184.1099). vmax 3458, 2928, 2873, 1738, 1437, 1199, 1087 and 1019 
cm-1. 1 H n.m.r. 8 3.80-3.63 (complex m, 2H), 3.65 (s, 3H), 3.47 (ddd, J = 11.4, 7.1 
and 4.3 Hz, 1 H), 3.10 (ddd, J = 9.8, 7.1 and 2.7 Hz, 1 H), 2.53 (dd, J = 15.2 and 7.7 Hz, 
1 H), 2.40 (dd, J = 15.2 and 5.4 Hz, 1 H), 2.21 (dd, J = 8.2 and 4.4 Hz, 1 H), 1.80-1.72 
(complex m, 1 H), 1.70-1.60 (complex m, 1 H), 1.48-1.12 (complex m, 3H), and 0.80 
(d, J = 6.5 Hz, 3H). 13c n.m.r. 8 171.6 (C), 83.5 (CH), 74.0 (CH), 63.7 (CH2), 51.6 
(CH3), 41.1 (CH2), 32.1 (CH2), 31.5 (CH2), 31.1 (CH) and 17.1 (CH3). Mass spectrum 
mlz 203 [26%, (M+H)+], 171 (100, (M -H3 CO-)+], 139 (73), 129 (57) and 97 
( 5 4). 
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Methyl [2R -(2a, 5/3, 6a)}-6-Formyltetrahydro-5-methyl-2H -pyran-2-acetate (14). 
A solution of alcohol (13) (1.0 g, 4.95 mol) and triethylamine (4.5 ml, 32.1 mmol) in 
CH2Cl2 (14.2 ml) was added, dropwise, to a magnetically stirred solution of sulfur 
trioxide/pyridine complex (2.52 g, 15.8 mmol, ex ALDRCH) in DMSO/CH2Cl2 (15.6 ml of 
a 3:2 v/v mixture) maintained at O °C (ice-bath) under a nitrogen atmosphere. The 
reaction mixture was warmed to 18 °C and after stirring for a further 1 h it was treated 
with water (130 ml) then extracted with hexane (3 x 75 ml). The combined organic phases 
were washed with brine (1 x 50 ml) then dried (MgSO4), filtered and concentrated under 
reduced pressure. The light-yellow oil thus obtained was subjected to flash chromatography 
(silica gel, 3:7 v/v ethyl acetate/hexane elution) and concentration of the appropriate 
fractions (Rt = 0.4) then afforded the title compound (14)9 (594 mg, 60%) as a clear 
colourless oil, [a]o = -65 (c 0.45) {lit. 2 [a]o = -62 (c 0.5 in CHCl3 )} [Found: (M 
-CHO·)+, 171.1020. Calcd for C10H15O4 (M -CHO·)+, 171.1021). vmax 2932, 1740, 
1437, 1200, 1090, 1021 and 857 cm-1. 1 H n.m.r. 8 9.51 (d , J = 2.3 Hz, 1H), 3.80 (m , 
1 H), 3.67 (s, 3H), 3.41 (dd, J = 10.6 and 2.3 Hz, 1 H) , 2.61 (dd , J = 15.4 and 7.6 Hz, 
1H), 2.44 (dd, J = 15.4 and 5.4 Hz, 1H), 1.88 (m , 1H) , 1.70 (m , 1H), 1.64-1 .50 
(complex m, 1 H), 1.45-1.20 (complex m, 2H) , 0 .91 (d , J = 6.6 Hz, 3H) . 13c n.m.r. 8 
200.6 (CH), 171.4 (C), 86.7 (CH), 73.5 (CH) , 51 .7 (CH3), 41.0 (CH2), 32 .1 (CH2) , 
30.8 (CH2), 30.5 (CH) and 16.3 (CH3). Mass spectrum m/z 201 [14%, (M+H)+], 171 
[100, (M -CHO·)+], 139 (88), 127 (52), 111 (57), 97 (88), 81 (57) and 69 (59). 
Methyl [2R-(2a,5f3,6a)J-6-Acetyltetrahydro-5 -methyl-2H -pyran -2 -acetate (15). 
Methylmagnesium chloride (0 .83 ml of a 3 M solution in thf, 2.5 mmol) was added , 
dropwise, to a magnetically stirred solution of aldehyde (14) (500 mg , 2.5 mmol) in thf 
(12.5 ml) maintained at -78 °C under a nitrogen atmosphere. After addition was complete 
the reaction mixture was allowed to warm to O °C then stirred at this temperature for a 
further 1 h then poured onto a mixture of ice (ca. 20 g) and NH4CI (20 ml of a saturated 
aqueous solution). The resulting mixture was extracted with ether (3 x 20 ml) and the 
combined organic phases washed with water (1 x 30 ml) then dried (MgSO4) , filtered and 
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concentrated under reduced pressure to afford a light-yellow oil (190 mg). Subjection of 
this material to flash chromatography (silica gel, 3:7 v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (Rf = 0.3) afforded the expected mixture of 
diastereoisomeric 2°-alcohols as a clear, colourless oil. This material was dissolved in 
CH 2Cl2 (8.0 ml) and the resulting solution treated with the Dess-Martin periodinane 1 7 
(560 mg, 1.32 mmol). The mixture thus obtained was stirred at 18 °C for 1 h then diluted, 
successively, with diethyl ether (10 ml), NaHCO3 (5 ml of a saturated aqueous solution) 
and Na2S2O3 (5 ml of a 1 M aqueous solution). Stirring was continued until two layers 
became apparent. The separated aqueous phase was extracted with diethyl ether (3 x 10 
ml) and the combined organic phases were washed with brine (1 x 10 ml) then dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting light-yellow oil 
was subjected to flash chromatography (silica gel, 3:7 v/v ethyl acetate/hexane elution) 
and concentration of the appropriate fractions (Rf = 0.3) then afforded the title compound 
( 15)9 (90 mg, 17%) as a clear colourless oil [a]D = -91 (c 1.2) {lit.2 [a]D = -95 (c 
1.5 in CHCl3)} [Found: (M+H)+, 215.1282. Calcd for C11H18O4 (M+H)+, 215.1283]. 
vmax 2931, 1741, 1719, 1437, 1354, 1199, 1083, 1022 and 894 cm- 1. 1H n.m.r. 8 
3.78 (m, 1H), 3.67 (s, 3H), 3.41 (d, J = 10.2 Hz, 1H), 2.57 (dd, J = 15.1 and 7.6 Hz, 
1H), 2.44 (dd, J = 15.1 and 5.4 Hz, 1H), 2.14 (s, 3H), 1.87 (m, 1H), 1.72-1.67 
(complex m, 1 H), 1.60-1.18 (complex m, 3H) and 0.82 (d, J = 6.6 Hz, 3H). 13c n.m.r. 8 
207.9 (C), 171.5 (C), 89.0 (CH), 73.7 (CH), 51.7 (CH3), 41.1 (CH2), 32.2 (CH2), 
31.8 (CH3), 31.1 (CH2), 25.8 (CH) and 16.9 (CH3). Mass spectrum m/z 215 [5%, 
(M+H)+], 171 [100, (M -CH3CO·)+], 139 (95), 111 (61) and 97 (92). 
Methyl {2R -[2a,5(3,6a(E)}-6-(3-Bromo-1-methy/-1-propenyl)tetrahydro-5-
methyl-2H -pyran-2-acetate (16). 
Vinylmagnesium bromide (1.6 ml of a 1 M solution in thf, 1.58 mmol, ex ALDRICH) was 
added, dropwise, to a magnetically stirred solution of ketone (15) (339 mg, 1.58 mmol) in 
thf (65 ml) maintained at -78 QC under a nitrogen atmosphere. The resulting mixture was 
stirred at -78 QC for a further 1 h then warmed to O QC, poured into NH4CI (25 ml of a 
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saturated aqueous solution) and extracted with diethyl ether (3 x 50 ml) . The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure to 
give a light-yellow oil (203 mg) which was subjected to flash chromatography (silica gel, 
1 :4 v/v ethyl acetate/hexane elution). Concentration of the appropriate fractions (Rt = 
0.3) then afforded the expected vinyl alcohol which was immediately subjected to the 
brominative rearrangement reaction. Thus, PBr3 (50 µI, 0.5 mmol) was injected , v,a 
syringe, into a magnetically stirred solution of the vinyl alcohol (100 mg, 0.41 mmol) in 
diethyl ether (10 ml) maintained at 0 °C under a nitrogen atmosphere. After the addition 
was complete, the reaction mixture was stirred at 0 °C for a further 1 h and then poured 
onto ice (ca. 10 g). The resulting mixture was extracted with diethyl ether (1 x 30 ml) and 
the separated organic phase dried (MgSO4), filtered and concentrated under reduced 
pressure to give a light-yellow oil. Subjection of this material to flash chromatography 
(silica gel, 1 :4 v/v ethyl acetate/hexane elution) afforded, after concentration of the 
appropriate fractions (Rt = 0.3), the title bromide (16) 9 (117 mg , 93%) as a clear, 
colourless oil, [cx]o = -29 (c 2.1) {lit. 9 [cx]o = -5 .2 (c 1.5 in CHCl3)} [Found: (M 
-Br-)+ , 225.1495. Calcd for C13H21BrO3 requires (M -Br-)+ , 225.1491]. v max 2951 , 
2926, 1740, 1436, 1200, 1069, 1019 and 865 cm -1. 1 H n.m.r. 8 5.69 (t , J = 9.0 Hz, 
1 H), 4.00 (m, 2H), 3.80-3.70 (complex m, 1 H) , 3.66 (s , 3H) , 3.35 (d , J = 9.8 Hz, 
1 H), 2.58 (dd, J = 15.2 and 6.5 Hz, 1 H), 2.40 (dd , J = 15.2 and 6.5 Hz, 1 H) , 1.90-1 .80 
(complex m, 1 H), 1.69 (s , 3H), 1.70-1.65 (complex m, 1 H), 1.62-1.47 (complex m, 
1 H), 1.40-1.15 (complex m, 2H) and 0.71 (d , J = 6.7 Hz, 3H) . 13c n.m.r. 8 171.7 (C) , 
141.5 (C), 123.9 (CH) , 89.5 (CH), 73.8 (CH) , 51 .6 (CH3), 41 .2 (CH2), 32.3 (CH) , 
32.2 (CH2) , 31.5 (CH2), 28.2 (CH2), 17.4 (CH3 ), 11.5 (CH3). Mass spectrum m/z 224 
[8%, (M -Br-)+] and 121 (100) . 
Methyl {2R -[ 2 a, 5 /3 , 6 a (E)} - 6-[ 3- (dip hen y Ip hosp hi no y I) - 1 - met h y /- 1 -
propenyl]tetrahydro-5-methy/-2H -pyran-2-acetate (2) . 
A magnetically stirred solution of bromide (16) (100 mg , 0.33 mmol) and 
diphenylethoxyphosphine (143 µI, 0.66 mmol, ex ALDRICH) in thf (10 ml) was heated at 
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reflux until the starting materials had been consumed (ca. 2 h). The cooled reaction mixture 
was concentrated under reduced pressure and the resulting solid recrystallised (diethyl 
ether) to give the phosphine oxide (2)9 (119 mg, 85%) as a fine white powder, m.p. = 
125-126 °C (lit. 9 m.p. = 125-126 °C), [a]o = -0.4 (c 1.4) {lit.9 [a]o -32.8 (c 0.5 in 
CHCl3) - see text} (Found: M+·, 426.1962. Calcd for C25H31O4P requires M+·, 
426.1960). vmax (KBr disc) 2924, 2847, 1736, 1437, 1180, 1120, 1069, 1018, 
745, 719, 697, 555 and 512 cm-1. 1 H n.m.r. 8 7.74 (m, 4H), 7.50 (m, 6H). 5.50 (m, 
1 H), 3.72-3.60 (complex m, 1 H), 3.63 (s, 3H), 3.26 (d, J = 9.7 Hz, 1 H), 3.23-3.10 
(complex m, 2H), 2.54 (dd, J = 15.1 and 6.5 Hz, 1 H), 2.37 (dd, J = 15.1 and 6.4 Hz, 
1H), 1.80-1.55 (complex m, 2H), 1.47 (s, 3H), 1.45-1.10 (complex m, 3H) and 0.42 
(d, J = 6.6 Hz, 3H). 13c n.m.r. 8 171.7 (C), 140.0 (d, C), 133.2 (d, C), 131.9 (CH), 
131.0 (d, CH), 128.5 (d, CH), 116.9 (d, CH), 90.0 (CH), 73.8 (CH), 51.5 (CH3), 41.3 
(CH2), 32.1 (CH2), 32.0 (CH3), 31.5 (CH2), 30.7 (d, CH2), 17.2 (CH), 12.2 (CH3) [d 
= doublet due to 13c_31 P coupling]. 31 P n.m.r. 8 31.0. Mass spectrum m/z 426 (51 %, 
M+·), 202 [100, (Ph2POH)+·] and 201 [94, (Ph2PO)+]. 
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